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C-Type Natriuretic Peptide (CNP) is an important neuroendocrine regulator, suggested to be 
involved with cognitive decline and pathological aging. From the literature, and based on 
pilot work contributing to a Master’s Thesis, three questions were identified for investigation 
regarding a putative involvement of CNP in age-related cognitive decline. 1) Do CNP and its 
related signalling system vary in cerebral tissue during normal brain aging? 2) Could an 
involvement of CNP activity be identified in relation to a rodent model of spatial/episodic-
like learning and memory? 3) What effects would administration of CNP have on rodent 
models of working, object and location recognition memory? During investigation of this 
final question, rodents were identified as cognitively impaired. 
Question one was addressed by housing aged rodents (23 months old) in an enriched 
environment, previously indicated as useful for modifying endogenous CNP expression and 
degradative regulation in young (8 to 9-month-old) rats. Response of CNP and related 
markers to this manipulation was markedly different in aged rats compared with young 
rodents. Data acquired indicated CNP synthesis and regulation to be dysfunctional within 
hippocampus and retrosplenial cortex during aging, identifying CNP as a novel target in age-
related cognitive decline. 
A study using a radial arm maze task of spatial reference memory was designed to 
address question two. For rodents learning a spatial reference task, CNP synthesis was 
increased in retrosplenial cortex and mammillary bodies during memory consolidation. In a 
second group, interference was introduced to the reference memory component by use of a 
forced-arm choice, yoked to rodents learning the spatial reference memory task. Increases in 
CNP synthesis were restricted to mammillary bodies in this group. Rodents in both 
behaviourally trained groups and a third control group (accounting for effects of 
environmental conditions) had reduced CNP concentrations in hippocampus compared with 
previous reports, suggesting an effect of food-deprivation on central CNP activity. Findings 
provided the first indication that endogenous CNP activity is modified during 
spatial/episodic-like memory formation, commonly impaired in cognitive disorders. 
As working memory, object recognition and memory ‘pattern separation’ are 
impaired during cognitive decline, the final question was addressed by investigating effects 
of infused CNP in rodent models of each. A working memory task (radial arm maze) was 
negatively affected by behavioural outcomes of CNP infusion, resulting in inclusion of a 
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rodent model testing anxiety (elevated plus maze). Object recognition was examined using a 
standard novel-object recognition paradigm, with pattern separation tested using a recent 
adaptation of spontaneous location recognition (Bekinschtein et al., 2014). Hypothesising that 
CNP would increase anxiety, decrease locomotion and interfere with recognition memory in 
a dose-dependent manner, doses ranging from 200 to 1000ng were administered (icv) prior to 
each task in a repeated-measures design. Contrary to the hypothesis, locomotion increased 
across increasing doses of CNP, an effect that was attenuated across multiple tasks, as were 
anxiogenic effects of the peptide. In line with the hypothesis, CNP interfered with recognition 
memory dose dependently in a spontaneous location recognition task with low pattern 
separation load. However, recognition memory was facilitated when pattern separation load 
was high. Dose-dependent effects on recognition were no longer apparent during novel object 
recognition, but recognition (measured by discrimination ratio) was overall improved 
compared with previous tasks. Immunohistochemistry for cyclic Guanosine Monophosphate 
(cGMP; directly stimulated by CNP) provided supporting evidence for attenuation of 
behavioural effects across chronic administrations, and indicated bidirectional effects of CNP 
on memory may relate to variable cGMP stimulation in frontal cortical regions. Taken 
together, results of this study provide the first experimental evidence that CNP can variably 
affect memory acquisition, but may overall improve memory deficits within a rodent model 
of cognitive decline. 
Several novel findings of this thesis present interesting implications regarding the role 
of CNP and its signalling system in relation to aging, memory and anxiety. Additionally, 
identification of dysregulation of this system during aging, partly accounted for by 
modifications to the Natriuretic Peptide C receptor, introduces theoretical considerations for 
Natriuretic Peptide research at large. Combined, investigations presented here point to a 
special relationship between CNP and retrosplenial cortex. This suggests CNP not only as a 
novel target in cognitive decline, but also for ongoing research within intersecting neural 
systems for incorporating sensation and emotion into memory. 
Keywords: C-type natriuretic peptide, CNP, NTproCNP, NPR-C receptor, aging, age-related 
cognitive decline, spatial memory, recognition memory, pattern separation, retrosplenial 
cortex, hippocampus, frontal cortex, rodents 
 
 
Chapter 1. General Overview 
C-type Natriuretic Peptide (CNP) is the primitive, but most recently discovered member of 
the Natriuretic Peptide family. Since its description, multiple biological actions have been 
identified for CNP, many of which are related to cellular growth and development. CNP is 
the major neuroactive peptide of the Natriuretic family, thus far exhibiting a critical role in 
nervous system development, neuroprotective activity, and modulatory actions in connection 
to food and fluid intake, response to drug administration and anxiety regulation. Recently, a 
contribution to memory formation has been posited, with several studies supporting this 
hypothesis. Though it has been nearly 30 years since its discovery, research regarding CNP 
still lags compared with other natriuretic peptides, A- and B-types. In particular, there is a 
paucity of research regarding memory and behavioural associations with CNP activity. 
Relatively well established biological activity of the CNP signalling pathway has 
indicated an involvement in regulation of multiple neurological activities including various 
neuroendocrine systems. In turn, CNP has been identified as a potential therapeutic target for 
neurological and psychiatric disorders, but much about this peptide remains to be understood. 
Beyond a possible contribution to memory acquisition and consolidation, CNP has become of 
interest where these functions intersect with clinical conditions. In addition to a possible 
functional role for CNP in learning, contributions to memory dysfunction have been 
suggested in cases of neurodegenerative disorders and general age related cognitive decline. 
To date, no experimental work had examined CNP specifically in this context.  
1.1 Aims of the current work 
Given the scarcity of behavioural studies involving CNP, and its relationship to memory, the 
primary aim of this thesis was a novel contribution to this small body of research. To date, 
there are two major experimental findings: CNP improves the acquisition and consolidation 
of passive avoidance memory (Telegdy, Adamik, & Glover, 2000; Telegdy, Kokavszky, & 
Nyerges, 1999) and reductions in CNP signalling improve object recognition (Barmashenko 
et al., 2014). Building from these, and initial work towards a Master’s Thesis (Rapley, 2012, 
unpublished Master’s Thesis), this thesis originally intended to examine CNP in rodent 
models of spatial/episodic-like memory and working memory. Whereas examination of CNPs 
influence on working memory was negatively impacted by anxiogenic effects of CNP, a 
resulting study examined the peptide in relation to spontaneous location recognition and 
“pattern separation” of memory. 
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Localisation of CNP gene expression, and that of its specific receptor (Natriuretic 
Peptide Receptor-B; NPR-B) has been relatively well described in brain and central nervous 
system. Several studies have examined CNP concentrations within cerebrospinal fluid (CSF) 
and hypothalamus of multiple species, with remarkably consistent results (Jankowski, Reis, 
Wang, & Gutkowska, 2004; Komatsu et al., 1991; Pemberton, Yandle, & Espiner, 2002; 
Totsune et al., 1994; Wilson, McNeill, Barrell, Prickett & Espiner, 2017). Though not strictly 
part of central nervous system, the pituitary gland has also drawn special interest from CNP 
researchers, with high concentrations of CNP consistently found therein (Pemberton et al., 
2002; Yandle, Fisher, Charles, Espiner, & Richards, 1993). Despite multiple reports outlining 
localisation of the CNP signalling system, there is a dearth of data regarding peptide or 
regulatory changes during specific behavioural conditions, including learning and memory. A 
secondary aim of this thesis was to provide these measures throughout select regions of 
rodent brain.  
Though CNP has been well studied in the developing nervous system, no work has 
considered it within the aging brain. Given recent suggestions that CNP may provide a novel-
target in cognitive decline and age-related pathologies (Mahinrad, de Craen, Yasar, van 
Heemst, & Sabayan, 2016), this presents a major gap in the literature. In addition to 
describing the CNP signalling system within aging cerebral tissue, this thesis also provides 
comparison of CNP response to an enriched environment between young and aged rodents. 
The general aim of this thesis, was to investigate CNP as a novel target influencing 
learning and memory that may contribute to cognitive impairment. 
1.2 Outline of Thesis 
In Chapter Two, I review literature regarding CNP, describe its actions within central nervous 
system, and outline research in regarding potential roles in regulating behaviour. Special 
focus is then given to research examining CNPs relationship to memory and neurological 
disorder. A potential role in age-related cognitive decline is described, providing rationale for 
the thesis. Chapters Three, Four and Five describe experimental contributions. A general 
discussion outlines major contributions of the thesis, addresses theoretical considerations, 
general limitations and directions for future work. 
 
 
Chapter 2. Literature Review 
2.1 Natriuretic Peptide Signalling System 
CNP was originally isolated from porcine brain tissue, and demonstrated similarity in 
structure to previously described A-type Natriuretic Peptide (ANP) and B-type Natriuretic 
Peptide (BNP; Sudoh, Minamino, Kangawa, & Matsuo, 1990). Specifically, the family shares 
a ring structure consisting of 17 amino acid residues, flanked by two cysteine residues which 
form a disulfide bond that is critical to biological activity (Pandey, 2005; Potter, Abbey-
Hosch, & Dickey, 2006). ANP and BNP share a common binding site (Natriuretic Peptide 
Receptor A; NPR-A; (Koller et al., 1991; Potter, 2011; Potter et al., 2006) and all NPs bind to 
a common clearance receptor, Natriuretic Peptide Receptor-C (NPR-C) with similar affinity 
(Pandey, 2005; Potter, 2011; Potter et al., 2006). However, CNP represents a unique member 
of the Natriuretic family. CNP has a specific receptor, Natriuretic Peptide Receptor B (NPR-
B) through which it exerts biological activity (Pandey, 2005; Potter, 2011; Potter et al., 
2006). Additionally, CNP has been identified as the oldest member of the NP family, with 
duplications of early CNP genes resulting in those for ANP and BNP (Inoue & Takei, 2006). 
Whereas ANP and BNP genes are located on chromosome 1 in humans, the NPPC 
(Natriuretic Peptide Precursor C) gene is located on chromosome 2 (Tawaragi et al., 1990). 
CNP-22 (the ‘mature’ active form of CNP) is the most highly conserved NP, has been 
identified in primitive species, and is identical in rodents, pigs and humans (Inoue et al., 
2003; Inoue & Takei, 2006; Pandey, 2005; Potter, 2011; Tawaragi et al., 1990).  
Expression of the NPPC gene results in three forms of the peptide. NPPC codes for an 
initial 126 residue precursor, preproCNP (Tawaragi et al., 1990) with further processing 
generating a 103 residue proCNP. This is then cleaved intracellularly to produce CNP-53 
which is secreted extracellularly with a biologically inactive amino terminal fragment, 
NTproCNP, in equimolar amounts (T C R Prickett & Espiner, 2012; Wu, Wu, Pan, Morser, 
& Wu, 2003). Further extracellular processing results in CNP-22. This process is summarised 
in Figure 2.1 (From Prickett & Espiner, 2012). CNP-22 is thought to be the fully active form 
of the peptide with CNP-53 proposed as a storage form (Barr, Rhodes, & Struthers, 1996). 
This is supported by high concentrations and differing regulation of the peptide within 
pituitary (Yandle et al., 1993; Wilson et al, 2017) and overlapping but distinct distribution 
patterns of CNP-22 and CNP-53 (Pemberton et al., 2002; Yandle et al., 1993). Regulation of 
NPPC expression has not been widely studied, but recent work from Professor Espiner’s 
research group shows it is upregulated in several nervous system tissues by dexamethasone, 
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indicating endogenous stimulation by glucocorticoids (Wilson et al, 2017). Experimental 
work in this thesis focusses on CNP-22 as the assumed major neuroactive form. 
 
Figure 2.1: Processing of CNP prohormone (proCNP) resulting in an amino terminal 
fragment (NTproCNP) and two active forms of peptide. From Prickett & Espiner (2012). 
Following expression and processing, NPs bind with NPR-A (ANP and BNP), NPR-B 
(CNP) or NPR-C (clearance) receptors. All three receptors exhibit strong homology, but 
NPR-C lacks intracellular domains (Potter, 2011). NPR-A and NPR-B consist of an 
extracellular ligand binding domain, a transmembrane region, and intracellularly, kinase 
homology and guanylyl cyclase catalytic domains (Potter, 2011; Potter et al., 2006). Binding 
with these receptors results in an increase of cyclic Guanosine Monophosphate (cGMP). 
NPR-C, the so-called “clearance” receptor, binds all NPs and clears them from the 
extracellular space via internalisation and degradation (Potter, 2011). Although nomenclature 
as the clearance receptor has persisted, some work indicates NPR-C may have a functional 
role beyond this, potentially acting through adenylyl cyclases to elevate cyclic adenosine 




All NPs and both active forms of CNP (22 and 53) stimulate cGMP (Potter, 2011; 
Potter et al., 2006; Yeung, Ho, Nicholls, & Cockram, 1996). As a second messenger, cGMP 
exerts biological activity by binding to cGMP gated ion channels, activating cGMP 
dependent protein kinases or regulating phosphodiesterases, each resulting in different cell 
signalling outcomes (Potter et al., 2006). Previous research implicates cGMP in multiple 
neural regulatory functions, including neurotransmitter release, long-term potentiation, 
neurodegeneration, and behaviour such as working memory and anxiety (see Boess et al., 
2004; Wang & Robinson, 1997; Wincott et al., 2014). While most research relating cGMP 
with these functions has focussed on stimulation by nitric oxide, associations with CNP in 
these regulatory roles have also been identified, and are outlined in later sections.  
The NP signalling system is additionally regulated by several proteolytic enzymes. 
Both CNP and ANP undergo proteolysis by neprilysin and insulin degrading enzyme (Potter, 
2011). While both peptides can be degraded by both enzymes, neprilysin preferentially 
degrades CNP, and ANP is the preferred substrate for insulin degrading enzyme (Kenny, 
Bourne, & Ingram, 1993; Muller, Schulze, Baumeister, Buck, & Richter, 1992; Potter, 2011, 
p. 1812; Watanabe, Nakajima, Shimamori, & Fujimoto, 1997). Interestingly, human BNP is 
more resistant to neprilysin degradation and is degraded by another metalloendopeptidase, 
meprin A (Pankow et al., 2007; Smith, Espiner, Yandle, Charles, & Richards, 2000). Figure 
2.2 provides a schematic of CNP binding sites and degradative activity.  
Regulation of NP receptor activity may be influenced by several other molecules, but 
these have been little studied. Gö6976 (an indolocarbazole) inhibits both NPR-A and NPR-B 
activity, while the endogenous indole (which is not bound to a carbazole) isatin can inhibit 
NPR-A activity and interfere with behavioural effects of infused CNP (Medvedev, Sandler, & 
Glover, 1999; J. W. Robinson, Lou, & Potter, 2011; Telegdy et al., 2000). A microbial 
polysaccharide – HS-142-1 – inhibits NPR-A and NPR-B activity allotopically, and can 
abolish electrophysiological effects of CNP (J M Decker et al., 2009; Poirier, Labrecque, 
Deschenes, & DeLean, 2002). The bioactive lipid, Sphingosine-1-Phosphate, is reported to be 
a highly potent NPR-B inhibitor and interacts with CNPs actions in fibroblasts and vascular 
smooth muscle (Abbey-Hosch, Cody, & Potter, 2004). In addition, NPR-C has a recently 
discovered endogenous ligand, Osteocrin, which may regulate NP actions on bone growth in 
rodents, but is also present in primate neocortex where it restricts activity dependent dendrite 
growth (Ataman et al., 2016; Moffatt et al., 2007). Of these molecules, Osteocrin particularly 
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presents an important consideration for central nervous system tissues where CNP 
degradation and clearance is concerned, especially in human and primate studies. 
 
Figure 2.2: CNP binding sites, degradative activity, and eventually affected 
neurotransmitters resulting from increases in cGMP. Adapted from Potter (2011). 
2.1.1 Functions and expression in bodily tissues 
The starkest difference among the major NPs are found in their actions as endocrine peptides. 
Both ANP and BNP are primarily synthesised in the heart, with ANP predominant in the 
atrium, and BNP in the ventricle (Pandey, 2005). ANP and BNP then reach extra-cardiac 
targets via the circulatory system in an endocrine fashion and are readily measurable in 
plasma (Barr et al., 1996; Pandey, 2005; Prickett & Espiner, 2012; Sellitti, Koles, & 
Mendona, 2011). ANP and BNP generally regulate blood pressure and fluid homeostasis, 
earning the title of “cardiac natriuretic peptides” (Espiner, Richards, Yandle, & Nicholls, 
1995; Prickett & Espiner, 2012; Scotland, Ahluwalia, & Hobbs, 2005). In contrast, highest 
concentrations of CNP are found in reproductive tissues, brain tissue and vascular 
endothelium (Pandey, 2005) with minimal expression in the heart (Cameron, Aitken, Ellmers, 
Kennedy, & Espiner, 1996; Langub, Watson, & Herman, 1995). Circulating CNP 
concentrations are low in human, and undetected in rodent (Komatsu et al., 1991; Toshio et 
al., 1996) but can become elevated following septic shock, and during pregnancy in 
ruminants (Hama et al., 1994; McNeill et al., 2009; Prickett et al., 2004; Wilson, Barrell, 
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Prickett, & Espiner, 2015). Low concentrations found in humans and other mammals likely 
follows in part from a short half-life in tissue and plasma (1.6 minutes in sheep and 2.6 
minutes in humans; Charles, Espiner, Richards, Nicholls, & Yandle, 1995; Hunt, Richards, 
Espiner, Nicholls, & Yandle, 1994). Fortunately, NTproCNP (the amino terminal fragment of 
proCNP produced in tissues) is readily identifiable in the circulation and can be used to study 
changes in CNP production under specified conditions (Prickett, Yandle, Nicholls, Espiner, 
& Richards, 2001). However, since multiple tissues express the gene, which contributes to 
circulating NTproCNP remains to be firmly established. 
It is important to note that the concentration of CNP at any time point is a function of 
both production and clearance or degradation rates. Since NTproCNP is not subject to rapid 
degradation or clearance (half-life of 30-40 mins compared with 2-3 minutes for CNP), it 
provides a reliable measure of NPPC gene expression and peptide production (Schouten et 
al., 2011; Woodward, Prickett, Espiner, & Anderson, 2017). Calculation of NTproCNP:CNP 
ratio (by taking NTproCNP/CNP concentrations) provides an index of CNPs clearance or 
degradation in the tissue sampled, either via NPR-C mediated internalisation or hydrolysis by 
neprilysin. Higher ratios reflect increases in the rate of loss of the bioactive form of the 
peptide. Combined measurement of CNP and NTproCNP, with calculation of the ratio, 
allows separate contributions of peptide production and metabolic clearance to be 
determined. 
CNP expression has been described in multiple bodily tissues and is widely accepted 
as acting in a paracrine/autocrine fashion. An important site of CNP production is the 
vascular endothelium. Here, CNP acts locally to regulate vascular tone and blood pressure, is 
vasoprotective following ischaemia/reperfusion injuries, and has been identified as a likely 
endothelium derived hyperpolarising factor (Ahluwalia & Hobbs, 2005; Qian et al., 2002; 
Scotland et al., 2005). These effects may occur through modification of calcium ion 
concentrations and nitric oxide production (Andrade, Restini, Grando, Ramalho, & 
Bendhack, 2014; Qian et al., 2002). CNP additionally regulates circulating immune cells and 
presents a potential therapeutic target in cardiovascular diseases, particularly diabetic 
cardiomyopathy (Abbey-Hosch et al., 2004; Cabiati et al., 2013; Chrisman & Garbers, 1999; 
Christoffersen, Bartels, & Nielsen, 2006; Scotland et al., 2005; Walther et al., 2000). 
Necessity for normal skeletal development is the best demonstrated of CNPs bodily 
functions with overexpression of CNP resulting in skeletal overgrowth, and interference with 
normal signalling leading to reduced stature (Prickett & Espiner, 2012; Tamura et al., 2004). 
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NTproCNP concentrations in plasma relate strongly to markers of bone formation and growth 
velocity in both young sheep and human children (Prickett et al., 2005, 2007; Prickett, Dixon, 
et al., 2008). Additionally, in growth hormone deficient rats, growth hormone treatment 
increases plasma NTproCNP and growth plate CNP, both of which also correlate with linear 
growth velocity (Prickett, Bothwell, Yandle, Richards, & Espiner, 2012). In humans, a loss of 
function mutation in NPR-B results in a specific form of dwarfism, acromesomelic dysplasia 
type Maroteaux (Bartels et al., 2004), and CNP is currently undergoing phase 2 trials as a 
treatment for children with Achondroplasia (clinicaltrials.gov NCT02055157). 
CNP has additionally been implicated in the regulation of several other organ 
systems. In the female reproductive system, CNP is apparently critical to normal 
development (Tamura et al., 2004) and expression therein varies with the estrous cycle in rats 
(Jankowski et al., 1997). Oestradiol increases CNP in both plasma and uterine tissue (Acuff, 
Huang, & Steinhelper, 1997; Prickett, Barrell, et al., 2008). Additionally, in sheep, CNP 
exhibits a strong relationship to both placental and fetal maturation, with synthesis elevated in 
fetal tissues (Mcneill et al., 2009; Prickett, Barrell, et al., 2008). Actions in the male 
reproductive system involve CNP in the central control of penile erection (Tamura et al., 
2004) and testis where the gene is expressed in Leydig cells (Middendorff, Muller, Paust, 
Davidoff, & Mukhopadhyay, 1996). Despite its name, CNP does not contribute to natriuresis 
or diuresis. Nevertheless, it is present in kidney tissue and presents a novel biomarker for 
identifying age-related renal changes (Sangaralingham et al., 2011). CNP not only regulates 
circulating immune cells, but is found throughout immune organs suggesting a general role in 
immune regulation (Vollmar, Gerbes, Nemer, & Schulz, 1993). Recently, CNP has been 
identified throughout the gastrointestinal tract and secretory glands of the digestive system, 
with the suggestion that NPs may participate in both central and local regulation of digestive 
secretion (Cho, Kim, Cho, & Park, 2000; Sabbatini, 2009 for review). Taken together, these 
findings indicate CNP and the NP family to be important regulators of multiple bodily 
functions. 
Juxtaposed with the circulation, CNP is readily detectable in CSF where it is present 
in higher concentrations than either ANP or BNP (Kaneko et al., 1993). NTproCNP and the 
ratio of NTproCNP:CNP are also much higher in CSF compared to plasma (Schouten et al., 
2011). The source of CNP present in the CSF may be closely related neural tissues, but is 
unlikely to be the systemic circulation as, in cases of elevated plasma CNP seen during ovine 
pregnancy, circulating concentrations do not affect those in CSF (Wilson et al., 2015). CNP is 
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reported to be the most potent NP in cerebral microvessels, with strong localisation of NPR-B 
receptors in choroid plexus and the ability to modify blood-brain barrier (Bohara et al., 2014; 
Herman, Dolgas, Rucker, & Langub, 1996; Vigne & Frelin, 1992). Overall, these findings 
indicate CNP to be an important molecule in regulation of both cerebrovascular and CSF 
environments. 
All NPs are found in the central nervous system, but CNP is the most abundant and is 
the major neuroactive member of the family (Kaneko et al., 1993; Langub, Dolgas, Watson, 
& Herman, 1995; Pemberton et al., 2002). As outlined, CNP directly activates cGMP, known 
to have a role in multiple neurological functions. It is also widely accepted that CNP acts in 
an autocrine/paracrine fashion, indicating that production within cerebral tissue results in 
function locally. Within the body, CNP acts as a regulator of development and normal 
function of multiple systems, including the blood-brain barrier. In central nervous system, 
CNP also exhibits growth factor-like and regulatory actions. Although research of CNP in 
brain is still relatively sparse, many biological actions therein have been well described. 
2.2 Biological Activity in Central Nervous System 
CNP is present throughout the central nervous system from its inception. Gene transcripts for 
CNP emerge with the onset of neurogenesis in the dorsal ventricular zone, hindbrain and 
spinal cord (DiCicco-Bloom et al., 2004). Expression in the ventricular zone is notable as a 
location where neurons are undergoing differentiation (DiCicco-Bloom et al., 2004). In 
olfactory neuronal precursors, CNP inhibits proliferation stimulated by BDNF (Brain-
Derived Neurotrophic Factor) and NGF (Nerve Growth Factor), and induces maturation 
(Simpson et al., 2002). Additionally, NPR-B was later shown to be essential for appropriate 
bifurcation of sensory axons within the spinal cord (Schmidt et al., 2007). CNP also 
stimulates axon outgrowth of dorsal root ganglia in culture, and CNP deficient mice lack 
bifurcated branches in sensory afferents (Zhao & Ma, 2009). 
CNP continues to be important in nervous system development postnatally. 
PreproCNP mRNA expression increases throughout rodent brain postnatally, plateauing at 
levels seen in adulthood by postnatal day 28 (Ryan & Gundlach, 1998). Within the 
hypothalamus, CNP concentrations rise steadily postnatally until adulthood (postnatal day 60; 
(Jankowski et al., 2004). Mice lacking the NPR-B receptor demonstrate disorganisation of 
auditory circuits (Lu et al., 2014), and some exhibit tonic-clonic seizures, self-clasping, and 
priapism (Tamura et al., 2004). 
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By adulthood, CNP and NPR-B receptors are widely dispersed throughout central 
nervous system tissues (see Cao & Yang, 2008 for review). In rodents, both CNP and NPR-B 
mRNA occur throughout olfactory bulb, basal forebrain, basal ganglia, limbic cortices, 
thalamus, amygdala, mammillary nuclei, hippocampus, and cerebellum (Herman et al., 1996; 
Langub, Watson, et al., 1995). Within hippocampus, CNP mRNA predominates in CA1 
through CA3, whereas NPR-B mRNA is largely expressed within DG (Herman et al., 1996; 
Langub, Watson, et al., 1995), leading to the interesting suggestion that within the 
hippocampus CNP is produced within CA1-3 but exerts action in DG, indicating a global 
influence on this important memory system. As previously mentioned, CNP-22 and CNP-53 
coexist across various subregions, but CNP-53 is the only form in ovine pituitary (Yandle et 
al., 1993). In rodent and ovine brain, highest concentrations of CNP are consistently found in 
the pituitary, hypothalamus and pineal gland (Middendorff et al., 1996; Müller et al., 2009; 
Pemberton et al., 2002; Yandle et al., 1993; Wilson et al, 2017). Few studies have examined 
distribution in human brain tissue, but have shown that CNP is also widespread, with high 
concentrations in hypothalamus (Totsune et al., 1994). Taken together, these findings indicate 
CNP and its signalling system are crucial to the normal development of the nervous system, 
with dysfunctions in this system a potential contributor to neurological disorder. 
Cellular targets of CNP in central nervous system are unclear. Within the brain, 
studies of ANP indicate a general process whereby NPs are produced by neurons and then 
target astrocytes which have prominent levels of NP receptors associated with them (Prado, 
Baltrons, Pifarré, & García, 2010; Simonnet et al., 1989; Yeung et al., 1996). However, 
reports vary as to whether this pattern consistently applies to CNP and the NPR-B receptor. 
For example, one study reported that NPR-B was less common than NPR-A in cultured 
astroglia, with CNP generating weaker stimulation of cGMP than ANP (Sumners & Tang, 
1992). Others have reported a greater stimulatory action of CNP than ANP in cultured 
astroglia (Yeung et al., 1996). Yet another study reported that CNP had a lower stimulatory 
activity than ANP and primarily acted in non-glial components of brain tissue derived from 
the diencephalon (Goncalves, Grove, & Deschepper, 1995). This finding, from tissue as 
opposed to culture, may be better representative of normal function in intact brain, but of note 
is that tissue examined was immature, acquired at a maximum age of postnatal day 9. As 
previously outlined, NP expression in the developing brain exhibits temporal changes, with 
CNP less widely expressed in the immature diencephalon than in adulthood (Langub, 
Watson, et al., 1995; Ryan & Gundlach, 1998) whereas ANP is the predominant 
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hypothalamic peptide at this early developmental stage (Jankowski et al., 2004). As the 
presence of NPs change in this region over time, so may the proposed neuron-glia interaction 
with CNP, but this remains to be examined in tissue of adult rats. 
Other than previously mentioned receptor mediation of CNP activity, brief half-life in 
plasma and known degradative regulation, relatively few studies have examined the 
pharmacokinetics of CNP within cerebral tissue. Arterial/Venous differences quantify the 
efficiency of molecular removal from organs, with those reported for CNP consistent with 
secretion from cerebral tissues (Potter, 2011). Though not directly studied for CNP, ANP is 
eliminated from cerebral tissues via brain-to-blood efflux with a half-life of approximately 20 
minutes (Ito, Ohtsuki, Katuskura et al, 2011). A similar mechanism may occur for CNP, 
given the reported arterial/venous difference and the paracrine nature of the peptide. As CNP 
may be involved in regulation of BBB (Bohara et al., 2014) and appears to have differential 
processing in central versus pituitary tissue (Wilson, Barrell, Prickett, & Espiner, 2018), it 
would be safe to assume that it does not cross BBB from the systemic circulation. 
Administration of intravenous CNP-22 to sheep across a two-hour time period at 
10pmol/kg/min resulted in a peak of cGMP between 60 and 90 minutes (Charles, Espiner, 
Richards, Nicholls, & Yandle, 1995b). In mouse astrocytes, 10nmol concentration of CNP-22 
or CNP-53 resulted in peak cGMP concentrations between 10 and 20 minutes of incubation 
(Yeung et al, 1996). This faster response at a lower dose may be an effect of species, tissue or 
methodological difference. Behavioural effects of icv peptide administration have been 
reported between 20 and 1000ng doses, 30 minutes following administration (Bíró, Tóth, & 
Telegdy, 1996b; Gardi et al., 1997; Telegdy et al., 1999). Given the molecular weight of CNP 
(2197.6) the dose of CNP required to elicit these behavioural effects is approximately 20-fold 
less than that used by Yeung and colleagues (1996) to investigate the cGMP response. As 
such, these latter reports are used to determine the dose range applied in this thesis (see 
Chapter 5). 
CNP can modify availability of, and exert action through, several neurotransmitters, 
primarily dopamine and norepinephrine. In tuberoinfundibular dopaminergic neurons of the 
dorsomedial arcuate nucleus, CNP inhibits neuron firing alone, and magnifies inhibitory 
effects of dopamine application (Pan, Lai, & Yen, 1996). In retinal amacrine cells, NPR-B is 
co-localised with the dopaminergic marker, tyrosine hydroxylase (Abdelalim, Masuda, & 
Tooyama, 2008) which is also indicative of norepinephrine. CNP modulates norepinephrine 
by increasing reuptake and decreasing release of the neurotransmitter in hypothalamus and 
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other encephalic nuclei, olfactory bulb and adrenal medulla (Fermepín, Vatta, Bianciotti, 
Wolovich, & Fernández, 2000; Vatta, Presas, Bianciotti, Zarrabeitia, & Fernfindez, 1996; 
Vatta, Presas, Bianciotti, Ambros, & Fernandez, 1997). In addition, NPR-C receptor is co-
expressed with catecholaminergic nuclei in rat brainstem, indicating peptide clearance in 
these regions (Abdelalim et al., 2008).  
Beyond the catecholamines, CNP has also been linked to modification of nitric oxide. 
Increases of nitric oxide production by CNP have been demonstrated in the context of its 
vasorelaxant, antithrombotic and anti-inflammatory effects in arteries (Andrade et al., 2014; 
Qian et al., 2002). Like CNP, nitric oxide also stimulates cyclic GMP, but acts via soluble 
guanylyl cyclase (Garthwaite, Goodwin, & Garthwaite, 1999) as opposed to the NPR-B 
membrane bound guanylyl cyclase. The complex relationship between CNP and nitric oxide 
as co-producers of cGMP remains to be elucidated and has not been investigated in brain 
tissue. However, inhibition of nitric oxide synthase by nitro-L-arginine can prevent 
behavioural effects of CNP (Telegdy et al., 1999), indicating a similar relationship may occur 
therein. 
CNP has also been linked with acetylcholine, GABA (γ-Aminobutyric Acid) and 
NMDA (N-Methyl-D-Aspartic acid) signalling. NPR-B and NPR-C co-localise with 
cholinergic neurons in retinal amacrine cells, and multiple brainstem nuclei, respectively 
(Abdelalim et al., 2008; Abdelalim, Masuda & Tooyama, 2008). CNP may also modulate 
GABA-mediated inhibition and NMDA receptors within the hippocampus (Decker et al., 
2009, 2010; Decker, Wojtowicz, Heinemann, & Braunewell, 2008). However, while 
antagonists of dopamine, norepinephrine, nitric oxide and acetylcholine activity all prevent 
actions of CNP on behavioural sequelae in the elevated plus maze and a passive avoidance 
learning paradigm, interference with GABA and NMDA receptors did not alter behavioural 
effects of CNP in either context (Bíró, Tóth, & Telegdy, 1996; Telegdy et al., 1999). 
Regardless, effects on multiple neurotransmitter systems indicate that CNP is a broad acting 
modifier of synaptic transmission.  
CNP can also modify secretion of various other peptides, acting in opposition to ANP. 
Studies of ANP indicate it inhibits release of progesterone, testosterone, luteinising hormone, 
vasopressin, corticotropin, prolactin and growth hormone (Huang, Skala, & Samson, 1992; 
Pandey, 2005). For those that CNP can also modify (thus far, prolactin, growth hormone and 
corticotropin) a notable feature is opposition of ANP action, with CNP stimulating, and ANP 
inhibiting secretions (Charles, Espiner, Richards, & Donald, 1995; Huang et al., 1992; 
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Samson, Huang, & Fulton, 1995; Shimekake, Ohta, & Nagata, 1994). In magnocellular 
neurosecretory cells, known for secreting oxytocin and vasopressin, CNP via the NPR-C 
receptor selectively inhibits L-type calcium channel currents (Leng & Ludwig, 2008; Rose et 
al., 2005), suggesting it may additionally interact with these peptides. Abundance of CNP in 
both hypothalamus and pituitary, alongside effects on endocrine peptides has led to the 
suggestion it may be important in neuroendocrine regulation of multiple functions, including 
reproduction (Fowkes & McArdle, 2000).  
As a potential neuroendocrine regulator, most research to date has examined CNP 
regulation of the HPA (hypothalamo-pituitary-adrenal) axis. CNP stimulates corticotropin 
releasing hormone, the key regulatory peptide of the HPA axis, which centrally regulates the 
peripheral anxiety response via release of adrenocorticotropin and cortisol. Central 
administration of CNP increases circulating levels of both adrenocorticotropin and cortisol in 
sheep, and magnifies the effects of the HPA-axis response to induced haemorrhage (Charles, 
Espiner, Richards, & Donald, 1995). CNP similarly magnifies adrenocorticotropin response 
in healthy males administered CNP prior to induction of panic attacks (Kellner et al., 2002). 
In rodents, centrally infused CNP increases corticotropin releasing factor-like 
immunoreactivity in the basal forebrain at low doses, but decreases it in hypothalamus at high 
doses (Gardi et al., 1997) and modification of anxiety by CNP is dependent on corticotropin 
releasing hormone (Jahn et al., 2001). Interestingly, the recent finding that NPPC expression 
in cerebral tissue is increased by dexamethasone, suggests that CNP and the endogenous 
glucocorticoids may form an important regulatory feedback loop (Wilson et al., 2017). 
As in the periphery, CNP can modify multiple biological subsystems of central 
nervous system that are critical to development and normal function. Demonstrated effects on 
various other signalling systems imply that CNP should be involved with a broad range of 
behaviours. To date few have been investigated, but CNP can affect food and fluid 
consumption, locomotion and response to drug, emotionality and memory.  
2.3 Central Regulation of Behaviour 
Unsurprisingly, high concentrations and localisation of CNP within the hypothalamus has 
drawn much research attention. Known involvement of the hypothalamus in regulating fluid 
intake, alongside NP roles in natriuresis and diuresis suggested possible involvement in 
central regulation of fluid and salt balance. Prior to discovery of CNP, ANP had already been 
shown to inhibit both water drinking and salt appetite (Samson, Skala, & Huang, 1991). 
14 
 
Conversely, centrally administered CNP was found to stimulate water drinking and magnify 
the effects of Angiotensin II induced water drinking in hypertensive rats. (Goto, Shibata, & 
Furukawa, 1997; Samson et al., 1991). Challenges to fluid and salt balance are also able to 
affect expression of CNP in olfactory regions and medulla (Cameron, Cumming, Espiner, 
Nicholls, & Richards, 2001). 
More recently, CNP has been considered as a potential regulator of food intake and 
energy expenditure in addition to its effects on fluid intake. CNP-null mice with targeted 
CNP expression in chondrocytes to reduce skeletal dysplasia, exhibited a reduction in food 
intake and modifications to multiple measures of metabolic function (Inuzuka et al., 2010). 
Furthermore, icv administration of either CNP-22 or CNP-53 reduced food intake in normal 
mice (Yamada-Goto et al., 2013). Complementing these findings, calorie restriction reduces 
plasma concentrations of CNP and NTproCNP (indicating reductions in peptide synthesis) in 
young lambs, and reduces plasma CNP via increases in degradative activity in adult sheep 
(Prickett et al., 2010; Prickett et al., 2007). These initial studies provide promising evidence 
that CNP contributes to the central control of both food and fluid intake. 
Several studies indicate CNP participates in neurological and behavioural response to 
drugs. Ventricular infusion of CNP prior to ip administration of cocaine, inhibits cocaine-
induced expression of the immediate early genes c-fos and egr-1 in nucleus accumbens and 
caudate-putamen (Thiriet et al., 2001). CNP can also attenuate cocaine-induced egr-1 
expression throughout striatum, after infusion into either the ventral tegmental area or 
caudate-putamen (Jouvert et al., 2004). Moreover, CNP reduces both cocaine-induced 
extracellular dopamine rises and cocaine-induced locomotor activity (Thiriet et al., 2001). 
When infused into medial prefrontal cortex, CNP reduces self-administration and motivation 
to seek cocaine, and concomitantly down-regulates expression of epigenetic markers 
associated with synaptic plasticity (Deschatrettes, Romieu, & Zwiller, 2013). Additional 
findings that CNP administration can reduce alcohol intake in a rodent model of addiction 
(Romieu, Gobaille, Aunis, & Zwiller, 2008), reduce acute antinociceptive effects of 
morphine, and prevent development of both acute and chronic morphine tolerance (Babarczy, 
Vizi, Toth, & Telegdy, 1995) suggest that CNP is involved in modifying the response to drug 
in dopaminergic neural circuits, and can alter behavioural outcomes of their reinforcing 
properties. 
Studies of CNP regulation of both food and fluid intake and response to drug have a 
pertinent common finding. In both cases, CNP was found to increase production of c-fos 
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alone (Thiriet et al., 2001; Yamada-Goto et al., 2013). In addition to modifying food intake, 
icv administration of CNP-53 increased immunoreactivity of c-fos in various nuclei of the 
hypothalamus (Yamada-Goto et al., 2013). CNP-22 administered icv also induced c-fos 
expression in frontal cortex (Thiriet et al., 2001). Another study did not find this effect for 
CNP (B. Zhu & Herbert, 1996), but used a lower dose range, indicating c-fos induction by 
CNP may be dose dependent. The c-fos gene, and its product Fos protein, are thought to be 
critical for translating short-term synaptic activity into long-term memory, because 
interference with its expression can impair memory (e.g. Seoane, Tinsley, & Brown, 2012; 
Tischmeyer & Grimm, 1999 for review). The mechanism by which CNP can induce c-fos 
expression is unknown, but this indicates a general role for CNP in information integration 
within central nervous system. 
As previously mentioned, CNP may also participate in regulation of anxiety 
behaviour, via interaction with the HPA axis. CNP was originally shown to be anxiolytic at 
doses of 100 to 200ng, infused centrally (Bíró et al., 1996b), though two subsequent studies 
failed to replicate this effect, and instead found infused CNP to be anxiogenic (Jahn et al., 
2001; Montkowski et al., 1998). Anxiogenic effects of CNP are better supported, but possible 
anxiolytic effects at low doses are not precluded, based on CNPs ability to increase 
corticotropin releasing factor-like immunoreactivity in basal forebrain in a similar dose range 
(Gardi et al., 1997). Moreover, as ANP is apparently consistently anxiolytic (Wiedemann, 
Jahn, & Kellner, 2000), and CNP action within the HPA axis opposes ANP, behavioural 
effects of CNP are more likely to be anxiogenic. This gains support from human studies 
where CNP given intravenously to healthy human males did not increase anxiety alone, but 
magnified anxiogenic effects of the panicogen cholecystokinin tetrapeptide (Kellner et al., 
2002). Opposing effects of ANP and CNP on anxiety have implicated them as a possible 
therapeutic target in panic disorder (Kellner, Jahn, & Wiedemann, 2003). Furthermore, 
activity and expression of CNP throughout frontal and limbic cortices, alongside its effects on 
anxiety, suggest it may represent an important molecule in regulation and processing of 
emotion more generally, potentially of interest in multiple psychological disorders exhibiting 
mood dysregulation. 
Alongside appetitive, locomotor, anxiety and drug-related behaviours, CNP may also 
participate in memory acquisition and consolidation. Aside from previously mentioned CNP-
induced modifications of c-fos and other immediate early genes, a hypothesised role for CNP 
in regulation of memory formation comes from four lines of evidence: 1) Localisation of 
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mRNA expression and NPR-B receptors within central nervous system; 2) improvement of 
memory in passive avoidance paradigms; 3) modification of synaptic plasticity towards long 
term depression (LTD) in both CA1 and CA3 of the hippocampus; and 4) opposing 
hippocampal plasticity modifications subsequent to functional downregulation of NPR-B 
receptor signalling associated with improved object discrimination in rats. However, as with 
central regulation of other behaviours, contribution of CNP has received little research 
attention. 
2.4 CNP and Memory 
Regardless of any additional information, localisation of NPR-B receptors and CNP precursor 
mRNAs suggest involvement in systems for integrating sensory input, emotion and memory. 
As previously outlined, CNP precursor mRNAs are found throughout the central nervous 
system, but are most abundant in olfactory and amygdaloid nuclei, limbic cortices, 
hippocampus, hypothalamus, mammillary bodies, cerebellum and various brainstem regions 
(Langub, Watson, et al., 1995). NPR-B receptors overlap greatly with this distribution 
pattern, but are also found throughout the neocortex, basal ganglia, and the anterodorsal 
thalamic nucleus (Herman et al., 1996). Furthermore, and as noted, within hippocampus 
precursor mRNA and NPR-B receptor expression exhibit localisation to CA1-3 or DG, 
respectively. Overall, CNP and NPR-B locations directly compare with multiple works 
indicating these regions represent overlapping systems underlying the integration of emotion 
and visceral sensation (Catani, Dell’Acqua, & Thiebaut de Schotten, 2013) with various 
aspects of declarative memory (Aggleton & Brown, 1999; Aggleton & Brown, 2006). 
Initial indication that CNP improves memory comes from studies of passive 
avoidance learning. Briefly, passive avoidance learning consists of an initial sample trial 
wherein a foot-shock is administered to a rat following entry to a dark compartment, which 
rats prefer to their brightly lit initial position. Memory for the aversive stimulus (foot-shock) 
is indicated by a subsequent increase in step-through latency following a delay period. 
Ventricular administration of 1µg (1000ng) CNP either 30 minutes before or immediately 
following a single acquisition trial, increased step-through latency when tested 24 hours later 
(Telegdy et al., 2000, 1999). The authors themselves identify that this finding may be 
complicated by CNPs aforementioned effects on anxiety (Telegdy et al., 1999). Doses used 
for passive avoidance studies were in the range demonstrated to be anxiogenic, potentially 
aiding memory for this task by increasing the salience of the aversive foot-shock. However, 
in both passive avoidance studies CNP had no effect on recall when administered prior to the 
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test trial, suggesting this was not solely an effect of anxiogenesis (Telegdy et al., 2000, 1999). 
Moreover, as anxiety tends to have negative impacts on learning and memory (Gülpınar & 
Yegen, 2004 for review; Izquierdo, Wellman, & Holmes, 2006), this indicates these studies 
demonstrate a genuine learning improvement. 
Three studies have examined CNP signalling in relation with electrophysiological 
correlates of synaptic plasticity (Decker et al., 2009, 2010; Decker et al., 2008). Application 
of CNP was initially demonstrated to decrease population spike amplitude in stratum 
pyramidale of CA1, measured following high frequency stimulation originating in stratum 
radiatum of CA3 (Decker et al., 2008). Subsequently, Decker and colleagues showed that 
CNP application also decreased the power of induced γ-oscillations and reduced the 
frequency of sharp wave-ripple complexes in hippocampal areas CA1 and CA3 (Decker et 
al., 2009). Finally, CNP application was shown to impede long-term potentiation (LTP) 
induction while facilitating LTD in area CA1 (Decker et al., 2010). Each of these 
electrophysiological functions provide important contributions to the process of memory 
consolidation (see Bartos, Vida, & Jonas, 2007; Buzsáki, 2015; Connor & Wang, 2016 for 
recent reviews).  
Identifying a behavioural connection between CNPs modulation of LTP/LTD was 
achieved by genetic modification of NPR-B receptors restricted to brain tissue. NPR-BΔKC 
rats exhibit a decrease (but not complete eradication) of CNP stimulation of cGMP via 
functional downregulation specific to NPR-B receptor activity, which can be isolated to 
central nervous system (Barmashenko et al., 2014; Langenickel et al., 2006). In hippocampal 
slices from these rats, LTP was facilitated at lower stimulus frequencies than wild type 
controls, complementing the opposite previous finding that CNP application inhibits LTP 
induction in hippocampal slices from wild-type rodents (Barmashenko et al 2014; Decker et 
al., 2010). NPR-BΔKC rats compared to wild-type also showed increased exploratory 
behaviour in an open field task, and better novel-object discrimination after a 24-hour delay, 
but performed no differently in a spatial variant of the object recognition task (Barmashenko 
et al., 2014). 
In addition to effects on synaptic plasticity and recognition behaviour, hippocampal 
slices from NPR-BΔKC rats exhibited metaplastic changes (Barmashenko et al., 2014) 
indicating a complex contribution of CNP to learning and memory. Metaplasticity, or 
“plasticity of synaptic plasticity” (Abraham & Bear, 1996) is a broad term used to describe 
multiple mechanisms exerting longer-term regulatory control over the ability of neurons to 
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generate LTP or LTD (Abraham, 2008). Temporal and mechanistic overlap in metaplastic 
and conventional plasticity functions (LTP/LTD) make this a challenging phenomenon to 
study experimentally, and to interpret (Abraham, 2008). Additionally, contributions of LTD 
to memory formation have only recently gained experimental support (Goh & Manahan-
Vaughan, 2013; Kemp & Manahan-Vaughan, 2004, 2007, 2008; Lemon & Manahan-
Vaughan, 2012; Manahan-Vaughan & Braunewell, 1999; Connor & Wang, 2016 for review). 
Furthermore, stress responses, as modified by CNP, also modify synaptic plasticity and 
learning and memory outcomes (Gülpınar & Yegen, 2004; Howland & Wang, 2008; Kim & 
Diamond, 2002 for reviews). This study not only demonstrates the complex relationship 
between anxiety, exploration, memory, synaptic plasticity and metaplasticity, but also 
indicates an overarching role for CNP within each of these domains. Although this complex 
relationship will require much research to tease apart, these broad and interactive actions of 
CNP suggest it is critical to normal cognitive function and the integration of sensory and 
emotional experiences into memory. 
2.5 CNP and Neurological Disorder 
If CNP is critical to normal cognitive function, it follows that it may also be affected in 
multiple conditions of cognitive dysfunction. Although CNP has been implicated in multiple 
neurological conditions, research in this area is again sparse. As previously mentioned, 
interactions of ANP and CNP in modifying anxiety and HPA axis response has suggested 
them as a therapeutic target in panic disorder (Kellner et al., 2003). CNP is elevated in CSF 
immediately following subarachnoid haemorrhage, protects against cytotoxic injury of retinal 
cells in vitro and in vivo, and ANP contributes to the neuroprotective effects of cortical 
spreading depression (Ikeda, Ikeda, Onizuka, Terashi, & Fukuda, 2001; Ma et al., 2010; 
Wiggins, Shen, & Gundlach, 2003). One recent review, focusing heavily on ANP, outlines a 
potential role in addiction (Hodes & Lichtstein, 2014), which could also be posited for CNP 
based on involvement in dopaminergic and behavioural response to drug (Babarczy et al., 
1995; Deschatrettes et al., 2013; Jouvert et al., 2004; Romieu et al., 2008; Thiriet et al., 
2001). Midbrain dopaminergic signalling is also of interest in schizophrenia, ADHD 
(Attention Deficit Hyperactivity Disorder) and Parkinson’s disease. Although the NPR-C 
receptor has recently been implicated in ADHD (Gong et al., 2017), CNP has only been 
specifically investigated in relation to Parkinson’s disease (Espiner, Dalrymple-Alford, 
Prickett, Alamri, & Anderson, 2014; Koziorowski, Tomasiuk, Szlufik, & Friedman, 2012; 
Woodward et al., 2017). 
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Various aspects of CNP and its signalling system suggest an involvement in 
Parkinson’s disease, with several studies now providing support for this notion. Expression of 
CNP and NPR-B receptors throughout dopaminergic pathways and structures, alongside 
interactions with dopamine signalling and effects on locomotion provide good indication that 
CNP may be modified in Parkinson’s pathology (Barmashenko et al., 2014; Herman et al., 
1996; Jouvert et al., 2004; Langub, Watson, et al., 1995; Tamura et al., 2004; Thiriet et al., 
2001). One study has indicated increased serum levels of NTproCNP in Parkinson’s patients, 
in association with elevated inflammatory factors, suggesting this indicates a contribution of 
CNP to neuroinflammation and development of the disorder (Koziorowski et al., 2012). 
However, a recent finding from Professor Espiner’s group indicates plasma NTproCNP is 
reduced in Parkinson’s disease (Woodward et al., 2017). In measures from CSF, NTproCNP 
is reduced in Parkinson’s disease and correlates with more rapid functional decline, indicated 
by earlier need for treatment intervention (levodopa; Espiner et al., 2014). Moreover, 
treatment with deprenyl which can delay levodopa treatment, prevented CSF reductions in 
NTproCNP, and ameliorated further reductions for participants starting delayed deprenyl 
treatment (Espiner et al., 2014). While these findings are positive indicators that CNP activity 
is modified in Parkinson’s disease, and may represent an additional treatment target to those 
already available, the authors highlight the need for ongoing research. 
Two findings from Espiner et al (2014) are particularly relevant to this thesis. First, 
their study found no relationship between CSF peptide measures and cognitive status of 
either mild cognitive impairment or dementia. Reasons to believe CNP may be involved in 
cognitive decline are outlined below, although this finding indicates no relationship as such in 
Parkinson’s disease at the level of CSF. They also report no relationship with participant age. 
However, the source of CNP and associated molecules in the CSF is not yet clarified, and 
CNP within cerebral tissues may exhibit a different profile.  
2.6 Proposed Role in Age-related Cognitive Decline 
Previously mentioned roles in modifying synaptic plasticity, anxiety, memory and in nervous 
system development, suggested that the CNP signalling system may vary further with normal 
brain aging within cerebral tissue. Indeed, ours was not the only research group to expect 
some involvement of CNP in the effects of brain aging, cognitive impairment or neurological 
disorders associated with age. Mahinrad and colleagues (2016) review possible contributions 
of all NPs to cognitive impairment, focussing on pathological endpoints of dementia and 
Alzheimer’s disease.  
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The process of ‘normal’ aging does not necessarily result in pathology, but is often 
accompanied by memory loss and accelerated cognitive decline (Mora, 2013). Across 
humans, non-human primates and rodents, this cognitive decline is typified by deficits in 
spatial and recognition memory (Erickson & Barnes, 2003 for review). Though these deficits 
are similar to those in Alzheimer’s disease, age-related cognitive deficits are less severe, and 
exhibit variation in the underlying neurobiology (Fjell, McEvoy, Holland, Dale, & Walhovd, 
2014 for review). While many memory deficits are hippocampal dependent, and extreme 
hippocampal neuronal loss occurs in typical Alzheimer’s pathology, the same cannot be said 
for healthy aging. Nonetheless the normally aging hippocampus exhibits reductions in the 
persistence of LTP induction, alongside a loss of synaptic connectivity and integration (Burke 
& Barnes, 2010; Erickson & Barnes, 2003). In addition to hippocampal synaptic effects 
reminiscent of CNP-related modifications (cf Decker et al., 2009, 2010; Decker et al., 2008), 
proliferation of new DG neurons also decreases with age (Burke & Barnes, 2010; 
Kempermann, Kuhn, & Gage, 1998; Verret, Trouche, Zerwas, & Rampon, 2007). Moreover, 
those neurons that are generated exhibit normal migration and survival, but delayed 
maturation and poor dendrite outgrowth (Rao, Hattiangady, Abdel-Rahman, Stanley, & 
Shetty, 2005). This links to CNP as the peptide promotes both maturation of olfactory 
neuronal precursors (Simpson et al., 2002) and dendrite outgrowth (Schmidt et al., 2007, 
2009). It therefore seems likely that CNP is implicated in age-related neurological changes, at 
least within the hippocampal formation. 
Aside from a role in synaptic regulation, Mahinrad and colleagues (2016) identify 
seven additional contexts indicating a role for NPs in cognitive decline, six of which CNP has 
been demonstrated to contribute to, and have been mentioned previously. These are 1) 
neurovascular dysfunction (through association with blood-brain barrier modification); 2) 
neuro-inflammation (modifications of immune and inflammatory responses); 3) 
neuroprotection (demonstrated in retinal cells); 4) anxiety (section 2.3); 5) memory (section 
2.4); and 6) fluid homeostasis of the central nervous system (through contributions to the 
regulation of CSF). The seventh context outlined by Mahinrad and colleagues (2016), a 
relationship with amyloid-beta and tau protein deposits, has not been demonstrated for CNP, 
and is more specifically relevant to proposed involvement in pathological aging. Currently, 
elevated levels of BNP in CSF are proposed as a novel biomarker for Alzheimer’s diagnosis 
(Craig-Schapiro et al., 2011) and BNP concentrations are increased in plasma alongside 
diagnosis of mild cognitive impairment or Alzheimer’s disease (Hu et al., 2012). Higher 
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serum levels of BNPs amino terminal fragment (NTproBNP) have also been associated with 
lower volumes of both gray and white matter, and poorer memory performance in an aging 
population (Sabayan, Buchem, Craen, Harris, & Launer, 2015). Relevance of these 
relationships between the least neuroactive NP and other markers of Alzheimer’s disease 
pathology remains to be investigated. However, there is historical precedent within NP 
research of BNP effects later becoming attributed to cross-talk with CNP receptors (CNPs 
contribution to skeletal development was originally attributed to BNP – (Prickett & Espiner, 
2012). As CNP is the major neuroactive NP, future investigation of its contribution in the 
context of pathological aging is critical.  
A final indication that CNP may either contribute to, or be affected by both normal 
and pathological aging, lies in its degradation by neprilysin. Aside from degrading CNP, 
neprilysin is the most potent enzyme to degrade amyloid-beta peptide (Higuchi, Iwata, & 
Saido, 2005). While amyloid-beta plaques are a hallmark of Alzheimer’s disease pathology, 
deposits have also been found in normally aging brains, although the density is much lower 
(Armstrong et al., 1996). Human and rodent studies indicate region specific, age-related 
reductions in neprilysin activity or expression, which correlate with plaque depositions, 
regardless of pathological status (Apelt, Ach, & Schliebs, 2003; Hellström-Lindahl, Ravid, & 
Nordberg, 2008; Iwata, Takaki, Fukami, Tsubuki, & Saido, 2002; Russo, Borghi, 
Markesbery, Tabaton, & Piccini, 2005; Yasojima, McGeer, & McGeer, 2001; Yasojima, 
Akiyama, McGeer, & McGeer, 2001). This has led some to suggest that the age-related 
downregulation of neprilysin may be a key factor in the switch from normal to abnormal 
amyloid deposition, and contribute to the development of Alzheimer’s disease (Iwata et al., 
2001; Yasojima et al., 2001; Yasojima et al., 2001). Reductions of neprilysin would suggest 
an accumulation of CNP with age, which would align with previously mentioned age-related 
reductions in LTP persistence and CNPs modification of synaptic plasticity toward LTD 
(Burke & Barnes, 2010; Decker et al., 2009, 2010; Decker et al., 2008). However, if higher 
concentrations of CNP improve memory, this suggests that increased CNP levels during 
aging may confer some benefit. One study has indicated such a benefit to learning and 
memory in aged neprilysin knock-out mice, seemingly conveyed by other peptides degraded 
by neprilysin (Walther et al., 2009). While a similar possibility is feasible for CNP, this 
remains untested. 
Accumulating evidence, reviewed here, indicates CNP is a critical molecule to normal 
function and integration of information within the nervous system, which is additionally 
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modified in cases of nervous system dysfunction and disorder. A multitude of questions 
remain within various fields of study concerned with this peptide, with few able to be 
answered within a single thesis. With a view to providing behavioural support for CNPs role 
in memory, and potential participation in age-related cognitive impairment, three lines of 
question were identified. 
2.7 Rationale for the Thesis 
Following from restricted previous literature, this thesis was highly investigative. A primary 
question is whether CNP expression or degradation within brain tissue varies during normal 
aging. Although no relationship was previously found with age in CSF across a specific age-
range (51-90 years; Espiner et al., 2014; Schouten et al., 2011), this does not exclude the 
possibility that regional variations may still be found within cerebral tissue. This remains 
plausible given paracrine/autocrine action of CNP and relationships with synaptic plasticity, 
memory, anxiety, neprilysin degradation and other functions outlined by Mahinrad and 
colleagues (2016). Investigation of CNP in the aging brain in the context of environmental 
enrichment is outlined in Chapter 3. 
Secondly, at the outset of this thesis (in 2013), no published findings had 
demonstrated a relationship between CNP and recognition or spatial/episodic-like memory. 
Associations with each of these measures is a suitable starting point to address contributions 
of CNP to cognition, given all are affected during both normal and pathological aging 
(Erickson & Barnes, 2003). A preliminary study for my Master’s thesis, showed statistically 
significant associations between endogenously measured CNP concentrations and novel 
object discrimination, wherein better novelty discrimination was associated with lower CNP 
concentrations in medial prefrontal cortex, retrosplenial cortex and dorsal hippocampus 
(Rapley, 2012, unpublished Master’s Thesis). The report that NPR-BΔKC rodents exhibited 
improved recognition memory was published late in 2014, providing excellent support for 
this hypothesis, but no effect was identified in a spatial object recognition task (Barmashenko 
et al., 2014). Outside this thesis, no research had examined CNP in association with 
exclusively spatial, or episodic-like memory. Concurring with Barmashenko and colleagues 
(2014) in terms of recognition memory, spatial/episodic-like memory associations were 
examined by measuring endogenous CNP in tissue from rats following acquisition of a 
spatial reference memory task in the radial arm maze (RAM), outlined in Chapter 4. 
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Although multiple memory difficulties occur during aging, deficits in pattern 
separation of memory have been suggested to underpin the combined cognitive issues 
(Burke, Wallace, Nematollahi, Uprety, & Barnes, 2010). Initial investigation of CNP in 
association with working memory was unsuccessful, due to interference with the working 
memory paradigm by the anxiogenic effects of CNP and small final numbers for data 
analysis. A subsequent study was designed to quantify this anxiogenic effect, and examine 
effects of infused CNP on object recognition and a spontaneous location recognition variant 
which manipulates pattern separation (Bekinschtein et al., 2014; Kent, Beynon, et al., 2015). 
Though it was an unplanned aspect of this study, rodents used were cognitively impaired as 
demonstrated by poor discrimination performance in recognition tasks. This study is outlined 
in Chapter 5. 
Regions of Interest (ROI) across all studies were selected following multiple 
considerations. Included were medial prefrontal cortex, occipital cortex, retrosplenial cortex, 
dorsal hippocampus, hypothalamus and mammillary bodies. Additional ROIs and subregional 
examination are used in Chapter 5 (outlined therein). This general selection was based on 1) 
demonstrated distribution of CNP and NPR-B receptors (Herman et al., 1996; Langub, 
Watson, et al., 1995); 2) Previously demonstrated effects of enrichment within these regions 
(relevant to Chapter 3; Mohammed et al., 2002 for review); and 3) involvement of many of 
these regions in a neurological system underpinning spatial/episodic and recognition 
memory, relevant to Chapters 4 and 5 (Aggleton & Brown, 1999; Aggleton & Brown, 2006). 
These regions also provided a basis for potential ongoing research linking CNP, enriched 
housing and amelioration of cognitive deficits seen after brain injury or during aging. In 
addition, many of these regions show age-related changes, particularly the hippocampus 
(Burke & Barnes, 2010; Erickson & Barnes, 2003), and/or involvement in regulating anxiety 
and the HPA axis (Jankord & Herman, 2008). Although the hypothalamus is usually not 
directly considered where memory is concerned, in terms of CNP it is important to include. 
Hypothalamus has been a consistent brain region for investigation of CNP within CNS 
tissues, thus provides an indicator of both cross-species and cross-experimental consistencies. 
Additionally, feedback regarding anxiety and bodily cues relating to food and fluid intake 
especially, are mediated by the hypothalamus. Inclusion of the hypothalamus thus represents 
an important neurological structure for consideration of CNP’s affects related to memory, 
although it does not influence memory consolidation directly per se.
 
 
Chapter 3. Age, Environmental Enrichment and CNP 
3.1 Rationale 
Use-dependent nervous system plasticity, initially proposed by Donald Hebb in 1949, was 
demonstrated a decade later using enriched environments by Rosenzweig, Bennett, Diamond 
and colleagues (Rosenzweig & Bennett, 1996 for review). Their initial findings of 
modifications to cortical acetylcholinesterase, weight and thickness by environmental 
complexity (e.g. Rosenzweig et al., 1962) have inspired nearly 60 years of ongoing research 
into the neurobiological effects of enriched environments. Generally, an enriched 
environment refers to housing methods for laboratory rodents that provide additional social, 
physical and cognitive stimulation, and thus opportunities for ‘informal’ learning experiences 
(Clemenson, Deng, & Gage, 2015; Hannan, 2014; Nithianantharajah & Hannan, 2006; 
Rosenzweig & Bennett, 1996; van Praag, Kempermann, & Gage, 2000; Will, Galani, Kelche, 
& Rosenzweig, 2004). Enriched environments elicit a broad array of effects in terms of 
neurogenesis, synaptic plasticity and neuroprotection across the lifespan. I briefly outline 
below my previous research on the CNP response to enriched housing (Rapley, Prickett, 
Dalrymple-Alford, & Espiner, 2018; Abstract and link provided in Appendix A), and work 
regarding enriched environments and the aging brain. 
Based on previously outlined works implicating CNP in neuroplasticity, 
neuroprotection and new neuron growth, we posited that an enriched environment would 
provide excellent context to study CNP within brain tissue. Using the same design as that 
reported here (see Methods), my initial Master’s thesis study (published alongside results 
from this study; Rapley et al., 2018) demonstrated that in young adult rats (8-9months old) 
CNP was present in higher concentrations throughout all regions of interest (outlined below) 
following a brief period (14 days) of enrichment, and that this increase in CNP occurred via a 
decrease in either degradative or clearance activity on the peptide. However, increased 
concentrations of CNP were unsustained after a longer period of enrichment (28 days) and 
this effect was weakest in hippocampus. This difference across time since enrichment 
initiation, suggested CNP is part of the early cascade of neuroplastic changes due to enriched 
housing. In addition to the major pattern of results (elevated CNP with concurrent ratio drop 
following 14 days of enrichment), NTproCNP concentrations were also altered in 
retrosplenial cortex, hippocampus and hypothalamus. In retrosplenial cortex and 
hypothalamus this related to the rehousing period. NTproCNP increased across time for 
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rodents housed in standard cages within retrosplenial cortex, and decreased across time for all 
rodents within hypothalamus. Within hippocampus NTproCNP was reduced by enrichment, 
regardless of rehousing period. This suggested that within these regions production of CNP is 
also a factor in the response to enriched housing, but that overall, degradative or clearance 
rate is a key determining factor in tissue concentrations of the peptide.  
Critical considerations in design of the original experiment were length of enrichment 
exposure (Clemenson et al., 2015; J. Simpson & Kelly, 2011) and regions of interest (ROI) 
for analysis. Time periods of 14 and 28 days of housing were selected to represent both a 
short- and longer-term exposure, typical of many enrichment studies (See Simpson & Kelly, 
2011 for review of enrichment durations). ROIs selected were medial prefrontal cortex, 
occipital cortex, retrosplenial cortex, dorsal hippocampus, hypothalamus and mammillary 
bodies. This selection was based on 1) demonstrated distribution of CNP and NPR-B 
receptors (Herman et al., 1996; Langub, Watson, et al., 1995); 2) Previously demonstrated 
effects of enrichment within these regions (Mohammed et al., 2002 for review); and 3) 
involvement of many of these regions in a neurological system underpinning spatial/episodic 
and recognition memory (Aggleton & Brown, 1999; Aggleton & Brown, 2006). These 
regions also provided a basis for potential ongoing research linking CNP, enriched housing 
and amelioration of cognitive deficits seen after brain injury or during aging. In addition, 
many of these regions show age-related changes, particularly the hippocampus (Burke & 
Barnes, 2010; Erickson & Barnes, 2003), and/or involvement in regulating anxiety and the 
HPA axis (Jankord & Herman, 2008). The purpose of the current study was to investigate 
CNP in the aging brain in the context of differing housing experiences. 
Most enrichment studies use young or young-adult rats introduced to enrichment soon 
after weaning. As of 2011 only 2% of the literature examined animals aged over a year, 
representing enrichment onset at mid-life or later (Simpson & Kelly, 2011). Nevertheless, 
life-long enrichment can benefit age-related spatial, working and recognition memory 
impairments, counter loss of synaptic plasticity, and reduce anxiety and stress-reactivity of 
aged rats both behaviourally and neurologically (Kobayashi, Ohashi, & Ando, 2002; Leal-
Galicia, Castañeda-Bueno, Quiroz-Baez, & Arias, 2008; Lores-Arnaiz et al., 2006; Lores-
Arnaiz et al., 2004; Mora, Segovia, & del Arco, 2007; Segovia, Arco, Blas, Garrido, & Mora, 
2008; Segovia, Del Arco, Garrido, de Blas, & Mora, 2008). Furthermore, life-long 
enrichment can prevent memory deficits in mouse models of Alzheimer’s disease 
(Jankowsky, 2005) and reduce amyloid deposition (Lazarov et al., 2005). 
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Whereas life-long-enrichment provides greater benefits, short-term enrichment can 
also improve memory performance in aged rats (Kobayashi et al., 2002; Winocur, 1999). 
Introduction of enrichment at an advanced age promotes new neuron survival in the dentate 
gyrus, although this has not been consistently linked to better memory performance (Burke & 
Barnes, 2010; Kempermann et al., 1998; Segovia, Yag, & Mora, 2006 but see Kempermann, 
Gast, & Gage, 2002; Speisman et al., 2013 for concurrent memory improvement). 
Improvements in spatial memory occur in both male and female aged mice (Bennett, McRae, 
Levy, & Frick, 2006; Frick & Fernandez, 2003; Harburger, Lambert, & Frick, 2007) but 
neurobiological effects of enriched housing can vary across sexes during aging (Bennett et 
al., 2006; Frick & Fernandez, 2003; Kolb, Gibb, & Gorny, 2003). In aged male rats, 
enrichment enhances Synapsin I, glucocorticoid receptor expression, and astrocytic density 
and complexity within the hippocampal formation, all of which are additionally associated 
with better spatial memory and greater control of anxious responses (Sampedro-Piquero, De 
Bartolo, et al., 2014; Sampedro-Piquero, Arias, & Begega, 2014; Sampedro-Piquero, Begega, 
& Arias, 2014). These studies collectively indicate enrichment also provides a valid approach 
for investigating CNP during brain aging. 
Based on previous work indicating neprilysin concentrations decline with age in a 
region specific manner, reductions of CNP degradation measures (NTproCNP:CNP ratio) 
were expected in aged rats throughout fronto-temporal regions due to reductions in neprilysin 
(Apelt et al., 2003; Fjell et al., 2014; Iwata et al., 2002). As this is the first study of its kind, 
no predictions could be made about how age or enriched housing may affect concentrations 
of CNP, or synthesis of the peptide measured by NTproCNP concentrations 
3.2 Methods 
3.2.1 Subjects 
Thirty-six male PVGc hooded rats were used, weighing between 293 and 440g, and aged 22-
23 months old at the start of enrichment. Prior to enrichment, all rats were housed in standard 
opaque plastic cages (45 cm x 27 cm x 22 cm high) in groups of three or four until the start of 
this experiment. All rats received food and water ad libitum and were behaviourally naïve (no 
previous experimental participation) until this point. Rats were accustomed to handling from 
regular cleaning and general care procedures, and this increased in the two weeks prior to the 
experiment start to become accustomed to the experimenter. On the first day of enrichment, 
24 rats were re-housed in two enrichment cages (12 per cage) for either 14 or 28 days (1 cage 
per time-period; Enriched-14-day and Enriched-28-day). Twelve remaining rats were re-
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housed with new cage mates in standard cages (3 rats per cage) for the same time periods (2 
cages per time-period; 6 rats total per time-period; Standard-14-day and Standard-28-day). 
All rats were rehoused with novel cage mates. Rats were maintained on a reversed light-dark 
cycle (lights off 0800 – 2000h) and colony rooms were maintained at 22°C and 48%rH. Food 
and water were available ad libitum. All procedures conformed to the NIH guide for the care 
and use of laboratory animals and were approved by the University of Canterbury Animal 
Ethics Committee. 
3.2.2 Enrichment 
A standardised enrichment protocol developed at the University of Canterbury was used 
(Harland, Collings, McNaughton, Abraham, & Dalrymple-Alford, 2014; and see 
http://www.psyc.canterbury.ac.nz/Standardized%20Enrichment.shtml for details of, objects, 
arrangements and procedures). Enrichment cages were made of wire mesh with a sawdust 
covered metal floor and measured 85 cm x 60 cm x 30 cm high. Each day of enrichment 
consisted of a different combination of “junk” objects such as ceramic figurines, metal 
chains, PVC pipes and junctions and other small items, along with an ever-present wooden 
block to discourage chewing of enrichment objects. Enrichment configurations differed over 
40 different days (though a maximum of 28 was used here) and ensured no object was 
repeated within five days of itself. On every seventh day, PVC pipes and junctions were 
presented in a “tubing only” day, and on every eighth day, all objects (except the wooden 
blocks) were removed from the cage. Additionally, food and water positions were changed 
daily, and cages were rotated through one of four possible positions in the colony room every 
fourth day. Objects were changed at the start of the dark period (between 0900 and1000h), 
during which rats from one enrichment cage were held together in a large opaque plastic cage 
(62 cm x 40 cm x 22cm high). 
3.2.3 Sacrifice and Tissue extraction 
After either 14 or 28 full days of enrichment, or the same period of standard housing with 
new cage mates, rats were placed in standard cages at the same time enrichment objects were 
usually changed and held in a novel, dimly lit room separate to both the colony room and 
tissue dissection room. Rats from Enriched and Standard Housing were euthanised 
throughout a single day, with two Enriched rats sacrificed per one Standard Housed, and 
order of sacrifice randomised within these groups of three. Rats were deeply anaesthetised 
with an overdose of Sodium Pentobarbitone (1mL, 300mg/mL, ip). Once unresponsive to 
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both tail pinch and plantar reflex (approximately 5 minutes following injection), with no 
discernible heartbeat, rats were decapitated and brains rapidly removed from the skull and 
placed in a brain matrix (Ted Pella). An initial coronal cut was made at the level of the optic 
tract. Additional coronal cuts were made 5mm anterior and posterior to the initial cut, 
resulting in two ‘slabs’ of fresh tissue (see Figures 3.1 & 3.2 for approximate location of the 
anterior face of each slab, and 3.3 for posterior extent). These tissue slabs were placed 
anterior-face-upwards on a glass petri dish, previously sterilised with 70% ethanol and rinsed 
with saline. Sterilisation and rinsing was repeated between rats. Microdissection scissors 
were used to acquire tissue samples from seven regions of interest, starting in the posterior 
slab, in the order: occipital cortex, retrosplenial cortex (containing both dysgranular and 
granular B tissue), dorsal hippocampus (left and right hemispheres separately), mammillary 
bodies, hypothalamus and medial prefrontal cortex. Tissue samples were placed in pre-
weighed Eppendorf tubes, weighed, and snap frozen with liquid nitrogen, within 15 minutes 
post-sacrifice, before long-term storage at -80°C. 
 
Figure 3.1: Approximate location of anterior face from anterior ‘slab’ of tissue. Tissue 
sampled for peptide measures in prefrontal cortex (mPFC) is indicated by gray box. All 




Figure 3.2: Approximate location of anterior face from posterior 'slab' of tissue. Tissue 
sampled for peptide measures in hypothalamus (HTh), dorsal hippocampus (Hpc) and 
retrosplenial cortex (Rsp) are indicated in gray. 
 
Figure 3.3: Posterior extent of poterior tissue slab. Furthest extent of tissues sampled from 
occipital cortex (Occ) and mammillary bodies (MB) are indicated in gray, and for dorsal 





3.2.4 Tissue preparation and peptide measurements 
CNP and NTproCNP were measured by radioimmunoassay (RIA), described in detail in 
Yandle et al (1993; CNP) and Prickett et al (2012; NTproCNP). Prior to assay, frozen tissue 
samples were transferred to scintillation vials and kept frozen on dry ice, then held at 98°C in 
a water bath for 5 minutes in 10mL of distilled water containing 0.01% Triton X-100. 
Samples were acidified with 610µL glacial acetic acid and homogenised prior to extraction 
on Sep-Pak C18 cartridges (Waters Corporation, Milford, MA, USA). Following extraction, 
samples were dried under an air stream and frozen for later re-suspension in assay buffer for 
RIA. All tissues from an individual rat were processed in the same extraction, with tissues 
from housing groups counterbalanced across extractions. 
3.2.5 CNP assay 
As mentioned previously, CNP is identical in all mammals studied thus far. The amino 
terminal extended form CNP-53, containing the 17-amino acid ring essential for bioactivity, 
has 100% cross reactivity with CNP 22 in the assay used to measure CNP. Antiserum to 
CNP-22 (Phoenix pharmaceuticals, Belmont, CA) was diluted 1:2000 with assay buffer. 
Labelled CNP was prepared by chloramine-T iodination of [Tyr0] CNP-22 (Peninsula Labs), 
and purified by reverse-phase HPLC. Fifty microliters each of antiserum and CNP standard 
(0.7 – 235 pmol/L) or sample extract (all in duplicate) were mixed and incubated for 22-24h 
at 4°C, followed by addition of 50µL labelled CNP containing ~3000 cpm for 22-24h at 4°C. 
Bound and free labelled CNP were separated by a solid-phase secondary antibody method 
(Sac-cell, Rabbit-Anti Goat, IDS Ltd., England). CNP assays had a detection limit of 0.6 
pmol/L and ED50 of 7.3 pmol/L; intra- and inter-assay coefficients of variation were 5.9 and 
7.4%, respectively, at 17 pmol/L. 
3.2.6 NTproCNP assay 
For NTprocCNP an in-house antiserum was used that recognises the C-terminal epitope in 
the region of proCNP (38-50), which is identical in human, mouse, and rat (Prickett et al., 
2012). Fifty microliters of sample extract or 0.5-372 pmol/L proCNP(38-50) standards (again 
in duplicate) were incubated with 50µL antiserum for 22-24h, followed by addition of 50 µL 
tracer solution (proCNP(38-50)-[125I]Tyr37) containing ~3000 cpm for 22-24h at 4°C. 
Bound and free labelled proCNP were separated by solid-phase second antibody method 
(Sac-cell, Donkey-Anti Rabbit, IDS Ltd., England). NTproCNP assays had a detection limit 
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of 0.4 pmol/L and ED50 9.9 pmol/L; intra- and inter-assay coefficients of variation were 6.8 
and 7.5%, respectively, at 45 pmol/L. 
3.2.7 Statistical Analyses 
CNP and NTproCNP concentrations were expressed as femtomoles per gram of wet tissue 
(fmol/g). NTproCNP:CNP ratio was calculated by dividing NTproCNP concentration by 
CNP concentration. In aged rats, a portion of one sample from the hypothalamus in the 
Enriched-28-day group was lost, and data subsequently excluded. Two tissue samples had 
NTproCNP concentrations beyond the detection limit of the assay: one from mammillary 
bodies in the Enriched-14-day group and one from hypothalamus in the Enriched-28-day 
group. For these two samples, the NTproCNP:CNP ratio could not be calculated, and CNP 
concentrations were also excluded from analysis. Thus, sample Ns for aged rats are reduced 
for each of these regions (mammillary bodies and hypothalamus). For all other regions of 
interest, final Ns for aged rats were: Enriched-14-day, N = 12; Enriched-28 day, N = 12; 
Standard-14 day, N = 6; Standard-28 day, N = 6. Data from young rats is available in Rapley 
et al, 2018 (link provided in Appendix A) with reference made to these data for across-age 
comparisons. Initial analysis indicated there were no differences in any measure (CNP, 
NTproCNP or ratio) between left and right hemispheres of the dorsal hippocampus. Data was 
averaged across hemispheres for each rat and analysed as a single value. Because multiple 
effects were identified in young rats (Rapley et al, 2018), Null Hypothesis Significance 
Testing was inappropriate for data gathered from aged rats. Cohen’s d effect sizes (±95% CI) 
were calculated on specific mean differences using 20% trimmed means to enable 
comparison with data from young rats (Rapley et al, 2018). This also accounted for outlying 
data points, which represented different rats in each case, meaning individual exclusions of 
outlier were unnecessary. 
3.3 Results 
3.3.1 NTproCNP 
NTproCNP concentrations did not vary across conditions in occipital cortex, medial 
prefrontal cortex, retrosplenial cortex or hippocampus (Figures 3.4 – 3.7, top panels, all p’s > 
.05). In the mammillary bodies (Figure 3.8), NTproCNP concentrations increased across the 
rehousing period, for rats housed in Standard cages only (Standard-14-days vs Standard-28-
days d = 1.44 [0, 2.88], p = .05). In hypothalamus, NTproCNP concentrations were lower in 
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rats rehoused in Standard cages for 14 days than those rehoused in Enrichment for 14 days 
(Standard-14-days vs Enriched-14-days d = 1.66 [0.45, 2.87], p = .01). 
3.3.2 CNP 
CNP concentrations did not vary across conditions in occipital cortex, retrosplenial cortex, 
mammillary bodies, hippocampus or hypothalamus (Figures 3.4, 3.6 – 3.9, middle panels; all 
p’s > .05). In medial prefrontal cortex, CNP concentrations were higher following 14 days of 
rehousing than at 28 days of rehousing, regardless of housing environment (Figure 3.6 middle 
panel; 14-days vs 28-days d = 0.68 [-0.01, 1.38] p = .05).  
3.3.3 Ratio of NTproCNP:CNP 
Ratios of NTproCNP:CNP did not vary in medial prefrontal cortex, retrosplenial cortex, 
hippocampus or hypothalamus (Figures 3.5 – 3.7, 3.9, all p’s > .05). Ratio values increased 
across the rehousing period for rats housed in Standard cages only in both occipital cortex 
(Standard-14-days vs Standard-28-days d = 1.95 [0.39, 3.51] p = .02) and mammillary bodies 
(Standard-14-days vs Standard-28-days d = 2.13 [0.52, 3.74], p = .01).  
3.3.4 Comparisons to Young rats 
A key aspect in understanding data from aged rats, is a comparison to concentration 
measures from young rodents. These results are included here, from Rapley et al, 2018. All 
data used cohen’s d [±95%CI] mean comparisons. For NTproCNP data from both Young and 
Aged rats did not vary substantially, so was pooled and compared directly. For CNP and 
NTproCNP:CNP ratio, pooled data from Aged rats was compared with either Young-
Enriched-14-day rats, or a pooled mean of all other groups because of substantive differences 
in Young-Enriched-14-day rats. This was modified slightly for CNP measures in 
hippocampus and medial prefrontal cortex due to effects therein (see below). 
NTproCNP concentrations were higher in Aged rats in occipital cortex (d = 0.62 
[0.14, 1.11], p = .01) and lower than Young rats in medial prefrontal cortex (d = 0.62 [0.14, 
1.10], p = .01). NTproCNP concentrations were equivalent across ages in all other ROIs 
(retrosplenial cortex, hippocampus, mammillary bodies and hypothalamus). For Aged rats 
overall, concentrations of CNP were lower than the reported peak in Young-Enriched-14-day 
rats in occipital cortex, retrosplenial cortex, mammillary bodies and hypothalamus (see Table 
3.1 for between group comparisons). Of these regions, CNP concentrations were higher in 
Aged rats compared to other young rats in occipital and retrosplenial cortices (Table 3.1). In 
hippocampus of Young rats, CNP was affected by rehousing period, necessitating 
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comparisons reflecting this. In Aged rats overall, concentrations were equivalent to Young-
14-day rats (d = 0.12 [-0.46, 0.47], ns) but higher than Young rats rehoused for 28 days (d = -
1.01 [[-1.62, -0.4], p < .001). Because of the difference identified in medial prefrontal cortex 
across the rehousing period for Aged rats, data was pooled accordingly for this comparison. 
Concentrations of CNP in Aged medial prefrontal cortex were lower than the reported peak in 
Young-Enriched-14-day rats (Aged-14-day vs Young-Enriched-14-day d = -0.76 [-1.54, 
0.03], p = .06; Aged-28-day vs Young-Enriched-14-day d = -1.46 [-2.31, -0.6], p < .001). 
Additionally, CNP concentrations in medial prefrontal cortex of Aged rats rehoused for 14 
days was higher than all other Young rats (d = 0.89 [0.23, 1.55], p = .01), but there was no 
difference between Aged-28-day rats and other Young rats (d = 0.23 [-0.4, 0.86], p = .47). 
NTproCNP:CNP ratio was lower in Aged rats than Young rats (excluding Young-Enriched-
14-day rats) in occipital, medial prefrontal and retrosplenial cortices and hypothalamus, but 
not in mammillary bodies or hippocampus (Table 3.1). However, this ratio reduction was 
higher than that reported in Young-Enriched-14-day rats in occipital cortex, retrosplenial 




Figure 3.4: Concentration (femtomoles/g wet tissue) of NTproCNP (top), CNP (middle) and NTproCNP:CNP ratio (bottom) in occipital 
cortex. Summary data is 20% trimmed means (reduction of n = 2 for all groups), standard error (box) and 95% confidence interval (whisker) 




Figure 3.5: Concentration (femtomoles/g wet tissue) of NTproCNP (top), CNP (middle) and NTproCNP:CNP ratio (bottom) in medial 
prefrontal cortex. Summary data is 20% trimmed means (reduction of n = 2 for all groups), standard error (box) and 95% confidence 




Figure 3.6: Concentration (femtomoles/g wet tissue) of NTproCNP (top), CNP (middle) and NTproCNP:CNP ratio (bottom) in retrosplenial 
cortex. Summary data is 20% trimmed means (reduction of n = 2 for all groups), standard error (box) and 95% confidence interval (whisker) 




Figure 3.7: Concentration (femtomoles/g wet tissue) of NTproCNP (top), CNP (middle) and NTproCNP:CNP ratio (bottom) in dorsal 
hippocampus. Summary data is 20% trimmed means (reduction of n = 2 for all groups), standard error (box) and 95% confidence interval 




Figure 3.8: Concentration (femtomoles/g wet tissue) of NTproCNP (top), CNP (middle) and NTproCNP:CNP ratio (bottom) in mammillary 
bodies. Summary data is 20% trimmed means (reduction of n = 2 for all groups), standard error (box) and 95% confidence interval (whisker) 
overlaid by individual data points. For NTproCNP Standard-14-days < Standard-28-days. For NTproCNP:CNP ratio Standard-14-days < 




Figure 3.9: Concentration (femtomoles/g wet tissue) of NTproCNP (top), CNP (middle) and NTproCNP:CNP ratio (bottom) in 
hypothalamus. Summary data is 20% trimmed means (reduction of n = 2 for all groups), standard error (box) and 95% confidence interval 




Table 3.1: Between group comparisons (cohen’s d [±95% CI]) for CNP concentrations and NTproCNP:CNP ratio in aged rats overall versus 
Young-Enriched-14-day rats or all other Young groups within all regions of interest (see text for hippocampus and  medial prefrontal cortex 
CNP). EE: Enriched Environment; SH: Standard Housed; Other Young indicates pooled Young data, excluding Young-Enriched-14-day 
rats. p < .001 *** p < .01 ** p < .05 *. Originally published in Rapley et al, 2018. 
Region Aged Rats Overall CNP NTproCNP:CNP ratio 
Occipital Cortex Young EE 14 vs d = 1.22 [0.48, 1.96]*** d = -1.33 [-2.07, -0.58]*** 
 Other Young vs d = -1.57 [-2.17, -0.97]*** d = 0.9 [0.34, 1.45]*** 
Medial Prefrontal Cortex Young EE 14 vs  d = -0.63 [-1.32, 0.05] ns 
 Other Young vs  d = 1.52 [0.92, 2.11]*** 
Retrosplenial Cortex Young EE 14 vs d = 1.31 [0.59, 2.03]*** d = -1.0 [-1.70, -0.30]** 
 Other Young vs d = -1.13 [-1.71, -0.56]*** d = 1.24 [0.66, 1.82]*** 
Hippocampus Young EE 14 vs  d = -0.84 [-0.53, 0.15]* 
 Other Young vs  d = 0.45 [-0.08, 0.99] ns 
Mammillary Bodies Young EE 14 vs d = 1.75 [0.99, 2.52]*** d = -1.21 [-1.93, -0.49]*** 
 Other Young vs d = 0.30 [-0.24, 0.83] ns d = 0.15 [-0.39, 0.68] ns 
Hypothalamus Young EE 14 vs d = 1.21 [0.49, 1.94]*** d = -0.13 [-0.81, 0.55] ns 






Recent work has suggested CNP may be an important target molecule with respect to age-
related cognitive decline, and neurological disorders featuring cognitive impairment (Espiner 
et al., 2014; Koziorowski et al., 2012; Mahinrad et al., 2016). However, to date there has been 
no investigation of CNP in aging cerebral tissue. This study aimed to address this research 
gap by investigating CNP response to enriched housing conditions in aged rats and 
comparing with data previously acquired from young rats. A major aim was to provide a 
starting point for ongoing research testing the hypothesis that CNP is involved in 
neurological changes that occur during aging. This was also important given few previous 
studies have investigated tissue concentrations or degradative regulation of CNP within 
cerebral tissue. Previous work with young rats (8-9 months) showed that CNP was available 
in higher concentrations throughout six regions of interest, following a brief period of 
enriched housing (14 days), and that this greater availability of CNP occurred via reductions 
in either degradative (for example by neprilysin) or clearance (via NPR-C) activity (Rapley et 
al., 2018). This indicated that for young rats, CNP is likely to form part of the early cascade 
of molecular neuroplasticity effects previously demonstrated following enriched housing. 
Both studies used the same design, with the current study initiating enrichment at 
approximately 23 months of age.  
For aged rats overall, concentrations of CNP in occipital cortex and hypothalamus were 
similar to previous reports in adult sheep (Pemberton et al., 2002; Wilson et al., 2017), 
rodents (Jankowski et al., 2004) and humans (Komatsu et al., 1991; Totsune et al., 1994). 
NTproCNP concentrations were approximately half of those reported in ovine cerebral tissue 
(Wilson, McNeill, Barrell, Prickett, & Espiner, 2017). Concentration of CNP in hippocampus 
and mammillary bodies was also similar to those reported, with similarly reduced NTproCNP 
in these regions (Wilson et al., 2017). Concurring with previous reports, highest CNP 
concentrations occurred in hypothalamus and mammillary bodies, with moderate 
concentrations in prefrontal, hippocampal and retrosplenial tissue, and lowest concentrations 
in occipital cortex. Minimal modifications to CNP, NTproCNP and the degradative ratio were 
identified in aged rats, all related to the rehousing period rather than enrichment per se. In 
hypothalamus, mammillary bodies and occipital cortex, modifications to NTproCNP and the 
NTproCNP:CNP ratio across the rehousing period were restricted to rats rehoused in standard 
cages. This indicates a reaction which may be ameliorated by enrichment within these 
regions. Modifications to CNP concentrations in aged medial prefrontal cortex occurred 
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regardless of type of rehousing. Most notable for aged rats was the markedly different 
response of CNP and its signalling system when compared to young rats. 
3.4.1 Response to Enrichment 
A subtle enrichment effect occurred in occipital cortex, mammillary bodies and 
hypothalamus of aged rats. In mammillary bodies, significantly increased peptide production 
(NTproCNP) across time was paired with significantly increased degradative activity, for rats 
housed in standard cages only. Within occipital cortex, the same pattern occurred, but 
variation in NTproCNP was non-significant (Figure 3.4). This pairing of increased 
production with increased degradative activity results in stable active peptide concentrations. 
Within hypothalamus, peptide production was decreased after an initial period of 14 days of 
rehousing, resulting in marginal (but again non-significant) variation in CNP, with no 
apparent variation in degradative ratio. Interestingly, this pattern in hypothalamus was the 
only mild similarity to the response to 14 days of enrichment seen in young rats. Certain 
hypothalamic nuclei are reported to be stable during brain aging, with some exhibiting 
increases in activity (Coleman & Flood, 1987; Hofman, 1997; Lucassen, Ravid, Gonatas, & 
Swaab, 1993; Roberts, Killiany, & Rosene, 2012; Swaab & Bao, 2011; Swaab, Goudsmit, 
Kremer, Hofman, & Ravid, 1992). That this was the only ROI in aged rats with slight 
elevations to CNP following 14 days of enriched housing suggests there may also be a certain 
amount of stability in the CNP signalling system within hypothalamus during aging. As 
multiple nuclei were included within the tissue sampled, this will require more focussed 
examination. 
Subtle changes to peptide production and degradative activity in standard housed rats, 
which is apparently modified by enriched housing represents a stark contrast with the clear 
enrichment response seen in young rats, wherein higher concentrations of CNP following a 
brief period of enrichment were accounted for by reductions of degradation or clearance and 
were widespread (Rapley et al., 2018). This suggests that, while degradative activity 
continues to be an important contributor to regulating CNP concentrations within cerebral 
tissue across aging, peptide production (as measured by NTproCNP) also gains a degree of 
importance. Peptide production changes in response to external stimulus may represent a 
compensatory mechanism during aging to maintain peptide activity in the face of generally 
depleted degradative activity (see below). It is additionally possible that this initiation of 
enrichment later in life has been less effective than earlier initiation of enrichment for a 
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longer period in stimulating bioactive CNP for these rats – a concept supported by previous 
investigation of short-term, late-initiated enrichment which is expanded upon in Chapter 6. 
3.4.2 Rehousing period and Anxiety 
As in the regions outlined above, modifications to CNP concentrations in medial prefrontal 
cortex across the rehousing period were accompanied by non-significant modifications to 
NTproCNP, rather that degradative activity (Figure 3.5), but was not affected by enriched 
conditions. Whereas in aged rats, modifications due to enrichment were subtle – because 
above outlined modifications were restricted to rats in standard housing – the opposite was 
the case in young rats. For young rats, an effect on CNP concentrations following a brief 
rehousing period in enrichment was clear but more subtle effects on NTproCNP occurred 
across the rehousing period within hypothalamus and retrosplenial cortex (Rapley et al., 
2018). Because the general pattern in aged rats relates more to the rehousing period, and CNP 
has been previously related to anxiety regulation and behaviours (Bíró et al., 1996b; Jahn et 
al., 2001; Montkowski et al., 1998; Telegdy et al., 2000, 1999) this indicates a relationship 
with anxiety induced by rehousing with new cage mates. Moreover, it is likely that this is an 
initial response to the rehousing stressor for rodents rehoused in standard cages for a brief 
period because in rodents given 28 days of adjustment to rehousing in standard cages, 
concentrations of CNP or NTproCNP more closely resemble those seen in enriched animals.  
Though this was not explicitly tested here with behavioural tasks, several previous 
findings are supportive of this idea. Medial prefrontal cortex and limbic system structures 
participate in regulation of the HPA axis (Herman, Ostrander, Mueller, & Figueiredo, 2005). 
Changes to HPA axis signalling and glucocorticoid feedback are thought to contribute to 
neurological and behavioural changes during aging (Mizoguchi et al., 2009; Swaab & Bao, 
2011). Additionally, environmental enrichment has been previously shown to modify 
neuroendocrine and neurotransmitter related stress responses in both young and aged rats 
(Moncek, Duncko, Johansson, & Jezova, 2004; Segovia, Del Arco, De Blas, et al., 2008; 
Segovia, Del Arco, Garrido, et al., 2008; Segovia, Del Arco, & Mora, 2009). The current 
observation of a response in the CNP system relative to a stressful event, within pertinent 
neurological regions (particularly hypothalamus and medial prefrontal cortex), which can be 
modified by a brief enrichment period is highly suggestive that effects in standard caged rats 
across the rehousing period relate to CNP regulation of the HPA axis and an initial anxiety 
response in rats rehoused for only 14 days.  
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Because of this notably different effect in aged rats this may reflect age-related HPA 
axis dysregulation associated with the CNP signalling system. Dysregulation of HPA axis 
occurs during aging and modifies feedback in the glucocorticoid system (Mizoguchi et al., 
2009; Swaab & Bao, 2011). Moreover, increased concentrations of CNP seen in occipital, 
retrosplenial and medial prefrontal cortices of aged rats (see below) may be associated with a 
shift toward LTD in these regions (Decker et al., 2009, 2010; Decker et al., 2008) which 
occurs more readily during aging. This is also associated with stress impairment of 
hippocampal learning and memory functions (Burke & Barnes, 2010; J. J. Kim & Diamond, 
2002) wherein some accumulation of CNP was also seen with age. A potential involvement 
of CNP with age related HPA axis dysregulation also deserves consideration as modifications 
in these circuits are associated with executive dysfunction during aging (Buckner, 2004). 
Some clarity in interpreting this relationship could have been provided here by including a 
“zero day” group – rats of the same age, sacrificed at the start of rehousing. This would have 
provided some indication whether overall effects in aged rats related to the rehousing period 
definitely represent an initial response due to the anxious event of rehousing, or continuing 
gradual modifications to the signalling system over time. Additionally, this would account for 
the limitation – in comparing to young rats – that aged rats were housed in standard 
conditions for a much longer period before initiation of enrichment. As stated above, this may 
contribute to the relative lack of response to enrichment in aged rats and is expanded on in 
Chapter 6. However, because the overall response generally relates to the period of 
rehousing, this now encourages further investigation into the relationship between CNP, 
anxiety and aging. 
3.4.3 General effects of Age 
Both NTproCNP and CNP concentrations increased with age in occipital cortex accompanied 
by reduced degradative activity. Peptide production was reduced in medial prefrontal cortex 
which was also accompanied by a general reduction in degradative activity. In this region, 
increased CNP compared with young rats only occurred following 14 days of rehousing. CNP 
concentrations were also higher in the aged retrosplenial cortex in combination with reduced 
degradative activity. Unlike young rats, no modifications were seen in retrosplenial 
NTproCNP concentrations in response to the rehousing period or environment. The reduction 
in degradative ratio within these regions was as hypothesised and of a different magnitude to 
the drop seen in young rats housed in enrichment for 14 days. However, this did not occur in 
either mammillary bodies or hippocampus. This hypothesis was based on prior work 
indicating the CNP proteolytic enzyme, neprilysin, reduces with normal brain aging in a 
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region-specific manner – notably fronto-temporal regions including cortex, hippocampal DG 
and thalamus (Hellström-Lindahl et al., 2008; Higuchi et al., 2005; Iwata et al., 2001; Iwata 
et al., 2002; Russo et al., 2005; Yasojima et al., 2001; Yasojima, McGeer & McGeer, 2001). 
It was therefore highly surprising that degradative regulation of CNP was maintained across 
aging in hippocampal tissue particularly.  
Within hippocampus, this could be due to subregional differences in peptide 
degradation. Neprilysin activity is reportedly reduced in DG but maintained in CA1 and CA3 
(Iwata et al., 2002). Feasibly, modifications within a single subregion may be masked by 
inclusion of all regions in a single tissue sample. This indicates identifying subregional 
hippocampal CNP distribution and concentrations in future studies will be critical to further 
understanding of the peptide. However, this is also suggestive of an increase in NPR-C 
receptors within hippocampus because NTproCNP:CNP ratio is influenced by both neprilysin 
(decreased with age) and NPR-C mediated internalisation and degradation. In combination 
with age-dependent changes to peptide production and availability in medial prefrontal, 
retrosplenial and occipital cortices, this provides evidence that variations in CNP synthesis, 
regulation, and availability contributes to age-related cognitive decline. As outlined above, 
these regions are implicated in many changes that occur with aging including facilitation of 
LTD, modifications of glucocorticoid feedback and executive dysfunction (Buckner, 2004; 
Burke & Barnes, 2010; J. J. Kim & Diamond, 2002; Mizoguchi et al., 2009; Swaab & Bao, 
2011). Retrosplenial cortex in particular is thought to act as a key region underpinning 
functions such as episodic memory and navigation, and integration of these with executive 
function (Buckner, 2004; Fjell et al., 2014; Vann, Aggleton, & Maguire, 2009). It is also the 
first cortical region to develop hypometabolism in both mild-cognitive impairment and 
Alzheimer’s disease, possibly contributing to age-related cognitive decline by disconnecting 
frontal and temporal cortical networks (Nestor, Fryer, Ikeda, & Hodges, 2003). It is 
specifically this network identified here, and strongly suggests a contribution of CNP within 
this circuit to age-related cognitive decline. 
These data now encourage several continuing lines of question. Primarily, 
clarification of the interaction between CNP and glucocorticoids of the HPA axis. In 
combination with other recent findings from Professor Espiner’s research group (Wilson et 
al., 2017), these findings suggest a complex interaction between central CNP and HPA axis 
regulation, and their combined influence on stress, memory, and aging. Understanding this 
interaction will likely require clarifying target cells of CNP within cerebral tissue. Neuron-
glia interactions are indicated in a proposed involvement of CNP in cognitive decline 
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(Mahinrad et al., 2016) and additionally suggest CNP should be investigated in relation to 
amyloid-β deposition. Amyloid plaque deposition is associated with nearby astroglial and 
neprilysin upregulation (Apelt et al., 2003) which may in turn associate with local reductions 
in CNP. Additionally, neprilysin may increase with increased severity of Alzheimer’s disease 
pathology (Miners, Baig, Tayler, Kehoe, & Love, 2009), suggesting continued modifications 
to the CNP signalling system in cases of pathological aging. Ongoing research with CNP may 
help clarify why all age-related cognitive decline with amyloid plaque deposition does not 
result in Alzheimer’s disease. It will additionally be of interest to query how and whether 
CNP participates in neurogenesis within DG. Modifications to CNP clearance via NPR-C 
with age could potentially contribute to age-related reductions in neurogenesis and delayed 
maturation of new neurons (Kempermann et al., 1998; Lee, Clemenson, & Gage, 2012; Rao 
et al., 2005; Simpson et al., 2002). Additionally, while this provides initial evidence 
supporting a role for CNP in age-related cognitive decline, further attention should be given 
to other neurological factors wherein CNP may contribute to cognitive decline such as 
modifications to neurovascular function, synaptic regulation, anxiety and memory (Mahinrad 
et al., 2016). 
3.4.4 Limitations and Summary of Findings 
There are several caveats on the assertion that the CNP system contributes to age-
related cognitive decline including that no inferences can be made about cause and effect 
(whether modifications to synthesis or clearance activity precede cognitive decline). First, it 
is not known whether these rats were cognitively impaired. However, rats of the same strain 
and age are used in Chapter 5 and are demonstrated to have spatial and recognition deficits. 
This suggests it is also safe to assume cognitive decline in rats used here. Second, whether 
there were behavioural effects of enrichment, such as improved memory or reduced anxiety, 
was not tested here. If enrichment altered neither behaviour, nor CNP response, this would 
better support the supposition that these changes represent solely age-related neurological 
changes associated with cognitive decline. Third, that this study has not explicitly examined 
concurrent changes in neprilysin, relevant NP receptors or NPPC gene expression in these 
tissues. This was not possible here because of constraints from tissue processing and amounts 
required for RIA. However, NTproCNP is considered a reliable indicator of NPPC expression 
(Schouten et al., 2011; Woodward et al., 2017). Moreover, there is increasing recognition that 
gene expression may not equate with protein concentration at source, which is the primary 
factor determining function. Further research should consider alternative methods, expanded 
upon in Chapter 6. 
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Some of these issues were to be addressed as part of this thesis, but time and financial 
constraints prevented completion of a complementary study. Additionally, that study was to 
include further ROIs including perirhinal cortex, amygdala and the anterodorsal thalamic 
nucleus. Perirhinal cortex receives multiple sensory inputs and, alongside post- and 
entorhinal cortices, represents the major cortical input to the hippocampal formation 
(Burwell, 2006). Additionally, perirhinal cortex is also suggested to be involved in working 
memory, is connected to reward systems, is critical to recognition memory, and may 
participate in age-related recognition deficits (Aggleton & Brown, 2006; Buffalo, Reber, & 
Squire, 1998; Burke et al., 2010; Burwell, 2006; Erickson & Barnes, 2003). The amygdala 
has long been accepted as involved in emotion, but is also critical for emotion based learning 
and memory (Phelps & LeDoux, 2005). Anterodorsal thalamic nucleus has a strong 
localisation of NPR-B receptors, and represents a key node within the extended hippocampal-
diencephalic system, previously mentioned (Aggleton & Brown, 1999). Due to its size and 
location, this region was excluded by tissue acquisition methods and minimum RIA 
requirements. Because CNP and related receptors within these regions seem likely to 
contribute to dysregulation of sensory, emotional and mnemonic integration seen with age-
related cognitive decline based on results observed here, any future research should ensure 
their consideration. 
Although these data are generally limited by only having a single previous study in 
young rats for comparison (Rapley et al., 2018), the pattern of results suggest modifications 
to CNP synthesis and regulation within fronto-temporal networks contributes to age-related 
cognitive decline. This is proposed to occur via NPR-C receptor increases in hippocampus, 
alongside modifications to CNP synthesis and availability within retrosplenial cortex, medial 
prefrontal cortex, and occipital cortex. This latter may generalise to other regions related to 
sensory input. As a broad response to enrichment was not evident compared with young rats, 
this supports an age-related modification, or loss of sensitivity to external stimulus, of the 
CNP signalling system. Additionally, the assumed stress response based on observations 
across the rehousing period may be representative of dysfunction in HPA axis regulation. 
These observations also align with modifications to glucocorticoid feedback and executive 
function changes with age. As with all rodent models, this may not generalise to human 
research and if these generalisations are made, further investigation of the role of Osteocrin in 
relation to NPR-C regulation in primate and human-neocortex will be critical. Whilst CNP-22 
is highly conserved, meaning rodents represent a reasonable model system in this context, it 
is still plausible that CNP-22 and CNP-53 may have a varying role in age-related cognitive 
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decline. Because there is 100% cross-reactivity for the active forms of peptide in the RIA 
used here, it is impossible to determine from these data whether varying effects on each 
active form of the peptide have occurred. This may be especially important to consider in 
future work, because distribution of these two peptide forms varies across neurological 





Chapter 4. CNP synthesis increases in retrosplenial cortex and mammillary 
bodies following spatial reference learning. 
4.1 Rationale 
This study was designed to investigate an association between endogenous measures of CNP 
in relevant cerebral tissues and spatial/episodic-like memory. Various models of rodent 
spatial memory are thought to be representative of an ‘episodic-like’ memory, although 
rodents cannot be claimed to experience episodic memory as in the human experience, per se 
(Aggleton & Pearce, 2001; Morellini, 2013; Morris, 2001; Paul, Magda, & Abel, 2009). 
Nevertheless, rodent models of spatial memory provide an excellent tool in our understanding 
of learning, memory and human degenerative diseases (Aggleton & Pearce, 2001; Morris, 
2001). Aged rodents have deficits in various spatial tasks, which also align with age-related 
spatial learning deficits in humans (Rosenzweig & Barnes, 2003). Thus, in proposing a role 
for CNP as a novel target in cognitive decline, identifying some involvement in a rodent 
model of spatial, episodic-like memory is relevant. Aged rats are impaired in such tasks 
(Bennett et al., 2006; Kim et al., 2010; Lores-Arnaiz et al., 2004; Rosenzweig & Barnes, 
2003), so this study provides an initial approach to determine associations between spatial 
memory and CNP from the perspective of young adult rats. 
At the time of designing this study, no direct involvement of CNP in spatial/episodic-
like memory had been identified. Participation of CNP in spatial memory acquisition and 
consolidation would be expected based on 1) distribution of CNP and NPR-B receptors 
throughout multiple structures generally accepted as underlying rodent spatial memory 
(Aggleton & Brown, 1999; Aggleton & Brown, 2006; Herman et al., 1996; Langub, Watson, 
et al., 1995); 2) previous evidence that CNP contributes to the acquisition and consolidation 
of memory in passive avoidance (Telegdy et al., 2000, 1999); and 3) effects on locomotor and 
exploration behaviours (Barmashenko et al., 2014; Jouvert et al., 2004; Thiriet et al., 2001). 
Seemingly negating these expectations, NPR-BΔKC rats performed no differently to wild-
type counterparts in an object-location task (Barmashenko et al., 2014). Object recognition 
tasks that include a spatial component can be used to model aspects of ‘episodic-like’ 
memory in rodents. However, spatial memory itself is more commonly tested with radial arm 
mazes or the Morris water maze (Aggleton & Pearce, 2001; Hodges, 1996; Morellini, 2013; 
Paul et al., 2009; Vorhees & Williams, 2014) 
One consideration in selection of the radial arm maze (RAM) for this study was to 
minimise any confound of anxiety in the context of CNP and memory (cf Telegdy et al, 2000, 
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1999). Because of its aversive nature (Paul et al., 2009). the water maze was not used. Stress 
levels for rodents are minor in the RAM compared to the water maze (Hodges, 1996). An 
additional advantage of the RAM is its combination of ‘what?’ and ‘where?’ components, of 
‘episodic-like’ memory (Aggleton & Pearce, 2001) providing a long-term learning 
component (reference memory) across trials. Working memory (within trial avoidance of 
arms previously visited) is also required for optimal performance, whereas in the water maze 
generally only one of these aspects can be tested (Hodges, 1996). Reference memory in the 
RAM is often tested by having three to four arms always unbaited, requiring rodents to learn 
avoidance of these arms across successive trials (Vorhees & Williams, 2014). Here, a simpler 
reference memory paradigm used a single always-unbaited arm location (similar to Harland 
et al., 2014) to permit a clear criterion for reference memory learning. 
At the time of design, little could be claimed about CNP and memory except that 
peptide activity contributes to acquisition and consolidation processes in passive avoidance 
(Telegdy et al., 2000, 1999). During acquisition and consolidation of memory, two periods 
are sensitive to inhibition of protein synthesis – immediately following training, and 
approximately four hours later (Abel & Lattal, 2001). In consideration of the process required 
for tissue acquisition, the latter window was selected. This timing most likely captures CNPs 
participation in consolidatory functions, which occur across minutes to days, rather than a 
contribution to memory acquisition, which occurs within the immediate learning context 
(Abel & Lattal, 2001). 
A final consideration in study design was appropriate comparison groups. This 
required control for food restriction which could plausibly affect CNP concentrations (food 
effect citations from lit review), and a ‘disruption’ of the learning process to account for 
CNPs involvement in locomotor and exploratory behaviour (Barmashenko et al., 2014; 
Jouvert et al., 2004; Thiriet et al., 2001). In addition to the primary experimental group 
(“Active Learning” rats – see Methods), a control group of rats were similarly food-deprived 
and exposed to the testing environment, but received no exposure to the RAM nor any 
behavioural training (Methods). This provided baseline measures of CNP in context of food-
deprivation and environmental influences. Learning of the reference component was 
disrupted in a second behaviour group (“Passive-Learning” rats – see Methods). Whereas the 
“Active Learning” rats experienced a standard RAM with free selection of arm choices, 
“Passive Learning” rats were given a forced choice. This was in a manner and with a 
reinforcement history that was yoked to an “Active” learner. Matched within-trial (working 
memory) errors from “Active” learners were intended to serve as interference for the always-
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unbaited arm location across trials (reference memory) and disrupt representation of the 
reference memory location for “Passive” learners.  
Regions of interest for CNP analysis were retained from previous studies (Chapter 3) 
to provide a suitable range of neural structures, many of which contribute to spatial memory 
in the RAM. Hippocampal dependence of the RAM and spatial episodic-like memory is 
widely accepted (Aggleton & Pearce, 2001). Frontal cortical regions (pre- and infralimbic 
cortices) elicit similar deficits in the RAM to hippocampal lesions, and participate in working 
memory and prospective coding aspects of the task (Kesner & Churchwell, 2011; Kolb, 
Pittman, Sutherland, & Whishaw, 1982; Paul et al., 2009; Vertes, 2006). Spatial memory 
deficits have also been described following lesions and disconnections of retrosplenial cortex 
or mammillary bodies (Aggleton, 2010; Aggleton & Vann, 2004; Cain, Humpartzoomian, & 
Boon, 2006; Neave, Nagle, & Aggleton, 1997; Pothuizen, Davies, Aggleton, & Vann, 2010; 
Pothuizen, Davies, Albasser, Aggleton, & Vann, 2009; Santín, Rubio, Begega, & Arias, 
2000; Sziklas & Petrides, 1993, 1998; Troy Harker & Whishaw, 2004; Van Groen, Kadish, & 
Wyss, 2004; Vann & Aggleton, 2003, 2004, 2005; Vann et al., 2009; Vann & Nelson, 2015). 
Occipital cortex provides primary visual information input to several of these structures 
(Aggleton, 2010; Vann et al., 2009; Zhu, Brown, McCabe, & Aggleton, 1995). Retention of 
these ROIs thus provided several key nodes related to the integration of episodic-like 
memory and sensory input (Aggleton & Brown, 1999, 2006; Catani et al., 2013). 
4.2 Methods 
4.2.1 Subjects 
Thirty-six naïve male PVGc rats, aged 7-8 months and weighing between 320 and 395g prior 
to training, were housed in groups of four in standard opaque laboratory cages (45 cm x 27 
cm x 22 cm high). Prior to training, all rats were food deprived to 85% of their free-feeding 
weight, then maintained at 85-90% of this weight during behavioural testing. Twelve rats 
received standard training using a reference memory version of the RAM (see below; Active 
Learning group) and 12 rats experienced a forced choice version of this task, with their 
behaviour yoked to a rat from the Active Learning group (see below; Passive Learning). A 
final group of 12 rats (Control) did not experience any RAM training, but were exposed to 
the training room for the same length of time as both other groups. This group was to provide 
a baseline level of CNP and NTproCNP associated with food deprivation, handling and room 
exposure. Rats were maintained on a reversed light-dark cycle (lights off 0800 – 2000h) and 
colony rooms were maintained at 22°C and 48%rH. Water was available ad libitum. All 
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procedures conformed to the NIH guide for the care and use of laboratory animals and were 
approved by the University of Canterbury Animal Ethics Committee. 
4.2.2 Radial Arm Maze 
Apparatus and testing room 
Active and Passive Learning groups were pre-trained in an eight-arm RAM to run for reward 
(chocolate piece). The RAM consisted of a central wooden platform 35cm in diameter, 
painted black, with eight equally spaced detachable aluminium arms (65cm long x 8.6cm 
wide) with Perspex barriers (25cm high) extended a partial distance (19cm) along the arm 
length to discourage jumping between arms. Food wells (2cm diameter, 1cm deep) were 
located at the end of each arm, and entrance to the arms was controlled by clear Perspex 
doors, operated by the experimenter. The maze was cleaned between rats to reduce odour 
cues within the maze with a disinfectant solution suitable for use with laboratory animals (4% 
ExpressSani). During the testing phase, individual arm positions were pseudorandomly 
ordered (based on order 8 latin square from Drake & Myrvold, 2004) and arm placement was 
changed daily to prevent strategies relating to specific arms as opposed to locations. The 
maze was centrally located in a windowless room (approximately 4m x 4m) with various 
extra-maze cues located on the walls, and the experimenter visible in a constant corner 
location. Additionally, rats were held within the maze room during testing, such that home 
cages on a trolley provided a further extra-maze cue. Figure 4.1 shows rats exploring the 
apparatus during pre-training. 
 




Rats in their home cages were familiarised to the maze room on the first day for four to five 
hours. On days two and three, rats freely explored the maze with their cage mates. All maze 
doors were held open and chocolate pieces were scattered liberally on the maze floor. Rats 
then foraged individually in the open maze for ten minutes on days four and five, with 
chocolate pieces restricted to four pieces on each arm and four in each food well. Operation 
of the doors was introduced on day six, and chocolate reduced to two pieces in each food 
well. Rats were placed on the centre platform and all doors opened to allow the rat to enter an 
arm. Doors were opened for approximately 30 seconds, and if the rat did not enter an arm, 
closed again for approximately 30 seconds. This was repeated until rats successfully entered 
an arm, after which all other doors were closed until the rat re-entered the centre platform. 
After a brief confinement (~3 seconds) all doors were opened again and the rat allowed 
another arm entry. This continued for 10 minutes, 20 arm visits or until all rewards were 
claimed (whichever occurred first). This procedure was repeated on days 7 and 8, by which 
time all rats were successfully running for reward. 
Testing 
For Active Learning rats, the procedure was the same as that from the final days of pre-
training. Rats were placed on the central platform; all doors were opened and the rat allowed 
to freely choose an arm to gain reward (2 x 0.1g chocolate pieces) before returning to the 
central platform. The key difference during testing was that one arm location remained un-
baited throughout the testing period (consistent for a given rat, but varied across rats) 
providing a reference memory component in the task. The same criteria as during pre-training 
dictated completion of a session on a given day – 10 minutes, 20 visits, or all rewards 
claimed. Repeating an arm already visited within a session constituted a working memory 
error and entering the un-baited arm constituted a reference memory error (and a working 
memory error if it was repeated within a session). Rats were tested for a minimum of 15 days 
(maximum 35) until reaching a criterion of 2 out of 3 sessions without visiting the un-baited 
arm and with no more than 5 working memory errors across these 3 sessions.  
Maze experience for Passive Learning rats was yoked to an individual in the Active 
Learning group, such that the critical behavioural difference was that Active Learning rats 
made free choices of arm entries, and Passive Learning rats experienced forced choices, 
including repeats of arms where corresponding Active Learning rats made errors. In addition 
to matched arm entry, total time spent in the maze for Passive Learning rats was matched to 
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Active Learning counterparts as closely as possible. Control rats were held in the testing 
room for the same amount of time as Active and Passive Learning rats for each day of 
training and testing. For practical purposes, training of rats was staggered into three 
replications, with start dates for each replication separated by two weeks. Each replication 
constituted four rats from each group. 
4.2.3 Sacrifice and tissue extraction 
After reaching criterion, rats were returned to their colony room and fed per usual testing 
days. Sacrifices began approximately four hours after criterion and were conducted such that 
a “trio” of Active Learning, Passive Learning and Control rats were euthanized and tissues 
acquired in that order, to have approximately equivalent time for each rat between maze or 
room exposure and sacrifice (that is, based on the order in which they were tested earlier in 
the day). On days that multiple rats reached criterion, some variance was introduced to this 
interval, and the potential influence of this variation was examined in initial data analyses 
(4.2.5 Statistical Analyses). Sacrifice and tissue acquisition methods were the same as 
described in Chapter 3 
4.2.4 Tissue preparation and peptide measurements 
Tissue preparation, peptide extraction, CNP and NTproCNP assays were conducted as 
outlined in Chapter 3. During protein extraction, all tissues from individual rats and from a 
“trio” of rats were extracted together. CNP assays had a detection limit of 0.6 pmol/L and 
ED50 of 7.3 pmol/L; intra- and inter-assay coefficients of variation were 5.9 and 7.4%, 
respectively, at 17 pmol/L. NTproCNP assays had a detection limit of 0.4 pmol/L and ED50 
9.9 pmol/L; intra- and inter-assay coefficients of variation were 6.8 and 7.5%, respectively, at 
45 pmol/L. Protein extractions prior to assays in this experiment may have been less efficient 
than expected, indicated by reduced values acquired from QC standards in both CNP and 
NTproCNP assays. Although absolute values for both molecules were possibly reduced, 
relative concentrations for regions within single rats and between rats were likely maintained 
(T. Prickett, personal communication). 
4.2.5 Statistical Analyses 
CNP, NTproCNP and NTproCNP:CNP ratios were expressed and calculated as previously 
described (Chapter 3). Values from four tissues were excluded due to contamination or loss 
of tissue during processing: one retrosplenial cortex sample, one sample from left 
hippocampus and two samples from medial prefrontal cortex. For all other regions of interest, 
total N = 36, with N = 12 for each of the Active Learning, Passive Learning and Control 
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groups. Preliminary data analysis indicated that hippocampal concentrations were equivalent 
across hemispheres, so subsequent analysis used the average concentration from left and right 
hemispheres (except from one Passive Learning rat where only right hippocampus was 
available). Inspection of whether the use of three replication groups affected peptide 
measures indicated that replication had no effect, and was not considered further. Analyses of 
the effect of group on peptide measures used One-way ANOVA, followed up with robust 
one-way ANOVAs using medians to account for assumption violations and potential outlying 
values (see Wilcox & Keselman, 2003). Corresponding robust post-hoc comparisons between 
medians were conducted in the case of significant omnibus tests. As statistical tests were 
conducted on medians, data is presented as traditional boxplots 
4.3 Results 
Due to concern regarding peptide extraction efficiency, overall concentrations are first 
compared to previous reports. Generally, tissue concentrations of CNP were consistent with 
previous reports (Jankowski et al., 2004; Komatsu et al., 1991; Pemberton et al., 2002; 
Totsune et al., 1994; Wilson et al., 2017) and with concentrations reported in Chapter 3. 
NTproCNP concentrations were consistent with those reported in Chapter 3, with all ROIs 
exhibiting similar 50% reductions compared to the report of Wilson et al (2017). Overall, this 
suggests peptide extraction was of an acceptable efficiency. An exception was seen in 
hippocampal tissue. CNP concentrations were mildly reduced compared to those in Chapter 3 
and the report of Wilson et al (between 350 and 700 fmol/g here, versus 500 to 1000 fmol/g 
in Chapter 3 and Wilson et al., 2017; Figure 4.2). NTproCNP concentrations were consistent 
with those in Chapter 3 (see Figure 4.3), but NTproCNP:CNP ratio values were mildly 
increased compared with those reported in Chapter 3 (ratios between 2 to 4 in Chapter 3 and 
between 3 and 5 here – see Figure 4.4). The combined increase in ratio with reduction in 
CNP is internally consistent, suggesting a true difference from previous data (i.e. presented in 
Chapter 3 and Wilson et al, 2017). Hippocampal concentrations were not affected by 
behaviour group (4.3.2: Peptide Measures; Figures 4.2 – 4.4). Overall this finding suggests 
that manipulations relating to food deprivation and handling may have influenced peptide 




Figure 4.2: Boxplot with individual data points for CNP concentrations by behaviour 
group in dorsal hippocampus. All groups equal. Concentration reduced compared with 
Chapter 3. 
 
Figure 4.3: Boxplot with individual data points for NTproCNP concentrations by 





Figure 4.4: Boxplot with individual data points for NTproCNP:CNP ratio by behaviour 
group in dorsal hippocampus. All groups equal. Values increased compared to Chapter 3. 
4.3.1 Acquisition by Active Learning group 
Eight of 12 rats in the Active Learning group reached behavioural criterion (2/3 sessions with 
no reference memory error; <5 total errors across these sessions) in less than 20 days. Three 
rats reached criterion between 30 and 35 days, and one rat did not reach criterion by the 35-
day end-point. Figures 4.5 and 4.6 show working and reference memory errors respectively 
for individual rats in the Active Learning group; Passive Learning rats’ performance was 
matched to this via forced arm choice, and Control rats were not tested on the RAM. In all 
ROIs, number of days to reach criterion had no relationship with CNP (all rs < .10, all ps > 
.562), NTproCNP (all rs < .27, all ps > .118) or the NTproCNP:CNP ratio (all rs < .17, all ps 
> .310). As varying time to reach criterion had no apparent effect, all rats were retained for 




Figure 4.5: Total working memory errors summed across five-day blocks of trials for 
Active Learning group (12 rats) in the radial arm maze. 
 
Figure 4.6: Total reference memory errors summed across five-day blocks of trials for 
Active Learning group (12 rats) in the radial arm maze. 
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4.3.2 Peptide measures 
NTproCNP concentrations in retrosplenial cortex differed across groups (robust ANOVA: F 
(2, 11.49) = 5.20, p = .025; Figure 4.7). Examination of Figure 4.7 shows that NTproCNP 
was elevated in Active Learning rats compared to both Passive Learning and Control groups. 
Post-hoc comparisons confirmed a significant difference between Control and Active 
Learning rats (Median difference = 292.89, Ψ = -327.16, p = 0.010, CI of the estimate: [-
620.03, -34.29]), but the difference with Passive Learning rats failed to reach significance 
(Median difference = 138.11, Ψ = 218.11, p = .086, CI of the estimate: [-101.74, 537.97]). 
Control and Passive Learning rats did not differ (Ψ = -109.05, p = .196, CI of the estimate: [-
333.46, 115.36]. No effects were found for CNP concentrations or the NTproCNP:CNP ratio 
(Figures 4.8 and 4.9).  
NTproCNP concentrations also differed across groups in mammillary bodies (robust 
ANOVA: F (2, 13.96 = 4.08, p = .040; Figure 4.10). NTproCNP concentrations were elevated 
in both Active Learning and Passive Learning rats compared to Controls (Control vs Active 
Learning: Median difference = 1133.89, Ψ = -1018.46, p = .036, CI of the estimate: [-
2202.99, 166.08]; Control vs Passive Learning: Median difference = 1329.18, Ψ = -1096.76, 
p = .018, CI of the estimate: [-2199.87, 6.34]). Active and Passive Learning rats did not differ 
(Ψ = -78.31, p = .860, CI of the estimate: [-1251.81, 1095.20]). As in retrosplenial cortex, 
there were no effects for CNP or the NTproCNP:CNP ratio (Figures 4.11 and 4.12). All other 
effects were null and are provided with supplemental figures in Appendix A: Supplemental 




Figure 4.7: Boxplot with individual data points for NTproCNP concentrations by 
behaviour group in retrosplenial cortex. Active ≥ Passive = Control. 
 
Figure 4.8: Boxplot with individual data points for CNP concentrations by behaviour 




Figure 4.9: Boxplot with individual data points for NTproCNP:CNP ratio values by 
behaviour group in retrosplenial cortex. All groups equivalent. 
 
Figure 4.10: Boxplot with individual data points for NTproCNP concentrations by 




Figure 4.11: Boxplot with individual data points for CNP concentrations by behaviour 
group in mammillary bodies. All groups equivalent. 
 
Figure 4.12: Boxplot with individual data points for NTproCNP:CNP ratio values by 




Only three previous studies have directly examined CNP’s role in memory behaviourally 
(Barmashenko et al., 2014; Telegdy et al., 1999, 2000). Studies of alternative behavioural 
tasks, not directly influenced by an anxious response are necessary to broaden understanding 
of CNPs proposed role in memory formation. Additionally, identifying participation of CNP 
in spatial/episodic-like memory in adult rats without impairment is critical to fill a gap in 
research relating CNP with memory, and support the assertion that it may be involved in age-
related cognitive decline at a later stage when this type of memory is known to be impaired. 
The current study used a typical RAM reference memory task, with a behavioural comparison 
group (“Passive Learners”) in which interference was introduced to the reference memory 
component via forced arm choice, yoked to a freely navigating rat. Tissue samples were taken 
from six ROIs, approximately four hours after rats actively learning the task reached a 
criterion, indicating that memory for the reference location had been acquired. “Active 
Learning” rats had increased concentrations of NTproCNP (indicative of peptide production) 
in retrosplenial cortex. Additionally, both “Active Learning” and “Passive Learning” groups 
had increased NTproCNP in mammillary bodies. This is the first study to show modifications 
to endogenous CNP activity following a spatial memory task. Specifically, these data indicate 
that novel CNP synthesis occurs in both retrosplenial cortex and mammillary bodies during 
consolidation of spatial reference memory but is restricted to mammillary bodies when 
reference memory is disrupted. 
Upon initial inspection, these data indicate that behavioural interference with the 
reference component of the task was successful. Lesions of retrosplenial cortex result in 
reference memory deficits in the Water Maze and Radial-Arm Maze, but lesion-induced 
deficits for working memory aspects of RAM tasks are inconsistent (Aggleton & Vann, 2004; 
Aggleton, 2010; Harker & Whishaw, 2004 for reviews). Mammillary body lesions result in 
deficits of spatial working memory in both the RAM and Morris Water Maze (Neave et al., 
1997; Santín et al., 2000; Sutherland & Rodriguez, 1989; Sziklas & Petrides, 1993; Vann & 
Aggleton, 2003), but have no effect on reference memory (Santín et al., 2000). Furthermore, 
while the mammillary bodies are important for encoding allocentric cues, interactions 
between retrosplenial cortex and mammillary bodies are proposed to be responsible for 
translation of allocentric to egocentric cues and the separation of distinctive episodes 
(Burgess, 2002; Vann, 2010; Vann & Aggleton, 2004; Vann et al., 2009). Here, when rats 
could not separate distinctive reference location episodes (Passive Learners) no such 
interaction between these regions was apparent. Combined with the current observations, this 
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suggests CNP production contributes to both spatial and episodic-like memory encoding, and 
can be variably elicited in neurological subregions based on the type of memory encoded. 
Elevations of NTproCNP indicate novel peptide synthesis within these regions during 
the four-hour delay between criterion and tissue acquisition. As a biologically inactive by-
product of CNP synthesis and secretion, NTproCNP provides a more reliable marker of 
NPPC gene expression than CNP (Schouten et al., 2011; Woodward et al., 2017). Failure to 
detect a commensurate increase in CNP suggests other processes are involved in addition to 
NPPC expression. Reasons for this anomaly may include variable and/or increased loss of 
CNP at source due to activation of known degradative/clearance pathways, and variable loss 
during or after sample collection.  
Possible effects of these experimental manipulations in hippocampal formation also 
deserve consideration. While reductions in hippocampal CNP, alongside slight increases in 
degradative ratio may be an effect of general handling and environmental exposure across all 
groups, this finding seems to support previous reports of a relationship between CNP, food 
intake and energy expenditure (Inuzuka et al., 2010; Prickett et al., 2010; Prickett et al., 2007; 
Yamada-Goto et al., 2013). Interestingly, the same pattern of CNP reduction in plasma due to 
increased degradation or clearance occurred during caloric restriction in sheep (Prickett et al., 
2010). Data acquired here suggest a similar effect can occur centrally following manipulation 
related to a peripheral bodily system. Reductions of CNP would suggest a shift towards LTP 
within hippocampal tissues. These reductions may also align with previous reports indicating 
caloric restriction enhances cognitive performance and hippocampal neurogenesis (Kent, 
Oomen, Bekinschtein, Bussey, & Saksida, 2015). Though this study was not designed to 
examine effects of calorie restriction on central CNP, further investigation of the inter-
relationship between cognition, food intake and energy expenditure related to CNP is 
warranted. 
Also intriguing is a relationship between CNP, retrosplenial cortex and LTD. As 
previously mentioned, elevated CNP activity shifts synaptic plasticity towards LTD in 
hippocampus (Decker et al., 2008; 2009; 2010). In retrosplenial cortex slices, only LTD can 
be stimulated (Garden et al., 2009). This suggests that CNP may regulate a shift towards LTD 
in this region during memory consolidation. How this occurs and contributes to memory 
consolidation will require further elucidation. Initially it provides an interesting target for 
broadening our understanding of CNP, LTD and retrosplenial cortex in the neurological 
process of memory formation. 
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One concern of note regarding this data set is whether there may be an effect of 
variable learning rates. Although no relationship was identified between time to reach 
criterion and any CNP measure (Section 4.3), four rats (with their yoked counterparts) took a 
notably longer time to reach criterion than others, with one of these rats unable to reach 
criterion by the 35-day end-point. Exclusion of the rat unable to reach criterion from data 
analyses (data not shown) nullifies the statistical effect found in mammillary bodies for 
passive learners only, but not active learners. Effects identified in retrosplenial cortex remain. 
Exclusion of all slow learning rats nullifies all statistical effects. However, median values of 
NTproCNP in both mammillary bodies and retrosplenial cortex remain elevated beyond the 
interquartile range for active learners. This indicates loss of statistical effects arise due to a 
reduction in power to detect said effects, not a loss of the difference per se. Additionally, it 
suggests elevated concentrations of NTproCNP in mammillary bodies alone for passive 
learning rats may reflect an effect in these slow learning rats. Reasons for why this may be so 
are impossible to glean from this data. Mammillary bodies have been long known to 
contribute to memory processes, but have received renewed attention in recent years since 
their specific contribution is still unclear (for example, see Vann review “two memory 
systems”). Varying contributions of separate mamillary nuclei may be a contributing factor in 
this limitation here. In addition to further investigation of CNP in retrosplenial cortex 
indicated by these data, mammillary bodies should gain further consideration in future work. 
Like much research, this study raises more questions than it answers. For example, 
does novel CNP synthesis occur in other regions relating to spatial and episodic-like memory 
during various stages of acquisition and consolidation? Extending on this, is CNP synthesis 
required for certain types of memory formation, or can stored peptide be released and used on 
an as needed basis? As the timing of sample acquisition and criterion used here may represent 
an occasion of re-consolidation, does peptide synthesis vary during an initial consolidatory 
episode? What is the time course of CNP activity within this interacting neurological 
network? Is this novel synthesis neuronal or glial in origin, and which cell type is targeted? 
Can other interactive effects of CNP be identified by extending ROIs and tasks tested? Of 
interest will be hippocampal subregions which serve differing roles in information processing 
(e.g. Gilbert, Kesner, & Lee, 2001; Hunsaker & Kesner, 2008) and wherein CNP can modify 
synaptic plasticity (Barmashenko et al., 2014; Decker et al., 2008; 2009; 2010). Although 
RIA provides a valuable tool as it is both highly sensitive and specific, regionally specific 
analysis within rodent brain is limited by tissue volume requirements. Continued use of RIA 
analysing CNP in rodent brain would be best complemented by microdialysis experiments. 
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Employment of both designs will allow insight into sub-regional CNP activity, and timing of 
events in the CNP signalling system. 
Though limited in its conclusions, this study provides important supporting evidence 
for CNP as a novel target in age-related cognitive decline. Specifically, coinciding findings of 
possible age-related retrosplenial modification of CNP synthesis (Chapter 3), and 
retrosplenial CNP synthesis during episodic-like memory consolidation, indicate that the 





Chapter 5. CNP-22 variably affects “pattern separation” of memory, based 
on stimulus overlap 
5.1 Rationale 
Rats for this study were initially cannulated to examine effects of infused CNP on a working 
memory task in the RAM. Additional complications arose during this initial study from 
difficulties in locating appropriate cannulation co-ordinates during pilots. This unfortunately 
led to a long delay before surgery could be conducted on these rats, resulting in cannulation 
at approximately 14 months old (see Methods). Figure 5.1 summarises the timing of this 
unforeseen delay, the initially chosen task (not reported here; below), and the eventual study 
design (expanded in Methods). 
As previously mentioned, the RAM was selected in preference to the Morris water 
maze due to the aversive nature of the water-maze which makes it sensitive to stress and 
anxiety (Chapter 4; Paul et al., 2009). During RAM training, this cohort of rats were slow to 
learn at 14-19 months old compared with slightly younger rats (8-9 months old). This was 
unexpected given rats were “middle aged,” but may have been an effect of surgery, or rats 
with poorly placed cannulae causing tissue damage. Moreover, infusion of CNP apparently 
increased anxiety as indicated by previous work (Jahn et al, 2001; Montkowski et al., 1998), 
and impacted RAM performance. Rats showed a tendency for greater arm-entry latencies, 
greater time spent on the central platform and more freezing behaviour. Eventual 
identification of adequate cannula placement greatly restricted data available for analysis of 
this behavioural task. Effects of CNP on working memory are thus not reported here, but this 
task and associated general difficulties are mentioned to account for prior behavioural 
experience. Instead, a study was designed examining effects of infused CNP on anxiety in the 
elevated plus maze (EPM), spontaneous location recognition (SLR) and novel object 
recognition (OR). 
Although this thesis is focussed on CNP and memory, apparently increased anxiety 
following CNP infusions required quantification. This provided an opportunity to replicate 
reported anxiogenic effects of CNP (Jahn et al., 2001; Montkowski et al., 1998). 
Additionally, as CNP may be anxiolytic at low doses (Bíró et al., 1996) a dose range was 
selected to capture this possible bidirectional relationship. Based on these three previous 
works, and those investigating effects on passive avoidance learning (Bíró et al., 1996b; Jahn 
et al., 2001; Montkowski et al., 1998; Telegdy et al., 2000, 1999), doses of 0 CNP (Saline), 
200ng, 500ng and 1000ng concentrations of CNP were selected (see Methods for detail). As 
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infusion procedures may also affect anxiety, a ‘Baseline’ condition (no infusion) was 
introduced for all tasks (see Methods). Infusions of CNP were known to be anxiogenic prior 
to this study, thus it was hypothesised that behavioural effects of elevated anxiety at 500 and 
1000ng doses could be replicated in the EPM, and that anxiolytic effects may be evident in 
the low dose range (200ng). 
The mechanism of action and consequences of ventricular administration of CNP are 
only able to be assumed currently based on previous works. Generally, one expects that 
following infusion into lateral ventricles any given infusate would diffuse throughout CSF 
and into cerebral tissue. As previously outlined, CNP can bind to both NPR-B and NPR-C 
receptors, with both accessible from lateral ventricle infusions based on their localisation (J. 
P. Herman, Dolgas, Marcinek, & Langub, 1996; J P Herman et al., 1996; Langub, Watson, et 
al., 1995). Consequences of CNP binding with NPR-B receptor have been previously 
outlined (intracellular increase of cGMP). This receptor can be desensitised via repeated 
exposure to CNP, but no evidence has been found for its internalisation or recycling (Fan, 
Bryan, Antos, Potthast, & Potter, 2005; Potter et al., 2006). Rather, NPR-B is hypothesised to 
release peptide into the extracellular space (Potter et al., 2006). In contrast, NPR-C is known 
to act via internalisation, degradation of peptide and recycling of the receptor into the cell 
membrane (Potter et al., 2006). As both receptors are accessible from ventricular 
administration, IHC is used here to ensure NPR-B related activity is generated by infusions 
(see below). 
Several aspects of CNP indicate it may be involved in pattern separation functions of 
memory. Pattern separation is a term that has arisen from research in computational 
modelling to describe a mechanism whereby similar inputs are transformed into less similar 
outputs, resulting in non-overlapping representations (Bekinschtein et al., 2013; 
Bekinschtein, Oomen, Saksida, & Bussey, 2011; Kent, Beynon, et al., 2015; Sahay, Wilson, 
& Hen, 2011; Yassa & Stark, 2011). This mechanism is a crucial feature for separating 
complex memory representations in episodic memory and increases the likelihood for 
accurate encoding and subsequent retrieval of experiences that may be similar (Kent, Beynon, 
et al., 2015; Yassa & Stark, 2011). Pattern separation occurs during memory encoding, and 
experimental work indicates DG is critical (Aimone, Deng, & Gage, 2011 for review; Gilbert 
et al., 2001; Hunsaker & Kesner, 2008). Because CNP primarily influences memory encoding 
and not recall (Telegdy et al., 1999; 2000), and mRNA expression occurs in CA1 through 
CA3 whereas NPR-B receptors are isolated to DG (Herman et al., 1996; Langub, Watson, et 
al., 1995), an investigation of the peptide in “pattern separation” was indicated. Furthermore, 
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pattern separation deficits are now proposed to account for age-related changes in episodic 
and recognition memory in both rodents and humans (Burke et al., 2010; Yassa et al., 2011; 
Yassa & Stark, 2011). Hence, identifying a contribution of CNP to this process would 
provide valuable information regarding a role in age-related cognitive decline. 
To test possible effects of CNP in pattern separation, a spontaneous location 
recognition task was employed. SLR provides a task of object recognition wherein objects 
themselves are identical, but rodents must identify when an object is presented in a novel 
location (Ennaceur, Neave, & Aggleton, 1997; Warburton, Baird, Morgan, Muir, & 
Aggleton, 2000). A recent modification to this paradigm has been used to test the ability to 
keep complex memory representations distinct (pattern separation) by manipulating distance 
between objects at the time of encoding (Bekinschtein et al., 2013). Additionally, this task 
was previously sensitive to the peptide acyl-ghrelin (Kent, Beynon, et al., 2015), suggesting it 
may also be appropriate for study of CNP. 
Inclusion of SLR necessitated basic recognition testing to ensure rats could 
discriminate between objects generally. Inclusion of novel object recognition (OR) was also 
indicated by findings of Barmashenko and colleagues (2014) – that downregulation of CNP 
signalling improved recognition in the same task – and my own previous work showing 
correlations between better discrimination and lower concentrations of endogenous CNP 
(Rapley, unpublished Master’s thesis). EPM testing was carried out first and as SLR was the 
task of greater interest, it was conducted before OR. 
In addition to above outlined expected  effects on anxiety, higher doses of CNP were 
predicted to decrease exploratory behaviour in all tasks (following from Barmashenko et al., 
2014; Bíró et al., 1996; Jahn et al., 2001; Montkowski et al., 1998). Contrary to previous 
findings that administered CNP could improve memory in a passive avoidance task (Telegdy 
et al, 1999; 2000), here I hypothesised that increasing doses of CNP (500 and 1000ng) would 
interfere with memory acquisition during object recognition but that lower doses (200ng) 
may have a similar beneficial effect to that found by Barmashenko and colleagues (2014). 
This was hypothesised because reduction in CNP signalling improved recognition 
(Barmashenko et al., 2014) and my own work indicated improved recognition was associated 
with reduced endogenous CNP concentrations (Rapley, 2012, unpublished Master’s thesis). 
According to Bekinschtein, Kent and colleagues (Bekinschtein et al., 2013, 2014; Kent, 
Beynon, et al., 2015), control animals discriminate at chance levels (indicated by 
discrimination ratio - d2 ≈ 0) during SLR when pattern separation load is high (Extra-Small 
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separation), and show novelty preference when this load is reduced (Small separation – see 
5.2.2 Behavioural Procedures). This was expected here during Baseline conditions. As SLR is 
fundamentally a task of recognition, the same hypothesis as for OR was applied – that 
increasing doses of CNP would interfere with recognition.  
To test these several hypotheses (that high doses of CNP would increase anxiety on 
the EPM, decrease exploration overall, and interfere with object recognition in both OR and 
SLR tasks), all rats were tested on all possible tasks with all possible doses of CNP (see 
Methods) in a repeated measures design. Adequate cannula placement was achieved in nine 
rats. To ensure infused CNP generated neurological activity, brain tissue was stained for 
cyclic GMP using ABC-DAB immunohistochemistry. By the time rats performed the tasks 
reported here, cognitive impairment was apparent based on inability of most rats to 
discriminate novel locations in the spontaneous location recognition task (See 5.3 Results). 
While unintended, advanced age and cognitive deficits in these rats provides improved 
information for examining CNP during age-related cognitive decline. 
 
5.1 Outline of timing for behavioural tasks and surgery for cohort of rats receiving 
cannulation surgeries. Data from RAM testing is unreported here due to interference with 
the task by CNP infusions (as outlined in text). 
5.2 Methods 
5.2.1 General Methods 
Subjects 
Male PVGc rats (initial N = 42; N at sacrifice = 28 – attrition due to age-related illness; Final 
N (adequate cannula placement) = 9) aged between 13 and 15 months at surgery, were 
initially housed in groups of two to four in standard opaque laboratory cages (45 cm x 27 cm 
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x 22 cm high). Following surgery rats were housed in the same cages individually. Nesting 
paper was provided in each cage and socialisation occurred daily during behavioural tasks in 
groups of two to four rats (also in standard laboratory cages) to ameliorate any effects of 
isolated housing. Wooden gnawing blocks were provided during socialisation to discourage 
chewing of cannulae. Rats were maintained on a reversed 12-hour light-dark cycle (lights off 
0900-2100h), and colony rooms were kept at 22°C and 48%rH. Free feed was provided 
during surgical recovery and throughout all tasks comprising this study. Rats were also used 
to investigate whether infused CNP affected working memory in the RAM (data not reported) 
and experienced food deprivation during that task. Water was available ad libitum. All 
procedures conformed to the NIH guide for the care and use of laboratory animals and were 
approved by the University of Canterbury Animal Ethics committee. 
Surgery 
Rats were unilaterally implanted with a stainless-steel guide cannula (22ga; Plastics One, 
Roanoke) in either the left or right lateral ventricle under Ketamine / Domitor anaesthesia 
(Ketamine 85mg/kg ip followed by Domitor 0.35mg/kg ip) 30 minutes after Carprofen 
(5mg/kg sc) for pain relief. Rats were placed on a stereotactic frame (Stoelting) using 
atraumatic ear bars (Kopf) in a flat skull orientation, such that Bregma and Lambda DV 
coordinates were equivalent. Cannulae were attached to the skull with jewellery screws and 
dental cement. Dummy stylets (Plastics One, Roanoke) were inserted into guide cannulae to 
maintain patency. Location of the lateral ventricle was determined based on coordinates from 
Paxinos and Watson (1998), equivalent to: Bregma -.080 mm; Lateral +/- .14 mm; Ventral 
3.5mm from skull surface (Figure 5.2). Local analgesia (2mg/ml Mepivicaine) was applied at 
the site of incision, followed by Emla analgesic cream after suturing, and anaesthesia 
reversed with Antisedan (2.5mg/kg ip) five minutes after Atropine (0.15mg/mL ip) to reduce 
respiratory distress. All rats recovered for a minimum of one week before behavioural testing 
began. Adequacy of cannula placement was determined by an infusion of methylene blue 15 
minutes prior to sacrifice in combination with cresyl violet staining. 
Peptide infusate and treatment 
CNP was purchased from Bachem (CNP-22, Torrance, CA, USA) and infusate made in a 
stock concentration of 1.0 µg/2 µL (equivalent to 1000ng of CNP in 2µL) by dissolving in 
0.9% Saline under sterile conditions. Aliquots of 50µL stock infusate were stored at -80°C, 
with quantities and dilutions required for this experiment made on a single occasion to reduce 
possible effects of thawing and refreezing. Infusions were made by use of internal cannulae 
72 
 
(Plastics One, Roanoke) which protruded 0.5mm from the stainless-steel guide cannula. 
Internal cannulae were attached to PE50 tubing (Plastics One) and a 10µL Hamilton syringe, 
with administration controlled by an infusion pump (Harvard apparatus). Following the two-
minute infusion period, internal cannulae were left in position for a further two minutes, to 
allow diffusion of infusate away from the infusion site. All rats performed each behavioural 
task with no infusion initially (Baseline) followed by counterbalanced infusions of 2µL 0.9% 
Saline, or a 2µL volume of active infusate containing 200ng, 500ng or 1000ng CNP. 
Infusions occurred 30 minutes before being placed on the EPM or 30 minutes before sample 
trials of SLR and OR tasks. This timing was selected based on work by Bíró et al (1996), 
Montkowski et al (1998), and Jahn et al (2001) indicating effects on the EPM at this period 
post-infusion; and that CNP acts primarily during acquisition and consolidation of memory 
(Telegdy et al, 1999, 2000; SLR and OR tasks). 
Sacrifice and Perfusion 
Following completion of all behavioural tests, rats were given a final infusion of saline, 
200ng, 500ng or 1000ng of CNP in a between-subjects fashion. Assignment to groups for 
final infusion was determined using stratified randomisation based on performance on the 
EPM (following the assumption that anxiety response should be stronger in rats with best 
cannula placement). Five additional rats (excluded due to malfunctioning cannulae) which 
had never received an infusion, provided non-infused comparisons for 
immunohistochemistry. Rats were anaesthetised 30 minutes following final CNP infusion 
(and 15 minutes after infusion of 2µL of methylene blue) with an overdose of sodium 
pentobarbitone (1mL at300mg/mL ip). Once unresponsive to tail pinch and plantar reflex, 
rats were transcardially perfused with 60mL 0.9% saline followed by 60mL of 4% 
paraformaldehyde. Fixed brains were removed from the skull and placed in 4% 
paraformaldehyde prior to transfer to a 0.1M phosphate buffered 20% glycerol solution. Forty 
µm coronal sections were gathered as a 1:5 series using a freezing microtome (Thermo 
Fisher) prior to staining with cresyl violet or storage at -20°C in 40% 0.1M phosphate buffer / 




One series of 40µm coronal sections was mounted on gelatine coated slides and stained with 
cresyl violet for assessment of cannula placement. Sections were delipidised in ascending 
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then descending concentrations (70%, 95%, 100%) of ethanol. Distilled water was used to 
hydrate sections before staining with 0.5% cresyl violet acetate solution, and subsequently 
rinsed in distilled water. Sections were dehydrated and differentiated by immersion in 
solutions of 70% ethanol, 95% ethanol, 95% acid-alcohol (ethanol / glacial acetic acid) then 
100% ethanol, prior to cleaning in Xylene and mounting and coverslipping with Depex 
mounting medium. 
cGMP immunohistochemistry 
Cyclic GMP response was visualised using the ABC-DAB immunohistochemistry method. 
Free-floating sections were washed in phosphate buffered saline containing 0.3% Triton X-
100, then endogenous peroxidase activity quenched with incubation in 3% H2O2 prior to 
incubation in 5% normal goat serum to block non-specific binding of secondary antibody. 
Subsequent incubations contained 1% normal goat serum, and tissues were washed with 
phosphate buffered saline / 0.3% Triton X-100 between each incubation. Tissues were 
incubated overnight in polyclonal Rabbit Anti-cGMP primary antibody (1:8000, Merck 
Millipore, California, USA) then in Biotinylated Goat Anti-Rabbit secondary antibody 
(1:400). Tissues were then incubated in Avidin-Biotin complex (ABC kit, Vector, CA, USA), 
washed with Tris buffer, and antigen binding revealed with Diaminobenzidine (DAB) 
substrate. After final washes in Tris buffer, sections were mounted on gelatine coated slides 
from ice-cold phosphate buffer and allowed to dry before dehydration in ascending alcohols, 
clearing with Xylene and coverslipping with Depex mounting medium. 
Image Acquisition, Analysis and Regions of Interest 
For examination of cannula placement, microscopy images of cannulae tracts were captured 
using a Nikon DS-Fi1 camera mounted on Nikon eclipse E800M microscope at 20x objective 
magnification. Adequately located cannulae are described in section 5.3.1 Cannula 
placement. Cyclic GMP images were obtained using a Leica DFC 7000T camera mounted on 
Leica DM6B microscope at 100x objective magnification. Regions of interest were: 
prelimbic, infralimbic and medial orbital cortices; cingulate gyrus; anterodorsal thalamic 
nucleus; retrosplenial dysgranular and retrosplenial granular B cortices; dorsal hippocampal 
regions CA1, CA3 and DG; hypothalamus sampled from medial arcuate and ventromedial 
nuclei; amygdala containing medial, central, basomedial and basolateral nuclei; perirhinal 
cortex and medial mammillary nucleus. Regions were selected based on a previous 
demonstration of NPR-B receptor localisation, and pertinence of these structures in relation 
to behavioural tasks investigated. For each region of interest, a maximum of three images 
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were captured from each hemisphere, to provide an average density value for a region within 
that hemisphere. All images were processed and neuron density data acquired using FIJI 
(Image J) software. After conversion to grayscale, image backgrounds were subtracted and 
brightness/contrast automatically adjusted. Image noise (introduced in some images by dust 
and/or microbubbles) was reduced by excluding dark outliers smaller than five pixels. Image 
thresholds were adjusted to contain the darkest 2% of pixels, based on the assumption that 
using the most extreme values on the grayscale distribution would most likely represent only 
neurons expressing cGMP, and exclude any background staining, which was widespread 
(Appendix B). Counts were acquired using the FIJI automatic particle analysis operation with 
a size threshold between 4 and 20 µm based on average feret size of neurons from Albasser, 
Poirier, & Aggleton (2010). Counts were expressed as particles per µm2 by dividing particle 
count by total area sampled. 
5.2.2 Behavioural Procedures 
For all tasks, rats were initially tested with no infusion (Baseline) then with four possible 
infusion conditions: 0.9% Saline or 200, 500 or 1000ng CNP meaning each rat performed 
each task five times. The order in which infusions were administered was counterbalanced 
within a task, with several rats allocated to resulting infusion order conditions. Across tasks, 
no rat experienced the same repeated order of infusions. For example, a rat experiencing the 
infusion order 200ng, 500ng, Saline, 1000ng across exposures to the EPM, had different 
orders of infusions (e.g. 500ng, 1000ng, 200ng, Saline) during OR, which differed again for 
both versions of SLR (below).  
Elevated Plus Maze 
Apparatus 
The EPM consisted of two closed and two open arms (50cm long x 10 cm wide), set 
perpendicular to each other around a central platform (15cm x 15cm), raised 1 metre above 
the floor, located in a dimly lit room. Closed arms were made of plywood painted black 
(24.5cm high), with the walls of open arms made of Perspex to prevent rats from falling. 
Previous work (Martínez, Cardenas, Lamprea, & Morato, 2002) has indicated the presence of 
Perspex does not affect aversion to the open arms. Occupancy of and entry to the open arms 
indicates lower levels of anxiety, with entries to closed arms indicative of general activity 




Thirty minutes after infusion, rats were placed on the central platform of the EPM facing an 
open arm. Rats were observed via a CCTV camera mounted above the EPM, by the 
experimenter located in a corner of the room opposite an open arm. Arm occupancy and 
entries were noted every three seconds for five minutes with entry to an arm or location on 
the central platform defined as having all four feet located within the arm or central platform. 
The EPM was cleaned between rats with a disinfectant solution suitable for use with rodents 
(4% ExpressSani). At least one day was interposed between each test to ensure adequate 
clearance time of the infused substance. 
Spontaneous Location Recognition 
This task was based on Bekinschtein et al (2014) and Kent et al (2015). 
Apparatus  
SLR used a black circular arena (90cm diameter, 50cm high) constructed of a Perspex wall 
covered with a black adhesive covering (‘duraseal’) on a wooden base covered with bedding 
(sawdust). The arena was located on the floor of a dimly lit room, with three proximal visual 
cues and varied distal furniture. All trials were filmed by a web camera mounted above the 
arena and videos stored digitally for later exploration quantification. Objects used for this 
task were cans and bottles of various shapes, colours and sizes (maximum 25cm high, 25cm 
circumference) in triplicate, filled with sand to prevent rats tipping the objects over. All 
objects were cleaned between rats with the same disinfectant as used for the EPM, to remove 
potential odour cues. 
Procedure 
All rats were familiarised to the arena across three 10-minute habituation sessions (one 
session per day for three days). SLR consisted of a 10-minute sample, and a five-minute trial, 
24 hours later. Sample and trial phases for the entire cohort of rats ran across four-days, 
providing adequate infusate clearance within sample-trial delay and between individual trials. 
Object arrangement in sample and test phases is visualised in Figure 5.3. Objects were 
arranged in a triangular formation (one at the ‘apex,’ Object A; two at the ‘base,’ Objects B 
and C), located 15cm from the edge, and 30cm from the arena centre, with objects B and C 
equidistant from object A. Two versions of the task were used, where the major difference 
was distance between objects B and C during the sample phase. In the “small separation” 
condition (SM), objects B and C were separated by a 50° angle relative to object A (20.5 cm 
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apart); for the “extra-small separation” condition (XS) these objects were separated by 40° 
(15.4cm apart). All rats completed both separation conditions in a counterbalanced order (i.e. 
half experienced “small” condition first, and half experienced “extra small” first) at any given 
dose of peptide. For sample trials (30 minutes post-infusion), rats were placed centrally in the 
arena with three identical objects, and allowed to explore freely. During test phase, rats were 
placed in the arena with two object copies – one located as previously (object A; familiar 
location), and the other located centrally between object B and C locations (novel location). 
Recognition of the now centrally located object as novel was indicated by exploration 
preference for this object during the test trial. Exploration of an object included directing the 
nose or forepaws towards the object (<1cm) with vibrissae twitching, and excluded sitting on, 
chewing, or using the object to rear. Exploration was quantified by the experimenter from 
videos using a computer based stopwatch program which accumulated time based on 
keypress during exploration. 
Object Recognition 
Apparatus  
OR used a wooden arena (80cm x 80cm x 80cm high) painted black, with a sawdust covered 
floor, elevated 72cm above the floor of a dimly lit room. Objects used were ‘knick-knacks’ 
(e.g. egg cup, coloured cube, espresso cup) of assorted colours, textures and sizes (maximum 
15cm high, 8cm wide), held down by blu-tack to prevent rats from tipping them over. Objects 
were placed equidistant from each other and arena walls (see Figure 5.4 for configuration). 
All objects were cleaned between rats with disinfectant solution to reduce odour cues, and all 
trials were filmed with a web camera mounted above the arena. Videos were again stored 
digitally for later quantification of exploration. 
Procedure 
Rats were familiarised to the OR arena across three daily five-minute habituation sessions. 
OR consisted of sample (5 minutes; 30 minutes after infusions) and trial (5 minutes) phases, 
separated by a 24-hour delay, again allowing adequate infusate clearance. During the sample 
phase, rats were placed in the arena with two copies of a novel object (object A1 and object 
A2) and allowed to explore freely. Following a 24-hour delay, rats were returned to the arena 
which contained one copy of object A, plus another completely novel object (object B). 
Recognition of object A as familiar is indicated by a preference for exploring the novel object 
during the trial. Objects within a pair (A/B) were counterbalanced for use as the sample 
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object (half of rats experienced A in sample trial, half experienced B), as was novel object 
location within the trial phase. Exploration was classified and quantified as for SLR. 
Order and timing of behavioural tasks 
Prior to surgery, rats were pre-trained to run in a radial arm maze. Surgery occurred when rats 
were between 13 and 15 months old. Following a minimum one week surgical recovery, rats 
were trained on a working memory task in the RAM, before completing EPM, SLR and OR 
testing at between 19 and 23 months of age. At final sacrifice rats were between 21 and 23 
months of age (see Figure 5.1). 
5.2.3 Statistical Analyses 
Following identification of adequately placed cannulae, final N for analyses was 9 rats (N=9). 
Three dependent variables were calculated for EPM – percent time spent in the open arm (as 
a proportion of time spent in either arm), percent entries to the open arm (as a proportion of 
total entries to either arm) and number of entries to the closed arm. Exploration times (in 
seconds) for individual objects in both OR and SLR tasks were used to calculate total 
exploration time within sample trials. Recognition in both tasks was quantified by calculating 
the discrimination ratio (d2) which varies between -1.0 and +1.0, with positive values 
indicating novelty preference. The ratio is calculated by taking the difference in exploration 
time for the novel and familiar object during the trial phase and dividing that difference by 
total exploration time for both objects within the trial (i.e. novel object exploration – familiar 
object exploration / total exploration time). Cyclic GMP expression was quantified as a 
density measurement, particles per µm2, as outlined in 5.2.1.6 Image Acquisition, Analysis 
and Regions of Interest. 
All data analyses included initial checks that assumptions were met for relevant 
statistical tests. Initial analyses for OR and SLR data ensured that object copies were 
explored for equivalent times during sample trials using dependent means t-tests for OR 
(object A1 vs object A2) and one-way repeated measures ANOVA (object A vs B vs C) for 
SLR, followed by dependent means t-tests (location A vs location B+C). For the EPM and 
OR tasks, one-way repeated measures ANOVAs were conducted on each dependent variable. 
SLR exploration time and d2 were analysed using 2 x 5 (Task x Infusion) repeated measures 
ANOVA in a linear mixed effects model framework. All models were tested using 
polynomial contrasts, given the ordered nature of infusion conditions (linear for effect of 
Task in SLR; linear, quadratic, cubic and quartic for effect of Infusion in all analyses). Effect 
sizes (Pearson’s r) were calculated on significant trends. 
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As final infusions for cyclic GMP analysis were administered in a between-subjects 
fashion, this unfortunately resulted in small final Ns for varied infusion groups. As such, data 
were pooled into “Non-active” and “Active” infusions representing rats which received no 
infusion or Saline (N = 7; “Non-active”), versus rats which received final infusions of any 
CNP dose (N = 7; “Active”). This is recognised as problematic, but a preferable alternative to 
no analysis. Analyses were conducted by 2 x 2 (Infusion type x Hemisphere) repeated 
measures ANOVA for each region of interest. Medial mammillary nucleus was not separated 
by hemisphere, thus was analysed by independent means t-test. Effect sizes are reported as 
partial-eta squared for ANOVAs and Cohen’s d within mammillary bodies. 
 




Figure 5.3: Visual representation of spontaneous location recognition arena. Black stars 
indicate object locations in sample phase. Gray diamond indicates central novel location 
during trial phase. 
 
Figure 5.4: Visual representation of object recognition task. Gray stars indicate object 




5.3.1 Cannula placement 
Figures 5.5 A, B and C provide approximate locations of centrally located cannulae in rats 
retained for behaviour analysis and rats used as non-infused immunohistochemistry controls. 
Examples of cGMP immunostaining are provided in Appendix B. Note that one rat had a 
cannula located within the corpus callosum and was not included in behavioural analysis. 
This rat was retained to increase numbers for “Inactive” cGMP immunohistochemistry and 







Figure 5.5A, B, C: Approximate locations of cannulae tips (white circles) within lateral 
ventricles of rats retained for analyses. Note: single rat with non-central cannula was a 







5.3.2 Elevated Plus Maze 
Infusions did not affect percent of time spent in the open arms of the EPM (F (4, 32) = 0.68, p 
= .610, generalized η2 = 0.044) and no trends were evident across doses (all ts < 1.17, all p’s 
> .250; Figure 5.6). Although statistical tests were non-significant, 1000ng infusion of CNP 
exhibited a trend towards a reduced percent of time spent in the open arm compared with all 
other infusion conditions (mean difference compared with Saline infusion = 9.78). Infusions 
also did not affect percent entries to the open arm in the EPM (F (4, 32) = 0.83, p = 0.515, 
generalized η2 = 0.068), and no trends were evident (all ts < 1.40, all ps > .171; Figure 5.7). 
Infusions did affect number of entries to the closed arm (F (4, 32) = 2.79, p = .043, 
generalised η2 = 0.196; Figure 5.8) indicating an influence of CNP on general activity. A 
significant quadratic relationship across doses was identified (t (32) = 3.13, p = .004, r = 
0.484). Inspection of Figure 5.8 shows any Infusion (Saline) decreased closed arm entries. 
Entries were further decreased by 200ng CNP then increased across 500ng and 1000ng dose 
conditions. This indicates that infused CNP alters motor activity of rats in a dose dependent 
manner. 
Figure 5.6: Mean [± 95% CI] and individual percent time spent in open arms of the 




Figure 5.7: Mean [± 95% CI] and individual percent entries to open arms of the elevated 
plus maze across infusion conditions. No significant effects. 
 
Figure 5.8: Mean [± 95% CI] and individual number of entries to closed arms of the 
elevated plus maze across infusion conditions. Significant quadratic trend – infusion 
decreases activity. Low dose CNP decreases further, then increases with increasing dosage. 
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5.3.3 Spontaneous Location Recognition 
Initial analysis indicated that rats preferentially explored “Object A” compared with Objects 
“B” and “C” during the Sample trial for both the Extra-Small (XS) separation condition and 
the Small (SM) separation condition (Table 5.1; But note XS, 500ng condition and SM, 
1000ng condition). As “Object A” was in a separate location to Objects “B” and “C,” 
exploration times for objects B and C were combined, and dependent means t-tests indicated 
that exploration between the two maze locations was equivalent during sample trials for both 
tasks (Table 5.1) 
Total exploration during SLR sample trials was affected by both the separation 
condition and CNP infusions (effect of Task (χ2 (10) = 6.33, p = .012; F (1, 40) = 6.06, p = 
.018; effect of Infusion: χ2 (9) = 15.26, p = .004; F (4, 32) = 4.18, p = .008) but there was no 
interaction between the two (Interaction effect: χ2 (14) = 2.85, p = .583; F (4, 40) = 0.65, p = 
0.634; Figure 5.9). Rats explored less during XS conditions than SM conditions (Linear effect 
of Task: t (44) = 2.48, p = .017, r = 0.35). The Infusion effect had significant linear (t (32) = -
2.75, p = .010, r = 0.44) and quadratic (t (32) = 2.22, p = .033, r = .37) trends. Figure 5.9 
indicates that the introduction of an infusion (Saline vs Baseline) reduced exploration, which 
was then reduced further by an infusion of 200ng CNP in both tasks. 500ng of CNP increased 
exploration compared with 200ng doses in both tasks, with exploration not affected further by 
a 1000ng Dose in the SM task. In the XS task, a 1000ng Dose decreased exploration. This 
effect in the XS task is mitigated by the exclusion of two outlying rats (see Figure 5.9) from 
analyses. When these outliers are excluded (data not shown) the same effects of significant 
linear and quadratic trends across dose are found. Exclusion of these data points accounts for 
a lack of significant interaction (Task x Dose) in the data, when Figure 5.9 indicates 
exploration varies by dose and task at 1000ng of CNP in the XS task. Mean values for this 
condition following this exclusion are no longer significantly different to 1000ng CNP dose 
in the SM condition (data not shown). Overall, this indicates CNP modifies exploratory 
behaviour and does so in a dose dependent manner. 
One expectation for discrimination data was that rats would discriminate at chance 
levels (d2 ≈ 0) in the XS task and show a novel location preference in the SM task at 
Baseline. Instead, rats performed at chance on average in the SM separation condition, and 
showed a familiarity preference during the XS separation condition (Figure 5.10). This 
suggests rats on average were impaired compared to control rats reported by Bekinschtein et 
al (2014) and Kent et al (2015). Discrimination was not affected by Infusions or Task type 
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overall (Effect of Infusion: χ2 (9) = 1.68, p = .794; F (4, 32) = 0.57, p = .454; Effect of Task 
(χ2 (10) = 0.54, p = .464; F (1, 8) = 0.29, p = .607). Although the Interaction between Task 
and Infusion was non-significant (F (4, 40) = 1.94, p = .123), its inclusion within the linear 
mixed-effects model introduced a substantial (non-significant) improvement in model fit (χ2 
(14) = 7.97, p = .093). Within this model, there was a significant Linear trend interaction 
(Linear trend of Infusion x Linear trend of Task; t (40) = -2.36, p = .023, r = 0.35). Inspection 
of Figure 5.10 indicates that this Interaction occurred via a tendency for d2 to increase across 
Infusions in the XS task, but decrease across Infusions in the SM task. CNP therefore 
modifies location discrimination in a dose dependent manner, and its effect varies with 




Table 5.1: Mean [±95%CI] exploration time of each object (A, B, C) and exploration time of location (B+C) with accompanying repeated 
measures ANOVA (objects) and dependent t-tests (location) during spontaneous location recognition sample trials. Note: object A values are 
compared to B+C values for location comparison t-test. 
Condition A Mean [±95%CI] B Mean [±95%CI] C Mean [±95%CI] ANOVA B+C Mean [±95%CI] t-test 
Extra-Small       
Baseline 20.21 [11.88, 28.54] 11.12 [5.95, 16.29] 10.40 [3.89, 16.91] F (2, 16) = 18.27, p < .001 21.52 [10.25, 32.79] t (8) = -0.56, p = .591 
Saline 14.41 [9.65, 19.17] 7.75 [4.94, 10.56] 6.90 [3.63, 10.17] F (2, 16) = 16.68, p < .001 14.64 [8.82, 20.46] t (8) = -0.12, p = .908 
200ng 11.93 [9.28, 14.58] 6.52 [4.30. 8.74] 5.78 [3.47, 8.09] F (2, 16) = 7.89, p = .004 12.30 [10.16, 14.44] t (8) = -0.21, p = .840 
500ng 11.78 [8.45, 15.11] 10.09 [5.66, 14.52] 7.35 [4.71, 9.99] F (2, 16) = 2.27, p = .136 17.43 [11.61, 23.25] t (8) = -1.90, p = .094 
1000ng 11.54 [7.05, 16.03] 4.98 [3.16, 6.80] 5.47 [3.53, 7.41] F (2, 16) = 10.20, p = .001 10.46 [7.32, 13.60] t (8) = 0.56, p = .593 
Small       
Baseline 17.78 [12.94, 22.62] 12.54 [9.28, 15.80] 12.39 [7.52, 17.26] F (2, 16) = 4.56, p = .027 24.93 [17.22, 32.64] t (8) = -2.16, p = .063 
Saline 14.90 [10.88, 18.92] 11.74 [8.21, 15.27] 7.71 [4.08, 11.34] F (2, 16) = 4.68, p = .025 19.45 [8.15, 30.75] t (8) = -1.11, p = .301 
200ng 13.63 [11.49. 15.77] 8.71 [4.16, 13.26] 6.51 [4.23, 8.79] F (2, 16) = 8.12, p = .004 15.22 [9.24, 21.20] t (8) = -0.56, p = .589 
500ng 16.52 [12.01, 21.03] 10.93 [6.02, 15.84] 9.50 [5.01, 13.99] *F (2, 16) = 7.42, p = .005 20.43 [11.51, 29.35] t (8) = -1.12, p = .295 
1000ng 16.01 [11.18, 20.84] 10.40 [4.54, 16.26] 9.31 [5.27, 13.35] F (2, 16) = 2.96, p = .080 19.71 [13.04, 26.38] t (8) = -1.17, p = .275 






Figure 5.9: Mean (circles) ±95% CI exploration time (seconds) and individual data 
(squares) during spontaneous location recognition sample phase. XS = extra small 
separation; SM = small separation. Linear effect of Task: XS exploration < SM 
exploration. Linear and Quadratic effects of Infusion: Infusion decreases exploration; low 
dose CNP decreases further, then increases with increasing dose. 
 
Figure 5.10: Mean (circles)±95% CI discrimination ratio (d2) and individual data 
(squares) during spontaneous location recognition trial phase. Horizontal line indicates 
equivalent exploration of novel and familiar object, with positive values corresponding to 
novelty preference. XS = extra small separation; SM = small separation. Linear trend 
interaction: Increasing dose increases recognition across XS task; Increasing dose 
decreases recognition across SM task. 
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5.3.4 Object Recognition 
Both copies of objects used during sample trials were explored equivalently (descriptive 
statistics and t-tests provided in Table 5.2). Total exploration time during sample trials was 
unaffected by differing Infusions (Figure 5.11; F (4, 32) = 0.32, p = 0.865, generalised η2 = 
0.021) with no trends evident in the data (all ts < 1.04, all ps > .305). Three rats demonstrated 
a novelty preference (d2 < 0) during Baseline, indicating impairment, and were excluded 
from analysis. Analysis of discrimination from six remaining rats indicated infusions did not 
alter d2 (F (4, 20) = 0.29, p = 0.878, generalised η2 = 0.045; Figure 5.12). Additionally, no 
trends were identified in the data (all ts < 0.81, all ps > .429). Although no statistical tests 
were significant, it should be noted that CNP infusion introduced a novelty preference in four 
cases, representing three rats (one demonstrating novelty preference in both 200ng and 500 
ng conditions). 
Table 5.2: Mean [+/- 95%CI], mean-difference and dependent means t-tests for exploration 
time of each object copy (A1 versus A2) during object recognition sample trials. 
Infusion A1 Mean [±95% CI] A2 Mean [±95% CI] Mean difference t-test 
Baseline 13.45 [9.99, 16.91] 13.56 [10.29, 16.83] -0.11 [-5.28, 5.06] t (8) = -0.05, p = .963 
Saline 13.52 [8.08, 18.96] 14.45 [8.75, 20.15] -0.93 [-2.34, 0.48] t (8) = -1.52, p = .167 
200ng 13.23 [8.76, 17.70] 11.77 [8.74, 14.80] 1.46 [-1.41, 4.33] t (8) = 1.18, p = .273 
500ng 16.69 [11.25, 22.13] 12.88 [9.44, 16.32] 3.82 [-0.47, 8.10] t (8) = 2.06, p = .070 




Figure 5.11: Mean [± 95% CI] and individual total exploration (seconds) for both objects 
during object recognition sample phase. No significant effects. 
 
Figure 5.12: Mean [± 95% CI] and individual discrimination ratio (d2) during object 
recognition trial phase. Horizontal line indicates equivalent exploration of novel and 
familiar object, with positive values corresponding to novelty preference. 
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5.3.5 Cyclic GMP expression 
There were no Main Effects of hemisphere in any ROI analysed and no effects of Infusion on 
density measurements in the anterodorsal thalamic nucleus, retrosplenial granular B cortex, 
amygdala, perirhinal cortex or the medial mammillary nucleus (Table 5.3). Active infusions 
of CNP increased cyclic GMP expressing neuron density in prelimbic and infralimbic 
cortices, cingulate gyrus, and hippocampal areas CA1 and CA3 (Main Effects of Infusion, 
Table 5.3, highlighted; Example images for these regions provided in Appendix B). Infusions 
also contributed a substantial (though non-significant) amount of variance to density 
measurements in dentate gyrus and hypothalamus (Table 5.3, highlighted). Cyclic GMP 
expression density was decreased by CNP infusions in medial orbital cortex (Table 5.3, 
highlighted). 
Retrosplenial dysgranular cortex was the only ROI to exhibit an Interaction effect 
between Infusion type and Hemisphere (Table 5.3, highlighted; Figure 5.13). Calculations of 
Cohen’s d effect sizes between individual mean differences indicated that density measures 
were equivalent across both hemispheres for “Inactive” infusions, and in “Active” ipsilateral 
hemisphere (ds between 0.25 and 0.51, ps > .37). Cyclic GMP was higher in contralateral 
than ipsilateral hemisphere of “Active” infusions (d = 1.35 [0.06, 2.64], p = .04), and elevated 
compared to contralateral hemisphere of “Inactive” infusions (d = 1.43 [0.12, 2.73], p = .03). 
This indicates that “Inactive” infusions did not affect cGMP expression, but within “Active” 





Figure 5.13: Mean [±95% CI] cGMP expressing neuron density in the retrosplenial 
dysgranular cortex by Infusion Type and Hemisphere. Active: Rats given final infusions of 
any dose of CNP; Inactive: Rats given no final infusion or a final infusion of 0.9% Saline; 
Ipsi: measures from hemisphere ipsilateral to cannula placement; Contra: measures from 




Table 5.3: Mean [±95%CI] cyclic GMP expressing neuron density (particles/µm2) by infusion group and hemisphere, with repeated 
measures ANOVAs and effect sizes in previously outlined regions of interest. Statistical tests referred to in text are highlighted in gray. Note: 
Medial mammillary nucleus was analysed as a single region. Reported statistic is an independent means t-test across infusion groups with 
Cohen’s d effect size. 
ROI  Infusion: Inactive Active ANOVA effects  η2 
 Hemisphere      
Medial Orbital  Ipsi .0968 [.0933, .1003] .0947 [.0915, .0979] Infusion F (1, 12) = 16.62, p = .002 0.280 
cortex Contra .0970 [.0940, .1000] .0916 [.0894, .0938] Hemisphere F (1, 12) = 1.02, p = .332 0.058 
    Infusion x Hemisphere F (1, 12) = 1.29, p = .278 0.072 
Prelimbic cortex Ipsi .0962 [.0938, .0986] .0983 [.0956, .1010] Infusion F (1, 12) = 3.50, p = .009 0.191 
 Contra .0962 [.0938, .0986] .0987 [.0971, .1003] Hemisphere F (1, 12) = 0.09, p = .774 0.001 
    Infusion x Hemisphere F (1, 12) = 0.09, p = .773 0.001 
Infralimbic cortex Ipsi .0957 [.0920, .0994] .0980 [.0949, .1011] Infusion F (1, 12) = 5.13, p = .043 0.248 
 Contra .0951 [.0929, .0973] .0996 [.0970, .1022] Hemisphere F (1, 12) =0.32, p = .579 0.006 
    Infusion x Hemisphere F (1, 12) = 1.74, p = .212 0.032 
Cingulate gyrus Ipsi .0946 [.0907, .0985] .0995 [.0968, .1022] Infusion F (1, 12) = 6.12, p = .029 0.269 
 Contra .0960 [.0936, .0984] .0983 [.0957, .1009] Hemisphere F (1, 12) = 0.00, p = .955 0.000 
    Infusion x Hemisphere F (1, 12) = 2.17, p = .166 0.048 
Anterodorsal  Ipsi .0974 [.0949, .0999] .0986 [.0963, .1009] Infusion F (1, 12) = 0.18, p = .681 0.009 
thalamic nucleus Contra .0985 [.0960, .1010] .0982 [.0966, .0998] Hemisphere F (1, 12) = 0.16, p = .694 0.005 
    Infusion x Hemisphere F (1, 12) = 0.81, p = .385 0.024 
Dorsal CA1 Ipsi .0975 [.0948, .1002] .1002 [.0988, .1016] Infusion F (1, 12) = 4.83, p = .048 0.200 
 Contra .0968 [.0939, .0997] .0990 [.0964, .1016] Hemisphere F (1, 12) = 1.22, p = .292 0.037 




Table 5.3: Continued 
ROI  Infusion: Inactive Active ANOVA effects  η2 
 Hemisphere      
Dorsal CA3 Ipsi .0970 [.0955, .0985] .0981 [.0965, .0997] Infusion F (1, 12) = 8.27, p = .014 0.285 
 Contra .0966 [.0944, .0988] .0996 [.0984, .1088] Hemisphere F (1, 12) = 0.83, p = .381 0.028 
    Infusion x Hemisphere F (1, 12) = 2.20, p = .163 0.072 
Dorsal DG Ipsi .0970 [.0953, .0987] .0995 [.0959, .1031] Infusion F (1, 12) = 4.24, p = .062 0.211 
 Contra .0966 [.0947, .0985] .0991 [.0972, .1010] Hemisphere F (1, 12) = 0.29, p = .601 0.006 
    Infusion x Hemisphere F (1, 12) = 0.00, p = .996 0.000 
Retrosplenial dysgranular  Ipsi .0966 [.0927, .1005] .0957 [.0932, .0982] Infusion F (1, 12) = 1.13, p = .309 0.065 
cortex Contra .0946 [.0912, .0980] .0986 [.0973, .0999] Hemisphere F (1, 12) = 2.99, p = .594 0.006 
    Infusion x Hemisphere F (1, 12) = 8.06, p = .015 0.148 
Retrosplenial granular B  Ipsi .0943 [.0913, .0973] .0960 [.0905, .1015] Infusion F (1, 12) = 2.68, p = .128 0.129 
cortex Contra .0948 [.0916, .0980] .0989 [.0966, .1012] Hemisphere F (1, 12) = 1.95, p = .187 0.052 
    Infusion x Hemisphere F (1, 12) = 0.92, p = .356 0.025 
Amygdala Ipsi .0946 [.0928, .0964] .0944 [.0922, .0966] Infusion F (1, 12) = 0.63, p = .443 0.036 
 Contra .0937 [.0913, .0961] .0955 [.0939, .0971] Hemisphere F (1, 12) = 0.04, p = .854 0.001 
    Infusion x Hemisphere F (1, 12) = 2.47, p = .142 0.057 
Hypothalamus Ipsi .0933 [.0914, .0952] .0945 [.0908, .0982] Infusion F (1, 12) = 3.24, p = .097 0.126 
 Contra .0906 [.0881, .0931] .0934 [.0916, .0952] Hemisphere F (1, 12) = 3.43, p = .089 0.118 
    Infusion x Hemisphere F (1, 12) = 0.55, p = .472 0.021 
Perirhinal cortex Ipsi .0958 [.0937, .0979] .0959 [.0931, .0987] Infusion F (1, 12) = 0.01, p = .923 0.000 
 Contra .0952 [.0902, .1002] .0955 [.0873, .1037] Hemisphere F (1, 12) = 0.06, p = .811 0.003 
    Infusion x Hemisphere F (1, 12) = 0.00, p = .990 0.000 




Previous work investigating behavioural effects of CNP indicate possible bidirectional 
relationships of CNP related to anxiety and memory. In contrast with the hypothesis, no 
effects of CNP were identified in the EPM (Figure 5.6). Generally, opposing effects to 
expected were evident for exploratory behaviours, wherein increasing doses of CNP also 
increased movement (in the EPM) and exploration (in SLR; Figure 5.8 and 5.9). Increasing 
doses of CNP were also expected to reduce discrimination in all recognition tasks. However, 
this effect only occurred across small SLR conditions, and discrimination was improved by 
increasing doses of CNP during extra-small SLR (Figure 5.10). This is the first study to show 
that infused CNP can modify location recognition, in a dose dependent manner, and that 
effects vary based on stimulus overlap (“pattern separation” load). Effects on both 
exploration and discrimination were not apparent during OR (Figure 5.11 and 5.12). 
Alongside anxiety measures from the EPM, this suggests effects of CNP can be attenuated 
across time, perhaps associated with concomitant experience. As rats exhibited initial 
cognitive impairment – compared with reports of Beckinschtein et al., (2014) and Kent et al., 
(2015) – this study provides promising avenues for research into CNP as a target in relation 
to cognitive decline. This observation also provides support for the idea that pattern 
separation deficits contribute to age-associated memory impairment (Burke et al., 2010; 
Yassa & Stark, 2011). 
5.4.1 Failure to replicate anxiogenic effects of CNP 
That anxiogenic effects of CNP were not evident in EPM behaviour is somewhat surprising, 
but likely due to previous experience in the RAM. Although Perspex enclosed arms in the 
EPM do not usually affect the validity of the task (Martínez et al., 2002), in this instance prior 
exposure to the RAM (the arms of which are open to the surrounding environment) has done 
so. Because of this previous experience, the EPM no longer presents an anxious situation for 
these rats. However, slightly increased anxiety at the highest CNP dose (Figure 5.6) supports 
previous findings (Jahn et al., 2001; Montkowski et al., 1998), and suggests task validity was 
not entirely negated. 
An alternative possibility (alongside reduced exploration effects across tasks) is that CNP-
induced behaviours are attenuated across multiple experiences as learning occurs. This may 
behaviourally support CNP as a metaplasticity regulator. Metaplastic processes (regulation of 
LTP and LTD) can prevent learning from occurring too readily when salience of stimuli is 
reduced (Hulme, Jones, & Abraham, 2013). Arguably, multiple exposures to situations of 
95 
 
anxiety and exploration has reduced the salience of emotional inputs and novel environments. 
Following these experiences, CNP no longer greatly modifies these behaviours. 
5.4.2 Exploration Behaviour 
It was unexpected that increasing doses of CNP would increase exploration behaviour 
(EPM and SLR small separation; Figures 5.7 and 5.8). Low doses of CNP were expected to 
represent a comparable situation to downregulation of CNP signalling in NPR-BΔKC rats, 
which showed increased exploration behaviours (Barmashenko et al., 2014). Additionally, 
administered CNP reduces the increased locomotion resulting from cocaine administration 
(Thiriet et al, 2001). This unexpected effect may be due to reductions in anxiogenic activity 
also seen here. Elevated anxiety is usually associated with decreased exploratory behaviours, 
and this association is exploited in measures such as the open-field test and EPM. As CNP no 
longer induced anxiety, its related effects on locomotor and exploration behaviour may have 
varied also.  
Exploration was reduced generally, and dose-dependently, during extra-small SLR 
tasks compared with small separations (Figure 5.9). As these conditions were 
counterbalanced (half of rats performed extra-small first, and vice versa), this may not be an 
effect of CNP specifically. Perhaps the objects used during all extra-small occasions were 
less interesting than those for small separations. Additionally, as rats had difficulty 
discriminating the paired object location in SLR samples (Table 5.1), reduced proximity 
during extra-small conditions may have reduced interest for exploring the objects. However, 
this does not explain dose dependent reductions in exploration (as hypothesised) restricted to 
extra-small SLR. Combined with other findings here, this suggests behavioural effects of 
CNP are situationally dependent. 
5.4.3 Spontaneous Location Recognition 
Situation dependence of CNP effects is supported by data indicating the peptide can both 
facilitate and interfere with memory acquisition (Figure 5.10). Interference with memory 
acquisition was hypothesised based on improved recognition when CNP signalling was 
reduced (Barmashenko et al., 2014) and associations between lower endogenous CNP 
concentrations and better novel object discrimination (Rapley, 2012, unpublished Master’s 
Thesis). Conversely, CNP facilitates acquisition and consolidation during passive avoidance 
(Telegdy et al., 1999; 2000). Combined, these findings indicate CNP bidirectionally affects 
memory acquisition. Moreover, as SLR manipulates pattern separation load during 
acquisition, this suggests CNP affects neurobiology contributing to this function. 
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The mechanism by which this occurs was not tested here, but endogenous, 
bidirectional modification of hippocampal plasticity by CNP is most likely. Application of 
CNP facilitates LTD (Decker et al., 2010) but in NPR-BΔKC rats LTP is facilitated 
(Barmashenko et al., 2014). Synaptic LTP is broadly accepted as contributing to memory 
acquisition. LTD occurs endogenously during novel spatial learning and is necessary for the 
encoding of spatial information (Ge et al., 2010; Goh & Manahan-Vaughan, 2013; Kemp & 
Manahan-Vaughan, 2004; Lemon & Manahan-Vaughan, 2006, 2012; Manahan-Vaughan & 
Braunewell, 1999). LTD occurrence within hippocampal subregions can also be dependent 
on the nature of spatial information (Kemp & Manahan-Vaughan, 2007; Rosenzweig & 
Barnes, 2003), aligning with varied CNP effects across SLR tasks. Alongside current 
behavioural observations, CNP seems to regulate the shift between LTP and LTD, variably 
contributing to memory acquisition based on the nature of stimuli. 
5.4.4 Object Recognition 
Although statistical tests of object recognition effects were non-significant, several aspects of 
the data support previous suppositions made here. Null effects on exploration and recognition 
supports the idea that CNP action is situationally dependent and modified by previous 
experience. Lack of effects on discrimination may be an effect of differing tasks, but CNP 
infusions introduced familiarity preference in several instances (Figure 5.12). This supports 
hypothesised interference with memory.  
Performance on this task, combined with SLR observations, provides the first experimental 
evidence supporting CNP as a treatment target in cognitive decline. Two rats exhibited 
impaired recognition during baseline for this task but most rats were impaired during SLR. 
This suggests that across repeated administrations CNP has broadly ameliorated recognition 
deficits. However, as CNP also seems to interfere with memory, understanding of immediate 
versus long-term effects will be required to develop treatment paradigms. 
However, it is also possible given the time taken to initiate this study following initially 
outlined difficulties, that rats were too old to establish reliable or valid effects of the peptide. 
Baseline measures in both SLR and OR tasks indicated likely senescence in these rats. These 
findings cannot be generalised to understanding the role of CNP during typical function. 
However, differing linear effects of CNP within the SLR task suggest it will be interesting to 
investigate using younger rats where typical function is intact. That these results cannot be 
generalised to broader knowledge of CNP does not invalidate the indication that CNP may 
improve age-related recognition deficits. 
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5.4.5 Cyclic GMP 
Cyclic GMP analysis was used to ensure infused CNP promoted neurological activity. 
Expected increases of cGMP occurred in pre- and infralimbic cortices, cingulate gyrus, 
hippocampal areas CA1 and CA3, with statistically non-significant increases in DG and 
hypothalamus (Table 5.3). If infusions were followed by rapid clearance via NPR-C receptors 
from the ventricular space, cGMP would likely not be increased in these regions, and if this 
has occurred, it has not affected the ability of CNP to generate downstream neurological 
effects. Several observations were unexpected. cGMP was not increased by infusion in 
anterodorsal thalamic nucleus, retrosplenial granular B cortex, amygdala, perirhinal cortex 
and medial mammillary nucleus. In retrosplenial dysgranular cortex, cGMP was only 
elevated contralaterally to infusion. Combined these observations indicate a loss of cGMP 
stimulation by CNP which aligns with attenuation of behavioural effects on anxiety, 
exploration and recognition. 
Involvement of the amygdala in emotion processing is widely accepted, and it additionally 
provides integration of emotional states with cognitive function (Catani et al., 2013; Phelps & 
LeDoux, 2005). Perirhinal cortex, anterodorsal thalamic nucleus, retrosplenial granular cortex 
and medial mammillary nucleus are critical nodes within an extended hippocampal-
diencephalic network (Aggleton & Brown, 2006). These regions contribute to recognition 
processes, navigation, spatial memory encoding and normal hippocampal, prefrontal and 
retrosplenial function (Brown & Aggleton 2001; Aggleton & Brown, 2006; Vann & 
Aggleton, 2004; Vann 2010). Loss of CNP-stimulated cGMP activity in these regions 
indicates neurological effects accounting for long-term behavioural attenuation.  
Because cGMP activity was no longer stimulated, this suggests that NPR-B receptors have 
been either decreased or desensitised. Desensitisation is known to occur in this receptor 
following repeated exposure to CNP (Potter et al., 2006). That this has occurred in certain 
regions here gains some support from hemispheric effects in retrosplenial dysgranular cortex. 
Greater intensity of infusions near the cannula (ipsilateral hemisphere) have elicited this 
change more rapidly than at a distance (contralateral hemisphere). Also plausible is that 
potential age-related increases in NPR-C receptors (Chapter 3) have contributed to this effect 
by clearing CNP more rapidly and reducing cGMP stimulation. This possibility is addressed 
in Chapter 6 (General Discussion). 
Medial orbital cortex exhibited decreased cGMP in response to CNP infusion. This is 
the first indication that this may occur and is intriguing given bidirectional behavioural 
effects. Within rodents, this region (and associated pre- and infralimbic cortices, constituting 
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ventral medial prefrontal cortex) mediates working and temporal order memory for objects 
and spatial locations, and paired associate learning for objects in place (Kesner & 
Churchwell, 2011 for review). These skills are clearly engaged for learning during both 
recognition tasks used here. Unfortunately, this study and thesis are not targeted toward 
analysing these specific aspects of recognition, nor executive control of such processes. 
However, this raises the possibility that variable effects of CNP within frontal-cortical 
regions mediates other bidirectional neurological and behavioural sequelae of the peptide. 
This unexpected finding suggests that CNP should now be considered in terms of a 





Chapter 6. General Discussion 
6.1 Major contributions of the thesis 
Accumulating evidence has indicated that CNP provides a novel target in neurological 
disorders featuring cognitive decline (Mahinrad et al., 2016). However, CNP has been little 
studied in relation to memory and neurological disorder, or in relation to brain aging where 
cognitive decline commonly occurs. Although much about this fascinating peptide remains 
elusive, this thesis has provided multiple findings contributing to our understanding of CNPs 
role in memory encoding, and confirms that it provides a novel target for study of, and 
intervention in cognitive decline. Novel contributions of this these are outlined in Table 6.1 
Table 6.1: Novel contributions of the thesis 
Chapter 3 First description of CNP, NTproCNP and degradative regulation of CNP in 
aged rodent cerebral tissue. 
 Comparison of CNP and related measures in cerebral tissue between young 
and aged rodents 
 Evidence that the CNP signalling system response to brief enrichment in 
young rats, is lost with aging 
 Identification of CNP synthesis dysregulation in retrosplenial cortex during 
aging 
 Proposal of the hypothesis that modifications to CNP regulation via NPR-C 
receptors in hippocampus occurs during brain aging. In combination with 
broader reported changes to synthesis, availability and peptide regulation 
within connected neurological regions, this is proposed to contribute to age-
related cognitive decline 
Chapter 4 First identification of increased CNP synthesis during spatial information 
consolidation in mammillary bodies 
 First identification of increased CNP synthesis during spatial reference 
(episodic-like) memory consolidation in mammillary bodies and 
retrosplenial cortex 
Chapter 5 Evidence that effects of infused CNP on behaviour and cGMP can be 
attenuated across chronic infusions in combination with concurrent 
experience 
 Evidence that CNP can both facilitate and interfere with memory acquisition 
 First evidence that CNP contributes to “Pattern Separation” of memory 
encoding 
 Evidence that contribution of CNP to cognition is situationally dependent, 
varying by stimulus salience and (in memory) pattern separation load 
 Indication that CNP may elicit both Long-Term Depression and Long-Term 
Potentiation in vivo, in line with its proposed role as metaplasticity regulator 
 First experimental evidence that CNP may provide a treatment target in cases 
of cognitive decline 
 Indication that CNP may mediate executive functions through variable 




Data from Chapter 3 is believed to provide initial experimental support for a proposed 
role for CNP in cognitive decline and generates initial hypotheses for ongoing research in this 
regard. This proposal is supported by findings from chapter 4, providing the first indication 
that CNP synthesis occurs during ‘episodic-like’ memory consolidation. Although this was 
evidenced in younger rats, because this type of memory is commonly impaired with age, this 
provides supporting evidence that the peptide contributes to these memory functions. Chapter 
5 provides evidence within a single study of bidirectional behavioural effects at differing 
doses of the peptide. This indicates that previously demonstrated bidirectional effects on 
synaptic plasticity functions may also translate to behavioural outcomes. Moreover, the 
seemingly bidirectional effects on a “pattern separation” task lend additional credence to a 
proposed role for CNP in age-related cognitive decline, since this function is thought to 
contribute to age-related cognitive changes. When taken together, these experiments support 
the overall proposal that CNP and related receptors and regulatory enzymes contribute to age-
related cognitive decline. Additionally, they indicate that, while CNP may contribute to the 
regulation of multiple cellular and molecular functions, an overarching theme is of a role in 
information integration across intersecting networks – including but perhaps not limited to, 
emotionality, learning and memory. CNP should thus be considered highly important to 
central nervous system integrity and function. Ongoing research considering CNP should not 
only benefit understanding of the peptide itself, but perhaps other areas of research interest, 
some of which these several experiments have drawn attention to. 
6.2 General Considerations 
One difficulty in the consideration of experiments using enrichment is that enrichment 
more closely replicates “normal life” for wild rats. In a recent review, Hannan (2014) 
identifies the assumption that standard housing is “standard” or typical as a violation of 
‘environmental construct validity.’ Additionally, many human epidemiological factors such 
as lower socioeconomic status, less years in education or a more sedentary lifestyle, are 
known to be associated with increased incidence of cognitive decline and age-related 
neurological disorders. This may then represent a comparable situation to the declines seen in 
standard-housed rodents as compared with those exposed to enrichment, rather than 
enrichment being a special case, per se. 
Given a particular interest in this research area for the hippocampus, many studies 
examining enrichment effects in aged rodents focus on outcomes for spatial memory tasks. 
Life-long enrichment rescues age-related declines in both spatial working and reference 
memory measured in the eight-arm RAM (Lores-Arnaiz et al., 2006; Lores-Arnaiz et al., 
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2004). However, short-terms (two months) of enriched housing provide similar benefits when 
tested in the Radial-Arm Water Maze (Sampedro-Piquero, De Bartolo, et al., 2014; 
Sampedro-Piquero, Arias, et al., 2014). In mice, similar improvements to cognition seem to 
require continuous enrichment when compared with daily brief exposures (Bennett et al., 
2006). Benefits to spatial memory as measured by the Morris Water Maze submerged 
platform task have been shown following either two (Speisman et al., 2013) or eight (Segovia 
et al., 2006) weeks of enrichment in aged rats, and similar time frames in aged mice (Frick & 
Fernandez, 2003; Harburger et al., 2007). For rodents at least, cognitive benefits of enriched 
housing in terms of spatial working and reference memory thus seem consistent and can be 
conveyed via either life-long or short-term interventions. 
Though recognition memory is a key component of observed declines with aging, few 
studies have examined the effects of enrichment on recognition in aged rats. The most cited 
single study demonstrating a benefit in this context comes from Leal-Galicia and colleagues 
(2008). They demonstrate that intermittent, lifelong exposure to EE mitigates the declines in 
recognition memory seen in standard-housed rodents. Lifelong enrichment in the absence of 
exercise has also recently been reported to prevent age-related declines in recognition (Birch 
& Kelly, 2018). However, short-term enrichment beginning in late life (10-12 weeks in 20-22 
month old rats) was reported to have no effect on novel object recognition, but exercise alone 
led to recognition improvements (Kumar, Rani, Tchigranova, Lee, & Foster, 2012). These 
more recent studies support earlier work indicating that life-long enrichment conveys benefits 
of greater magnitude related to aging than short-term exposure (Kobayashi et al., 2002; 
Soffie, Hahn, Terao, & Eclancher, 1999).  
Just as the extent of “enriching” or cognitively beneficial factors across a human 
lifespan may vary greatly and lead to varying outcomes, the same seems to be true of rodents, 
as outlined. Any number of factors may contribute to the apparently more moderate or absent 
effects of enrichment when exposure begins in later life, as may have been the case here in 
Chapter 3. Changes to activity levels may result in lower engagement with enriching factors. 
Declines in sensory systems (for example, progressive vision or hearing loss) may result in 
lesser stimulatory effects of the same environmental factors during aging. Highly relevant to 
this thesis is age-related variance in hormonal systems (most notably, the ending of the 
oestrus cycle in females) which may influence other endocrine peptides and can contribute to 
variable incidence and outcomes in human neurological disorders for males and females 
(Galea et al., 2008). As seen here for CNP, the response in younger rodents following a brief 
period of enrichment was absent in aged rodents under the same conditions. Further research 
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is warranted into potential longer-term benefits of enrichment in the relationship between 
CNP and age-related cognitive decline. From the effects noted in chapter 5, a combination of 
enrichment and CNP administration in aging and the outcomes of this for age-related 
cognitive decline would also be of interest. Based on the loss of response to enrichment of 
CNP seen in chapter 3, would supplementation of the peptide result in better age-related 
outcomes when enrichment occurred with a late life exposure? The presence of cognitive 
benefits with a short-term of late life enrichment are encouraging for novel clinical research 
generalising ‘enrichment’ to humans and examining is protective contribution in clinical 
disorders. Greater understanding of how CNP contributes to the aging process and whether its 
presence may modify the benefits of enrichment could allow an application as treatment in 
cases of neurological decline. 
Findings from both Chapter 3 and Chapter 4 (and Chapter 5 to a lesser extent) draw 
attention to retrosplenial cortex. This raises the concern that methods used within these 
studies may have targeted retrosplenial cortex in some fashion. However, considering 
emerging understanding of the role of retrosplenial cortex in supporting integration of 
differing sensory and contextual modalities into memory (Kinnavane et al., 2017; Pothuizen 
et al., 2010, 2009; Robinson, Adelman, Mogul, Ihle, & Davino, 2018; Vann et al., 2009) this 
‘targeting’ may be unavoidable. Conditions used in each of the studies presented here are 
reliant on integration of sensory and environmental cues, as are many other paradigms 
throughout behavioural neuroscience. Thus, if this is the underlying function of retrosplenial 
cortex within the neurological circuits it provides interconnection for, then it will ultimately 
be targeted under any of these situations. More interesting is the consideration that, by virtue 
of the indication that retrosplenial cortex appears to be an important node for CNP activity 
within central nervous system, these findings lend support to the hypothesis that CNP is a 
critical molecule supporting said integratory processes. It may be that the identified functions 
of CNP in modifying LTP/LTD thresholds and contributing to metaplasticity, are intimately 
tied with integrative function of the retrosplenial cortex and contribute to further reaching 
modifications of broader neurological circuitry. As seen in hippocampal regions CA1-CA3 
and DG, CNP and NPR-B expression demonstrate variable overlap with NPR-C receptors 
within granular and dysgranular retropslenial cortex (Herman, Dolgas, Marcinek, & Langub, 
1996). This suggests that the differing distribution in this region should also be further 
investigated, as dysgranular and granular retrosplenial cortex apparently make variable 
contributions to spatial memory tasks (Pothuizen et al., 2009; Vann & Aggleton, 2005). Such 
research will be better served by more specific manipulation and sampling methods (outlined 
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below – General Limitations). Drawing together research regarding both CNP and 
retrosplenial cortex function is both indicated by this thesis, and will provide valuable insight 
in determining specific functions of both peptide and neuroanatomical region. 
As retrosplenial cortex has drawn attention across these three studies, it is useful to 
compare effects of lesions to this region, and reciprocally interconnected hippocampus and 
anterior thalamic nucleus, with findings reported here. Retrosplenial cortex lesions do not 
affect novel object recognition (Ennaceur et al., 1997; Vann et al., 2009). Earlier lesion 
studies indicate retrosplenial cortex is important for spatial memory (Pothuizen et al., 2010; 
Vann & Aggleton, 2005), with more recent studies supporting the hypothesis that its 
importance lies in the integration of proprioceptive and contextual cues to support spatial and 
episodic-like memory (Kinnavane et al., 2017; Pothuizen et al., 2010; S. Robinson et al., 
2018). Although a role in pattern separation has not been directly investigated, rodents with 
retrosplenial cortex lesions are impaired in object-in-place tasks (Vann et al., 2009). Findings 
from a recent study using contextual fear learning led the authors to suggest that further 
consideration should be given to retrosplenial cortex in contexts of both pattern separation 
and emotional learning (Robinson, Adelman, Mogul, Ihle, & Davino, 2018). This suggestion 
is supported by the convergent findings here of retrosplenial cortex as a key node for CNP 
activity, and a contribution of CNP to pattern separation (spontaneous location recognition 
task) in addition to previous work relating CNP with anxiety/emotionality. Based on the 
moderate success in replicating Bekinschtein and colleagues’ (2016) “pattern separation” task 
here, providing a modicum of external validity, this suggests the task may also be useful in 
continued investigation of retrosplenial cortex. 
Investigation of retrosplenial cortex contribution to ‘pattern separation’ is a logical 
next step given demonstration of its supporting role for traditionally hippocampal-dependent 
tasks. Like retrosplenial cortex, permanent lesions of hippocampus evidence no deficits in 
novel object recognition – though deficits are seen in temporary inactivation studies 
(reviewed by Cohen & Stackman, 2015). Hippocampal lesions are well known to produce 
deficits in spatial and episodic-like memory tasks. Additionally, research using hippocampal 
lesions has been the major contributor to pattern separation research, with the function 
thought to occur therein. Subregions CA1-CA3 and DG exhibit dissociable lesion effects in 
terms of their contribution to this function (Gilbert et al., 2001; Hunsaker & Kesner, 2008; 
Kesner, Gilbert, & Barua, 2002; Kesner, Hunsaker, & Ziegler, 2010; see (Hunsaker & 
Kesner, 2013; Kesner & Hopkins, 2006 for reviews). In part, these dissociable effects in 
pattern separation alongside variable expression of CNP mRNA and NPR-B receptors within 
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hippocampal formation were a motivating force for an examination of CNP infusions using 
the spontaneous location recognition task detailed here. Within those results, variable effects 
on cGMP expression were identified in CA1 and CA3 compared with DG. This is conclusive 
of very little, but once again highly suggestive for intersecting ongoing research related to 
CNP and its related regulatory system pertaining to a contribution to pattern separation within 
hippocampal formation. 
A single anterior thalamic nucleus (anterodorsal) was examined in this thesis 
regarding cGMP expression in chapter 5. Further inclusion was limited by both amount of 
tissue required for RIA and location of this nuclei group. ATN lesions have similar effects to 
those of retrosplenial cortex and hippocampus. No impairments are evident in object 
recognition tasks (Dumont & Aggleton, 2013; Mitchell & Dalrymple-alford, 2005; Moran & 
Dalrymple-Alford, 2003). ATN lesions produce impairments in various spatial tasks, 
including object-in-place tasks (Warburton et al., 2000) which are the closest analogue to the 
spontaneous location recognition/pattern separation task used here. Because hippocampal 
function seems to be dependent on informational input from these nuclei, this provides 
another interesting ongoing target for understanding pattern separation – an initial query 
being, does disruption of the ATN also disrupt pattern separation? Alongside effects on 
memory, two studies indicate ATN lesions may reduce anxiety (Dupire et al., 2013; Suárez et 
al., 2004). This is interesting because, at the molecular level, hippocampal lesions increase 
stress responses (Herman et al., 2005), and stressors themselves have variable effects on 
memory (e.g. intense memories for extreme stressors vs later impairments in attention and 
memory; (Kim & Diamond, 2002). Here may exist a divergence in the support role of ATN 
for hippocampal function. A majority of research seems to consider either mnemonic 
functions or stress and anxiety. However, these comparisons, previous CNP research, and this 
thesis indicate that both should continue to be examined in combination. In addition, this 
suggests that CNP research will need to look beyond singular neurological regions and 
specific behaviours and consider the broader interacting neurological systems through which 
it is distributed. CLARITY is a highly novel technique allowing visualisation of entire rodent 
connectomes. Should it become possible to adapt such a technique for investigation of 
peptide or peptide gene expression, this would be highly valuable in understanding the 
nervous system-wide contribution of CNP to memory integration. 
Although not traditionally considered as a contributor to memory formation, 
hypothalamus was included as a key ROI within this research given previous work indicating 
it as a major node for CNP activity and expression. Based on the above considerations, a 
105 
 
seemingly overall function for CNP as a regulator of information integration, and the known 
role of hypothalamus contributing to metabolism and emotional information, it is fortuitous 
that the region was retained. As outlined in sections 2.1.1 and 2.3, CNP has been implicated 
in both central and peripheral functions related to metabolism (central regulation of food/fluid 
intake, and peripheral regulation of digestive functions). Within chapter 3, hypothalamus was 
the only ROI to exhibit a mildly similar response to enriched conditions within aged rats 
when compared to young. Certain subnuclei of hypothalamus are relatively stable with aging, 
whereas others may be particularly vulnerable to neuroinflammatory and metabolic changes 
(Hofman, 1997; Maggi, Zasso, & Conti, 2015). This may account for the reduced effect of 
enrichment on hypothalamic response indicated by Chapter 3. A growing body of evidence 
supports the importance of metabolic processes (with a focus on caloric restriction and 
exercise) to positive cognitive outcomes, including beneficial effects during both typical and 
pathological aging (Cauwenberghe, Vandendriessche, Libert, & Vandenbroucke, 2016; 
Davies, 2017; Kent, Oomen, et al., 2015; Stranahan & Mattson, 2011 for reviews). Moreover, 
experimental studies indicate that caloric restriction enhances neurogenesis with hippocampal 
structures and is associated with improved memory (Hornsby et al., 2016; Lee, Duan, Long, 
Ingram, & Mattson, 2001). Evidence from Chapter 4 of this thesis indicates CNP 
concentrations were reduced in hippocampus alongside caloric restriction. Because increased 
CNP can switch BDNF-induced neuron proliferation to differentiation (Simpson et al., 2002), 
this observation of CNP reduction aligns with studies indicating enhanced BDNF expression 
alongside caloric restriction (Hornsby et al., 2016; Lee, Duan, Long, Ingram, & Mattson, 
2001). Futhermore, as lower concentrations of CNP are associated with LTP facilitation, this 
would be assumed to align with a facilitation of memory as seen in the same studies. In 
combination with previous considerations here, this further supports the suggestion that 
CNP’s contributions to cognitive function cannot be considered only in terms of memory, 
anxiety or metabolism, nor as it relates to only behaviours related to these processes. An 
integrative approach should be taken considering each of these aspects in future studies. 
6.3 Regarding future investigation of NPR-C receptors 
Generation of the hypothesis that NPR-C receptor modifications contribute to age-related 
cognitive decline was unexpected. This aspect of findings from Chapter 3 is given  
consideration here because loss of NTproCNP modification in retrosplenial cortex of aged 
rats was clear compared to young rats, whereas hypothesised modifications to NPR-C present 
additional implications for Chapter 5. Most in the NP field (including myself) have 
considered NPR-C to be a non-signalling receptor. As this thesis was targeted toward study 
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of CNP, little about this receptor has been outlined. These considerations are limited to 
speculation from the outset, in that age-related modifications to NPR-C have not been 
demonstrated directly. However, if confirmed, this finding may have important implications 
for understanding NP regulation and functional roles. 
Like CNP, relatively little research attention has been given to NPR-C. NPR-C 
receptor mRNA is found in frontal cortex, retrosplenial granular cortices, medial preoptic 
nucleus, ventral cochlear nucleus, choroid plexus, deep layers of neocortex, limbic cortex, 
posterior cortical amygdala, ventral subiculum, amygdalohippocampal area, and dentate 
gyrus (summarised in Figure 6.1 from Herman, Dolgas, Marcinek, & Langub, 1996). NPR-C 
distribution overlaps with several key nodes of CNP activity indicated in this thesis (frontal 
cortex, retrosplenial cortex, DG, hypothalamic nuclei). The choroid plexus is also of note as 
the major site of CSF production, interaction with the circulation, and of special interest 
regarding NP regulation of CSF (Herman et al., 1996; Johanson et al., 2006). 
Trachte (2005) outlines evidence that NPR-C provides signal transduction and is 
essential in regulating the neuromodulatory functions of NPs. Notably, CNP activity in rat 
magnocellular neurosecretory cells, and its inhibitory effects on dopamine release are 
dependent on activation of the NPR-C receptor (Rose et al., 2005; Trachte, 2000). Recently, 
NPR-C knockout mice were identified as having a phenotype likened to ADHD (Gong et al., 
2011). Alongside the suggestion from this thesis that NPR-C increases in retrosplenial cortex 
contribute to age-related disconnection between frontal and temporal structures (Buckner, 
2004), this implicates NPR-C in the executive control of CNP signalling. 
Sabbatini (2009) suggests that NPR-C mediates peripheral responses to NPs in the 
digestive system, whereas CNP and NPR-B are likely to provide central control. However, in 
agreement with Trachte (2005), it may be more accurate to say that NPR-C mediates whole 
organ NP responses, whereas CNP and NPR-B regulate specific cellular responses. Within 
central nervous system, this gains some support from consideration of regions where NPR-C 
co-localises with NPR-A and NPR-B. For NPR-A, this occurs primarily in brainstem regions 
associated with cardiovascular control (Abdelalim et al., 2008), aligning with primarily 
cardiovascular roles of ANP and BNP. NPR-C and NPR-B co-localise in frontal and 
retrosplenial cortex, DG and periaqueductal gray of the hypothalamus (Herman et al., 1996), 
aligning with the suggestion that NPR-C provides executive control over CNP signalling and 
behavioural effects via these interconnected regions. This now encourages an expansion of 




Figure 6.1: NPR-C mRNA expression (indicated by black dots) throughout rodent cerebral 
cortex. From Herman, Dolgas, Marcinek & Langub Jr (1996.) 
6.3.1 Possible influence of NPR-C increases on loss of cGMP stimulation 
Loss of NPR-C receptors has been shown to have no effect on CNP stimulated cGMP 
(Trachte, 2000). However, the clearance role of NPR-C acts to limit peptide availability 
which would attenuate cGMP generation (Herman et al, 1996). Hence, some consideration 
must be given to whether proposed age-related increases in NPR-C (Chapter 3) may have 
contributed to the attenuation of cGMP stimulation seen in Chapter 5. NPR-C increases are 
proposed to occur in hippocampus, but as NPR-C receptors are restricted to dentate gyrus 
(Herman, 1996), this consideration can be likewise restricted. It is also plausible that similar 
changes may occur in other regions identified in Chapter 3 within related neurological 
circuits (medial prefrontal, retrosplenial and occipital cortex). Medial prefrontal cortex and 
retrosplenial cortex both exhibited surprising effects of cGMP stimulation by CNP. 
NPR-C receptors are also located in hypothalamic and amygdaloid nuclei (which 
contributed to ROIs in Chapter 5) and perirhinal cortex (analysed directly; Herman et al, 
1996). Unfortunately, amygdala and perirhinal cortex were not included in investigation of 
age effects, so loss of cGMP activity in these regions may relate to either possible age-related 
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changes in NPR-C, or suggested modifications to NPR-B alongside behaviour (Chapter 5). 
CNP signalling within hypothalamus was identified as likely to be stable during aging in 
Chapter 3, indicating age effects have not contributed to attenuation of cGMP activity 
identified here. NPR-C receptors have not been described in anterodorsal thalamus nor 
medial mammillary nucleus (Herman, 1996). Thus, a loss of cGMP stimulation in 
anterodorsal thalamus, medial mammillary nucleus and hypothalamus cannot be attributed to 
possible NPR-C increases with age. This supports the postulation that loss of activity in most 
of these subregions aligns with attenuation of behavioural effects of CNP, and may occur 
through NPR-B receptor modifications. Loss of cGMP stimulation in retrosplenial granular 
cortex and DG cannot be definitively attributed to either chronic administration of CNP or 
possible age-related effects on NPR-C receptors with data available here. Reductions of 
cGMP in medial orbital cortex support postulations of a disconnect between frontal and 
medial temporal lobe structures centred on retrosplenial cortex which contribute to age-
related cognitive decline (Buckner, 2004; Fjell et al., 2014; Nestor et al., 2003; Vann et al., 
2009). Additional research of the CNP signalling system during aging, in combination with 
NPR-C interactions may prove valuable to our understanding of these neural systems and 
their sensitivity to age. 
6.4 General Limitations and Future Directions 
Several specific limitations and ongoing research suggestions have already been identified. In 
generating this thesis several limitations arose which require consideration for ongoing 
research design. First among them concerns recommendation that analysis of CNP activity 
within brain will benefit from immunohistochemical techniques. Use of ABC-DAB method 
here indicated a relatively prominent level of ‘background’ staining (Appendix B). This was 
not unexpected given CNP stimulates cGMP in both neuronal and glial components of brain 
tissue (Goncalves et al., 1995; Sumners & Tang, 1992; Yeung et al., 1996). 
Immunohistochemical analysis of CNP itself may result in similar issues, further highlighting 
a general need within this field to identify neuron-glia interactions of the peptide. Although 
immunohistochemical techniques are limited by these aspects of CNP, here they have 
provided valuable insight into subregional activity of CNP, not possible with RIA alone. 
However, alongside this valuable insight for the field regarding this technique, a drawback 
occurs for this thesis overall. Valuable analysis would be gained if tissue gathered for 
Chapter 5 could be compared directly with data gathered for Chapter 3. As tissue gathered in 
Chapter 5 was fixed during transcardial perfusion, it is no longer appropriate for RIA 
analysis. Access to additional antibodies (see below) would allow for further analysis in these 
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tissues of (for example) NPR-B or NPR-C receptors, neprilysin or IDE distribution, or 
regions of nppc gene expression. Any singular of these suggested examinations, or a 
combination, would be valuable in answering questions raised by this thesis. 
Necessity for further examination within the field of the specific neuron-glia interactions of 
CNP is highlighted by a potential limitation comparing younger rats with aged rats (Chapter 3 
and Chapter 4). Generally, it is now thought that substantial neuronal loss does not occur 
during typical aging (see Mora et al., 2007, p.79 for review), however in the aging rodent 
brain astrocyte hypertrophy occurs in specific regions including hippocampus (Soffie et al., 
1999). Thus, neuronal versus glial components of the tissue gathered may vary across the 
ages studied here and within young rats reported by Rapley and colleagues (2018), although 
this was not directly examined. As outlined previously, studies of ANP indicate that NPs are 
produced by neurons then target astrocytes, but this has not been consistently shown for CNP. 
If CNP follows the same pattern as ANP, and neuronal components of aged tissue are 
reduced relative to total weight (i.e. are of a lesser volume) one would expect reduced 
production of CNP in similar weight of tissue (which was achieved). Tissue concentrations in 
aged rats would then be reduced in comparison to young rats. However, in comparisons 
within chapter 3, and across chapters 3 and 4 concentrations of both NTproCNP and CNP 
were strikingly consistent across age, and increased in aged occipital cortex. If a varying 
volume of neural tissue has been collected across young and aged rats, it has not affected 
tissue concentrations of the peptide. Alternatively, several of the age-related changes 
identified within chapter 3, including hypothesised increases in NPR-C receptors may 
represent compensatory mechanisms to maintain CNP activity as cellular changes occur. 
Access to, and cost of antibodies and CNP-related antagonists also introduced general 
limitations to this thesis. As mentioned in Chapter 3, a complementary study was designed 
with the intention of identifying neprilysin, NPR-B receptor and CNP distribution within 
aged rodents in association with both enrichment and behaviour. Budget restrictions 
prevented acquisition of relevant antibodies. Additionally, design of the study for Chapter 5 
underwent multiple iterations, several of which were rejected due to inaccessibility of an 
NPR-B receptor antagonist (HS-142-1). Gö6976 was similarly rejected following calculations 
indicating amounts required would be prohibitively expensive. These limitations will be 
common for many studying CNP and will need careful consideration as research moves 
forward. 
Further to this limitation, the use of indwelling icv cannulae providing an assumed 
broad exposure to CNP may not be an ideal method in CNP research. To date, all studies 
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administering CNP centrally have used icv cannulation (e.g. Babarczy et al., 1995; Bíró et al., 
1996b; Gardi et al., 1997; Telegdy et al., 2000, 1999). Hence, this was employed here for 
comparative purposes. All studies of this nature have the limitation that indwelling materials 
may cause inflammation of cerebral tissue. Additionally, as CNP has been proposed to 
mediate inflammatory processes (Qian et al., 2002) this may result in either additive or 
contrasting effects in this context. As mentioned in the rationale to chapter 5, the specific 
mechanism of action following ventricular administration of CNP can only be assumed at this 
juncture. Moreover, rapid degradation of the peptide at source, and modification of blood-
brain barrier (Bohara et al., 2014) suggest targeted administration, manipulation or 
measurement procedures will be of greater value in understanding neurological functions of 
CNP. Microdialysis experiments would address several concerns noted herein, including 
targeted measurements (e.g. localised to hippocampal CA1, CA3 or DG), and can be used in 
combination with RIA to avoid background staining complications of IHC. Such 
methodology could also be applied in administering CNP to targeted regions – retrosplenial 
granular versus dysgranular suggested by the data gathered for this thesis. Optogenetic 
techniques can be used to target gene expression within specific nuclei and would provide 
interesting follow up to the results of Chapter 4 indicating increases in nppc expression in 
retrosplenial cortex and mammillary bodies. In a relatively nascent area of study, even the use 
of limited methodology may provide insight into ongoing research directions. 
A final general limitation of this thesis is a reliance on solely male rodents. Because 
previous research of CNP and behavioural effects was limited, possible central interactions 
with reproductive hormones across the oestrous cycle (outlined in Chapter 2) could not be 
predicted. Gonadal hormones (estrogens and androgens) have varying effects neurologically 
and behaviourally, and can account for sex differences in both incidence and etiology of 
neurological disorders (see Galea et al., 2008 for review). Importantly, sex-differences occur 
during both healthy aging and Alzheimer’s disease (Ishunina, Kamphorst, & Swaab, 2003; 
Kolb, Forgie, Gibb, Gorny, & Rowntree, 1998; Kolb et al., 2003; Swaab & Bao, 2011). In 
addition to previous suggestions regarding ongoing CNP research in contexts of normal aging 
and Alzheimer’s disease (Chapter 3), integration of a consideration of sex-differences will be 
vital.  
As research regarding central activity of CNP moves forward, it will benefit from 
consideration of the neurovisceral integration model (Thayer & Lane, 2000). Thayer & Lane 
(2000) focus on emotion regulation, dysregulation and the cardiovascular system to outline a 
model integrating “autonomic, attentional, and affective systems into a functional and 
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structural network” (Thayer & Lane, 2000, p.201) from a dynamic system perspective. This 
description could equally apply to roles and functions identified for CNP. Recent 
experimental work supports the neurovisceral integration model, with greater heart-rate 
variability in older adults linked to weakening of functional connections between amygdala 
and ventrolateral prefrontal cortex (Sakaki et al., 2016). A similar disconnect was identified 
here regarding CNP signalling. This suggestion is further supported by recent work indicating 
an influence of central CNP on heart-rate regulation related to both NPR-B and NPR-C 
receptors (Buttgereit et al., 2016; Moghtadaei, Langille, Rafferty, Bogachev, & Rose, 2017). 
As all natriuretic peptides could be described as participating in homeostatic regulation of 
multiple peripheral and central systems, they present an intriguing target system in the 
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Appendix B: Supplemental Figures 
Endogenous measures of CNP activity after RAM learning 
CNP 
 
Figure A0.1: Boxplot and individual data points of CNP concentrations by behaviour 
group in occipital cortex. 
 
Figure A0.2: Boxplot and individual data points of CNP concentrations by behaviour 




Figure A0.3: Boxplot and individual data points of CNP concentrations by behaviour 
group in hypothalamus. 
NTproCNP 
 
Figure A0.4: Boxplot and individual data points of NTproCNP concentrations by 




Figure A0.5: Boxplot and individual data points of NTproCNP concentrations by 
behaviour group in medial prefrontal cortex. 
 
Figure A0.6: Boxplot and individual data points of NTproCNP concentrations by 





Figure A0.7: Boxplot and individual data points of NTproCNP:CNP ratio values by 
behaviour group in occipital cortex. 
 
Figure A0.8: Boxplot and individual data points of NTproCNP:CNP ratio values by 




Figure A0.9: Boxplot and individual data points of NTproCNP:CNP ratio values by 
behaviour group in hypothalamus. 
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Statistical Tests 
Table A0.1: Mean [±95%CI] CNP, NTproCNP and NTproCNP:CNP ratio for Control, Passive and Active Learning rats throughout six 
regions of interest, with accompanying statistical tests demonstrating generally null effects. Results reported in text are highlighted in gray. 
 Mean [±95% CI]   
CNP Control Passive Learning Active Learning ANOVA Robust ANOVA 
Occipital Cortex 235.10 [207.11, 263.09] 250.40 [221.04, 279.76] 250.82 [221.74, 279.90] F (2, 33) = 0.47, p = .630 F (2, 13.97) = 0.14, p = .876 
Medial Prefrontal Cortex 420.85 [355.66, 486.04] 425.57 [364.16, 486.98] 484.76, [397.06, 572.46] F (2, 31) = 1.19, p = .317 F (2, 9.83) = 0.55, p = .546 
Retrosplenial Cortex 414.22 [352.00, 476.44] 414.52 [340.49, 488.55] 451.97 [378.54, 525.40] F (2, 32) = 0.48, p = .625 F (2, 13.19) = 0.21, p = .816 
Dorsal Hippocampus 461.16 [394.63, 527.69] 534.51 [473.04, 595.98] 516.26 [429.06, 603.46] F (2, 33) = 1.34, p = .276 F (2, 13.99) = 1.89, p = .187 
Mammillary Bodies 1557.16 [1408.94, 1705.38] 1728.61 [1532.97, 1924.25] 1704.53 [1365.21, 339.32] F (2, 33) = 0.71, p = .497 F (2, 12.84) = 2.67, p = .107 
Hypothalamus 1066.88 [863.79, 1269.97] 1414.98 [1091.47, 1738.49] 1167.19 [782.31, 1552.07] F (2, 33) = 1.59, p = .220 F (2, 12.51) = 1.67, p = .228 
NTproCNP      
Occipital Cortex 979.39 [887.96, 1070.82] 979.94 [894.41, 1065.47] 967.98 [871.17, 1064.79] F (2, 33) = 0.03, p = .974 F (2, 13.08) = 0.00, p = .997 
Medial Prefrontal Cortex 1670.39 [1522.71, 1818.07] 1899.62 [1570.61, 2228.63] 1802.21 [1571.64, 2032.78] F (2, 31) = 1.09, p = .346 F (2, 9.07) = 1.10, p = .374 
Retrosplenial Cortex 1479.47 [1398.25, 1560.69] 1683.89 [1242.33, 2125.45] 1846.01 [1655.95, 2036.07] F (2, 32) = 2.36, p = .111 F (2, 11.49) = 5.20, p = .025 
Dorsal Hippocampus 2066.70 [1984.83, 2148.57] 1982.98 [1808.37, 2157.59] 2170.32 [2054.41, 2286.23] F (2, 33) = 2.45, p = .102 F (2, 13.35) = 1.72, p = .216 
Mammillary Bodies 5531.72 [4979.90, 6083.54] 6458.11 [5888.99, 7027.23] 6322.52 [5380.07, 7264.97] F (2, 33) = 2.40, p = .107 F (2, 13.96) = 4.08, p = .040 
Hypothalamus 4007.33 [3423.71, 4590.95] 5071.20 [4964.36, 5178.04] 4696.44 [4560.89, 4831.99] F (2, 33) = 1.28, p = .293 F (2, 10.83) = 1.15, p = .352 
NTproCNP:CNP Ratio      
Occipital Cortex 4.25 [3.80, 4.70] 4.01 [3.53, 4.49] 3.99 [3.31, 4.67] F (2, 33) = 0.35, p = .708 F (2, 13.81) = 0.53, p = .604 
Medial Prefrontal Cortex 4.14 [3.55, 4.73] 4.56 [3.89, 5.23] 3.83 [3.34, 4.32] F (2, 31) = 1.77, p = .187 F (2, 12.57) = 2.21, p = .150 
Retrosplenial Cortex 3.70 [3.30. 4.10] 4.24 [3.06, 5.42] 4.23 [3.74, 4.72] F (2, 32) = 0.87, p = .427 F (2, 13.21) = 1.17, p = .342 
Dorsal Hippocampus 4.68 [4.09. 5.27] 3.87 [3.28, 4.46] 4.46 [3.85, 5.07] F (2, 33) = 2.39, p = .107 F (2, 13.35) = 1.85, p = .196 
Mammillary Bodies 3.58 [3.25, 3.91] 3.80 [3.43, 4.17] 3.80 [3.49, 4.11] F (2, 33) = 0.67, p = .520 F (2, 13.94) = 0.36, p = .701 
Hypothalamus 3.93 [3.35, 4.51] 3.72 [3.22, 4.22] 4.26 [3.72, 4.80] F (2, 33) = 1.19, p = .316 F (2, 13.91) = 0.91, p = .426 
 
119 | P a g e  
 
Appendix C: Images of histology for cyclic Guanosine Monophosphate 
     
Figure C0.1: cGMP staining in cingulate gyrus following Saline (left) or CNP (right) 
     
Figure C0.2: cGMP staining in dorsal CA1 following Saline (left) or CNP (right) 
     
Figure C0.3: cGMP staining in dorsal CA3 following Saline (left) or CNP (right) 
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Figure C0.4: cGMP staining in dorsal dentate gyrus following Saline (left) or CNP (right) 
    
Figure C0.5: cGMP staining in hypothalamus following Saline (left) or CNP (right). Scale 
bar = 100µm, applies to all images. 
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